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Summary 
 
The present thesis was an investigation into developing a full picture of the Mef2-
interacting proteins in muscle differentiation of Drosophila melanogaster by using a 
mixture of wet-lab and computational approaches. Understanding how Mef2 is 
regulated is of general importance due to its pivotal role in cell differentiation 
programs. An overview of the transcription factor's interacting proteins contributes a 
significant part to understanding how Mef2 performs its functions. The proteins 
identified to interact with Mef2 at its endogenous level and in its normal pattern of 
expression and activity in the context of development were identified through a 
complex purification approach that can detect systematically protein complexes and 
networks. The method of choice was Tandem Affinity Purification (TAP), which 
offers a good recovery of the Mef2 used as bait as well as a low level of 
contaminants. The identified candidates were subjected to an analytical pipeline 
based on in silico database mining for expression and protein interactions 
information, as well as literature querying for existing functional information. Based 
on the derived information, it was possible to profile the type of proteins Mef2 
interacts with during development. New candidates confirmed to be associated with 
muscle differentiation were shown to be quite distant towards Mef2 when known 
functionality based on literature was used as a relatedness coefficient. One of the 
identified candidates in the screen, HDAC4, was used for further biological 
validation in vivo. HDAC4 was extracted during a screen of 11-13 h old embryos, the 
developmental time point where terminal muscle differentiation occurs. The 
biological assessment confirmed that the two proteins Mef2 and HDAC4 interact in 
the context of myogenesis as HDAC4 was found to repress the expression of a Mef2 
target protein in somatic muscle. The knowledge derived from this screen suggests 
that Mef2 does not only interact with muscle specific genes during myogenesis.  
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1.1 Overview 
The main question this project aims to answer is how the transcription factor Mef2 is 
regulated during muscle development. Mef2 is the central transcription factor that 
governs the development of muscle. Pinpointing how Mef2 is regulated by other 
proteins is crucial to our understanding of muscle differentiation. The project 
therefore focussed primarily on identifying the Mef2 interactome in its physiological 
context during development. The model organism selected for this study was 
Drosophila melanogaster because this organism expresses one Mef2 gene and can be 
cultured to obtain large sample quantities for protein purification. Additionally, any 
candidate proteins identified can be tested in vivo with relative ease due to the range 
of existing genetic tools. The main approach taken to identify proteins that interact 
with Mef2 during myogenesis has been to perform a large scale study of protein 
purification that maintains physical protein-protein interactions under physiological 
conditions, thereby isolating not only proteins directly interacting with Mef2 but also 
further indirectly bound components of Mef2 protein complexes.  
1.2 Drosophila life cycle 
The Drosophila life cycles consists of four distinct stages (Figure 1.1A): embryo, 
larva, pupa and adult (Bate and Martinez-Arias, 1993; Hartenstein, 1993). The 
Drosophila females deposit the fertilised egg on the surface of the food and the egg 
develops externally. This aspect makes Drosophila embryos easily accessible for 
collection in relatively high numbers. The embryonic development takes 24 hours 
and comprises 17 stages of development (Campos-Ortega and Hartenstein, 1997). 
The first and second instar stage each last for 24 hours and it takes another 48 hours 
for the third instar larvae to grow enough to pupate. Most of the larval tissues are 
histolysed during pupation and the adult fly is formed during the metamorphosis 
process. The pupal stages are distinguishable by changes in colour, which range from 
the white colour of the larva that becomes stationary for the prepupal stage to the 
brownish shade of the pupal case. At the end of metamorphosis the eyes develop 
pigmentation and become visible and the wings turn black. The pupal stage lasts for 
approximately 4 days and it ends with the adult emerging from the pupal case. It 
takes approximately 11 days from egg to adult fly at 25°C. 
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Figure 1.1: Drosophila life cycle and muscle development 
(A) Drosophila has four distinct stages: embryo, larva, pupa and adult. Larva and 
adult stages are motile and have distinct types of muscles. The larval muscles are 
formed in the first phase of myogenesis occuring during embryogenesis. The adult 
has a variety of muscles that are formed de novo from adult muscle precursors 
(AMPs) or through differentiation of larval muscles that do not get histolysed during 
metamorphosis. The adult muscles are formed in the second phase of development. 
(B) Anatomical muscle pattern in a larval body hemisegment. Muscles are named 
according to their location along the dorso-ventral axis (D = dorsal, L = lateral, V = 
ventral) and its orientation (A = acute, O = oblique, T = transverse, L = longitudinal). 
SBM = segment border muscle. Colour indicates muscle depth: green = external, red 
= intermediate, blue = internal. Adapted from (Weitkunat and Schnorrer, 2014). 
(C) Scheme of muscles in adult Drosophila. Thorax muscles: Indirect flight muscles, 
fibrillar type: Dorso-ventral muscles (DVMs, pink) located along the dorso-ventral 
axis, Dorso-longitudinal muscles (DLMs, red) located along the antero-posterior 
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axis. The direct flight muscles (DFMs, green) are located at the base of the wing 
insertion and are tubular. The Tergal depressor of the trochanter (TDT) or jump 
muscles are located from the dorsal thorax to the second leg of the thorax. 
Abdominal muscles located in the posterior part of the fly have a more uniform fate 
compared to the thoracic muscles, they present a stereotyped repetitive pattern in 
each segment. Abdominal muscles are smaller and more numerous than thoracic 
muscles. Representation taken from (Laurichesse and Soler, 2020).  
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Two of the Drosophila developmental stages, larva and adult, are mobile and present 
different types of muscles that are adapted to the respective lifestyle (Bothe and 
Baylies, 2016). The larval musculature has a repeated muscle pattern that consists of 
30 distinct muscles that are formed from individual muscle cells developed during 
embryonic myogenesis. Each muscle name is indicative of the position and the 
orientation of each muscle fibre which presents a distinctive size, shape, orientation, 
number of nuclei, tendon attachment and innervation (Figure 1.1B).  Adult 
musculature is formed either de novo from precursor muscle cells or through 
transdifferentiation of larval muscles. The adult muscles are multifibrillar and present 
distinct muscle structures (Figure 1.1C): fibrillar muscles (structure specific for the 
Indirect Flight Muscles (IFM)) and tubular muscles (structure specific for abdominal, 
leg, jump, and direct flight muscles (DFMs)) (Dobi et al., 2015). The present study 
only focused on muscles formed during embryogenesis. 
There are three main types of muscles in the embryo: somatic, cardiac and visceral. 
All these muscles are derived from the mesoderm that is formed in the ventral part of 
the embryo. The somatic musculature presents in each abdominal hemisegment of 
the embryo a pattern of thirty distinct muscle fibres with specific characteristics. 
Each muscle fibre is derived from a single founder cell (FC) that will fuse to fusion 
competent myoblasts (FCMs) to differentiate into a syncytial myotube. During the 
pupal stage, most of the larval muscles are destroyed and adult muscles are formed 
de novo from adult precursor muscle cells that are related to the embryonic precursor 
cells. The adult muscle progenitors (AMP) are formed in the embryo and are kept in 
an undifferentiated state until metamorphosis when they will give rise to abdominal 
and thoracic myofibers de novo (Dobi et al., 2015). There are two types of larval 
muscles that escape histolysis and together to AMP will be remodelled into adult 
fibres: abdominal intersegmental muscles are transformed into temporary dorsal 
oblique muscles and the three larval oblique muscles (LOMs) will form the dorso-
longitudinal muscles (DLMs) (Soler and Taylor, 2009). Both de novo and 
remodelled muscles present a common myoblast proliferation program to form 
segment-specific muscle fibres. 
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1.3 Embryonic development 
There are 17 stages of development during Drosophila embryogenesis (Campos-
Ortega and Hartenstein, 1997). Once fertilised, the egg's nucleus undergoes several 
rounds of divisions before the nuclei migrate to the periphery of the egg. This is 
followed by cellularisation, which consists of approximately 6000 cells and 
completes two to three hours after egg laying (AEL). After this, the embryo 
undergoes gastrulation, whereby the three germlayers are formed (Figure 1.2A): 
endoderm, ectoderm and mesoderm. The endoderm gives rise to the midgut derived 
from two independent regions that develop separately in the anterior and posterior 
part of the embryo and use cell migration to connect in late embryogenesis. The 
ectoderm is split into regions with different fates: the foregut and hindgut are formed 
from cells located anteriorly and posteriorly, adjacent to the respective endodermal 
primordia. The nervous system is derived from neuroblasts originating from the 
neuroectoderm located ventrally, while the lateral and dorsal ectoderm will form the 
epidermis and the tracheal system.  The dorsal side of the embryo will form the 
amnioserosa, while the ventral side of the embryo is occupied by the mesoderm. This 
germlayer differentiates into fat body and all muscles, including heart, pharyngeal 
muscles, visceral muscles, and somatic muscles (Leptin, 2004). Since this work 
focuses on muscle development in the Drosophila embryo, the subdivision of the 
mesoderm is explored further in more detail.    
1.4 Formation of the mesodermal germlayer and its subdivision 
The development of muscles from the mesodermal germ layer can be subdivided into 
three steps. First, the fate specification of mesodermal cells (see Figure 1.2A), 
second, the specification of a subset of mesodermal cells as muscle progenitors that 
express muscle-specific genes (see Figure 1.2B), and third, the muscle differentiation 
program by which muscle progenitors develop into individual muscles (see Figure 
1.2C) (reviewed in Dobi et al., 2015). The mesodermal cell fate is specified by the 
maternally deposited transcription factor Dorsal, which is located on the ventral side 
of the embryo as a result of embryonic dorso-ventral axis formation (Roth et al., 
1989; Rushlow et al., 1989). Two target genes of Dorsal, snail and twist, are then 
both required for the ventral cells to adopt the mesodermal identity (Boulay et al., 
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1987; Ip et al., 1992; Jiang et al., 1991; Kosman et al., 1991; Pan et al., 1991; Thisse 
et al., 1991). To achieve this, Snail represses genes expressed by the other 
germlayers, and Twist activates the late mesodermal genes. Near embryonic stage 8, 
all cells that express both of these invaginate as part of gastrulation and undergo two 
cell divisions while spreading along the ectodermal cells towards the dorsal side 
(Borkowski et al., 1995; Dobi et al., 2015; Leptin, 2004; Leptin and Grunewald, 
1990; Riechmann et al., 1997). Twist is a helix-loop-helix protein and activates 
transcription of both the homeobox gene tinman (tin)  and the MADS domain 
transcription factor mef2 (Taylor, 1995; Yin et al., 1997). All three proteins, Twist, 
Tinman and Mef2, are uniformly expressed in the early mesoderm and together they 
regulate its developmental transcriptional network (Ip et al., 1992; Lilly et al., 1995; 
Nguyen et al., 1994; Sandmann et al., 2006; Taylor et al., 1995; Yin et al., 1997). 
As the mesodermal cells spread across the ectoderm, they enter signalling domains 
established by the ectodermal cells (Figure 1.2B). Along the dorso-ventral axis, 
Decapentaplegic (Dpp) influences mesoderm subdivision, while along the anterior-
posterior axis it is influenced by Wingless (Wg) and Hedgehog (Hh) (Baylies et al., 
1998; Borkowski et al., 1995; Frasch, 1995; Halfon et al., 2000; Staehling-Hampton 
et al., 1994; Tixier et al., 2010). Dpp is located dorsally in the ectoderm, and 
promotes the dorsal mesodermal fate in those cells that migrate the furthest (Azpiazu 
and Frasch, 1993; Dobi et al., 2015; Frasch, 1995). By helping to maintain tinman 
expression, Dpp not only promotes the formation of the dorsal mesoderm but also 
inhibits ventrally expressed genes (Dobi et al., 2015; Staehling-Hampton et al., 
1994).  
Along the anterior-posterior axis, pair-rule genes act to subdivide the mesoderm once 
the germ band is extended. This includes even-skipped (eve) and sloppy-paired (slp). 
Areas subject to eve develop into the visceral musculature, fat body, gonadal 
mesoderm, mesodermal glial cells and some dorsal somatic muscles due to the 
influence of Dpp and Hh (Baylies et al., 1998; Tixier et al., 2010), while mesoderm 
in the slp domains receive only Wg and form the somatic musculature and the heart 
(Borkowski et al., 1995; Lee and Frasch, 2000; Riechmann et al., 1997; Tixier et al., 
2010). These parts of the mesoderm form the outer layer that maintains contact with 
the ectoderm, while the eve layer detaches from the ectoderm (Ruiz-Gómez, 1998).  
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Figure 1.2: Development of the mesoderm and somatic musculature 
(A) Drosophila gastrulation, the process by which the undifferentiated blastoderm 
separates into the three germlayers, ectoderm, mesoderm and endoderm. The 
amnioserosa, also called extraembryonic tissue, undergoes apoptosis and is fully 
reabsorbed by other cells during the late stages of embryogenesis. Adapted from 
(Leptin, 1999). 
(B) Genetic patterning of the mesoderm shortly after gastrulation. Ectodermal signals 
pattern the mesoderm. Dpp patterns the dorso-ventral axis, while Wg and Slp pattern 
the antero-posterior axis. Myogenic competence domains are determined by Twi, 
which has a high expression in Slp sections and low expression in Wg sections. 
Somatic mesoderm forms in the antero-ventral part of each segment. Cardiac 
precursors form from the most dorsal portions of high-Twi domains of each segment. 
In the posterior part of each segment, in low-Twi domains, visceral muscles and fat 
body are specified. See main text for detail. Adapted from (Tixier et al., 2010). 
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(C) Embryonic development of somatic musculature by the example of four ventral-
longitudinal muscles (VL1-4, blue) and three lateral transverse muscles (LT1-3, 
green). Approximate timing and embryonic developmental stage is given below each 
diagram. The process can be roughly subdivided into five stages, which are 
explained in section 1.5.1. Adopted from (Weitkunat and Schnorrer, 2014). 
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By this point, the subdivision of the mesoderm also becomes apparent in the 
expression of Twist. The external mesodermal layer in contact with the ectoderm 
expresses high amounts of Twist while those cells that detached express low levels 
(Bate et al., 1993; Borkowski et al., 1995; Tixier et al., 2010). This subdivision of 
Twist expression differs between the segments depending on the specific 
mesodermal tissues that develop in each of them (Baylies and Bate, 1996; Castanon 
and Baylies, 2002; Tixier et al., 2010). 
1.5 The larval musculature  
1.5.1 The body wall musculature 
At the end of embryogenesis, the somatic muscles have developed a complex pattern 
of syncytial striated muscles located under the surface of the ectoderm (Bate, 1990; 
Bate et al., 1993). There are in total 30 multinucleated fibres per abdominal segment 
(Bate, 1990). Each fibre is formed from a single founder cell (FC), to which several 
fusion-competent myoblasts (FCMs) fuse during myogenesis (Abmayr and Pavlath, 
2012). 
Muscle development begins in parallel to the onset of germ band retraction 
(Schnorrer and Dickson, 2004). The first process is the fusion of doublets or triplets 
of cells in the ventral mesoderm. These small group are the future syncytia of the 
ventral muscles, but such syncytia also form dorsally and laterally by the end of germ 
band retraction. The exact positions are defined by the location of the precursors, 
which act as a sort of blueprint for the muscle pattern (Bate and Rushton, 1993; 
Campos-Ortega and Hartenstein, 1997). Each precursor founder cell fuses with 
fusion competent myoblasts while growing in size starting from stage 12. 
Simultaneously, the syncytium expresses structural proteins and begins forming 
attachment sites with the ectoderm. By the end of embryonic stage 15, the 
characteristic points where muscles insert on the ectoderm have formed, marking the 
finalisation of the muscle pattern (Figure 1.2C). Each fibre is formed by a founder 
cell (FC) and fusion-competent myoblasts (FCM), whereby each FC seeds a specific 
type of muscle (Baylies et al., 1998; Chen and Olson, 2004; Weitkunat and 
Schnorrer, 2014). 
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FCs are selected out of clusters of cells within domains of high Twist expression that 
express lethal of scute (l’sc). L'sc expression is gradually resticted by Notch-
mediated lateral inhibition, specifying a single remaining cell expressing l’sc as an 
FC (Carmena et al., 1995; Dobi et al., 2015), the remaining cells becoming FCMs 
(Baylies et al., 1998; Carmena et al., 1998; Chen and Olson, 2004). FCs then 
undergo asymmetric cell division, giving rise to either two daughter FCs, or one FC 
and one adult muscle progenitor (AMP). Before developing into FCs, muscle 
progenitor cells express different combinations of identity genes, which are not 
necessarily maintained during division into two daughter cells. As a result, when FCs 
are specified at the onset of germ band shortening, each of them expresses a specific 
combination of identity genes (Dobi et al., 2015; Tixier et al., 2010). These genes are 
characteristic of individual muscles and determine muscle differentiation of specific 
myofibers with different sizes, shapes, attachment sites and number of nuclei 
(Abmayr and Pavlath, 2012; Baylies et al., 1998; Chen and Olson, 2004). During the 
fusion process, FCMs are recruited to the characteristic pattern of identity genes of 
the founder cells they fuse with. Therefore, the syncytial muscle precursors and, 
later, the muscles themselves can be identified by their pattern of identity gene 
expression. Although each founder has a characteristic identity gene profile, the 
process of fusion with FCMs is similar (Figure 1.2C). The process can be described 
as 1) cell attraction of the FCM by the FC or in later fusion events by a syncytial 
myotube, 2) adhesion of FC or syncytial myotube with the FCM mediated by cell-
surface molecules, 3) alignment and fusion, which involves formation of a plaque 
through actin polymerisation and vesicle recruitment from which FCM invasive 
structures will protrude into the FC/myotube, 4) absorption of the FCM into the 
myotube (Abmayr and Pavlath, 2012; Doberstein et al., 1997; Dobi et al., 2015). 
1.5.2 The visceral musculature 
Visceral muscles surround the larval midgut and are involved in the peristaltic 
movement of digestion (Campos-Ortega and Hartenstein, 1997). Visceral muscles 
comprise two types: binucleated circular muscle fibres that derive from the trunk 
visceral mesoderm and multinucleated longitudinal muscles coming from the caudal 
visceral mesoderm. The two types form a web around the midgut and their correct 
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development is required for proper separation of the gut into four chambers (Klapper 
et al., 2001; Rudolf et al., 2014; San Martin and Bate, 2001; Schröter et al., 2006).  
The visceral mesoderm is derived from cells expressing low levels of twist that also 
express the transcription factor Bagpipe (Bap) that is activated by Tin. Mutations in 
the two genes result in disruption of the visceral mesoderm. Visceral mesoderm starts 
by segregation of clusters of cells expressing bap and binou (bin) in the dorsal 
mesoderm (Azpiazu and Frasch, 1993; Zaffran et al., 2001). These two factors 
cooperate to form rows of visceral cells on each side of the egg yolk. This process is 
followed by visceral myoblasts fusion, a similar process of fusion of FCs with FCMs 
as for somatic musculature. The circular muscles form binucleated syncitia 
interconnected with multiple cytoplasmic bridges and with the ability to stretch in 
order to enclose the gut along the dorso-ventral axis. The longitudinal FC myoblasts 
originate from the caudal visceral mesoderm and migrate anteriorly along the trunk 
visceral mesoderm and most probably fuse with FCMs after the circular muscles 
fusion occurs (Aghajanian et al., 2016; Klapper et al., 2001; Martin et al., 2001; 
Rudolf et al., 2014; Schröter et al., 2006). This myoblast fusion process is 
independent from contact with adjacent tissue, but elongation processes from late 
visceral myogenesis are dependent on contact with the endoderm (Aghajanian et al., 
2016). 
During its development, the midgut forms three constrictions which require the 
correct differentiation of the visceral mesoderm (Azpiazu and Frasch, 1993). Bap is 
required for visceral mesoderm development but is not maintained in visceral muscle 
differentiation. Tin activates Mef2 and β3-tubulin (Cripps et al., 1998) in the 
developing visceral mesoderm where Mef2 is the central component of the 
differentiation process (Lilly et al., 1995). In mutants of Mef2 the midgut forms and 
tin and bap are expressed at normal levels (Lilly et al., 1995), but the gut fails to 
contract and the non-contracting midgut musculature expresses very little myosin 
(Bour et al., 1995). However, β3-tubulin is not a target of Mef2 in the visceral 
musculature (Damm et al., 1998), its expression being activated by the cooperation 
and partial redundancy of Bin and Bap (Zaffran and Frasch, 2002). 
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1.5.3 The heart 
The Drosophila heart, also called the dorsal vessel, is a dorsomedial muscular tube 
that pumps haemolymph throughout the body in a back to front direction. It consists 
of two types of cells: cardioblasts and pericardial cells (Cripps and Olson, 2002; 
Zaffran and Frasch, 2002). The cardioblasts express muscle proteins and form the 
contractile heart tube. They are arranged in two rows at the dorsal midline and are 
surrounded by four rows of pericardial cells. No muscle proteins are expressed in the 
pericardial cells (Ward and Skeath, 2000). The different heart cell types derive from 
the dorsal mesodermal cells expressing high amounts of Twist. As embryogenesis 
progresses, heart precursors migrate from each side of the embryo to the dorsal 
midline.  
Around stage 10, Tin is activated early by Dpp and restricted to the dorsal 
mesoderm. During stage 11, the mesoderm displays alternating domains of high and 
low Twist expression. The low Twist cells will form the precursors of the circular 
visceral muscles, while the high Twist domains will generate the precursors for the 
heart and some dorsal muscles (Figure 1.2B). The heart progenitors further divide 
into two rows of bilaterally symmetrical cells. One row will form the cardioblasts 
and one row will form the pericardial cells (Bodmer and Frasch, 2010). Tin is 
involved in specification of both types of heart cells (Bodmer and Frasch, 2010; 
Reim and Frasch, 2010). Tin activates Mef2 which is involved in the differentiation 
of cardioblasts. Mef2 activates expression of pan-muscular structural genes in 
cardioblasts such as Act57B, Mhc, TnI, Prm. β3-tubulin, which seems to be a cardiac 
specific gene (Bryantsev and Cripps, 2009), is expressed in differentiated 
cardioblasts, however it is not a direct Mef2 target in these cells, but rather of Tin 
(Kremser et al. 1999; Damm et al, 1998). Complex networks of genes are involved in 
the specification of the various heart cell populations. At the dorsal midline 
differential gene expressions allow to distinguish the cardioblasts from pericardial 
cells. The genes characteristically expressed in cardioblasts during development are 
mef2 (Lilly et al. 1995; Taylor et al. 1995), myosin, β3-tubulin (Damm et al., 1998) 
and tin (Azpiazu and Frasch, 1993). Genes involved in the functioning of the mature 
cardiac tube have distinct expression patterns: some are expressed throughout the 
tube and most often their expression is Mef2-dependent, others are restricted to Tin-
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expressing cells and they are direct targets of Tin. The ostium cells, which form the 
inflow valves at the end of the heart, present a distinct characteristic in that Tin 
initially induces expression of both Svp and Mef2 that will activate specific ostial 
genes, but the expression of the two TFs becomes Tin-independent (Bryantsev and 
Cripps, 2009). 
1.6 Muscle as a model system for cell differentiation programs 
Cell development involves patterns of gene expression which are regulated spatio-
temporally via the activity of transcription factors (TFs) and cell signalling cascades. 
Cis-regulatory modules (CRMs) or enhancer elements are transcriptional regulatory 
regions where multiple transcription factors bind DNA in order to orchestrate 
activation of various batteries of target genes (Bonn and Furlong, 2008).  CRMs can 
be simultaneously bound by multiple TFs in a dynamic manner, and different 
concentrations and combinatorial interactions between co-occupying TFs can 
radically change the impact of an enhancer on the transcription of its downstream 
gene(s). Furthermore, even for two TFs that elicit similar phenotypes in loss-of-
function mutant embryos and thus appear to perform similar functions, the molecular 
relationship between these two proteins can result in a diversity of transcriptional 
responses within the same cell depending on the cell's external environment. Many 
developmental processes in Drosophila embryos are governed by hierarchical 
networks of TFs that integrate at transcriptional level signals from environmental 
stimuli or intercellular interactions (Cunha et al., 2010). The embryonic 
developmental processes can be classified as either differentiation processes that 
form dozens of tissue types or dramatic temporal transitions as found in gastrulation 
or segmentation (Zhou et al., 2019). 
The segmentation network of the Drosophila embryo that defines its antero-posterior 
axis is characterised by the interaction of transcriptional activators with broad 
expression profile with the transcriptional repressor that have restricted activity 
domains. For example, the second stripe CRM of eve is activated under the influence 
of Bicoid and Hunchback, two maternal factors expressed in the anterior part of the 
embryos and the expression of the same enhancer elements is repressed by the TFs 
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Giant and Krüppel that are expressed only in specific regions (Bonn and Furlong, 
2008; Small et al., 1991; Stanojevic et al., 1991).  
The dorso-ventral axis is defined by a concentration gradient of the TF Dorsal which 
is highly expressed in the ventral region and at lower levels in the lateral and dorsal 
domains of the embryo (Bonn and Furlong, 2008). The dorso-ventral gradient of 
Dorsal expression occurs under the transmembrane receptor Toll signalling which is 
active ventrally and is able to transport the Dorsal TF from the cytoplasm in the 
nucleus. In the dorsal region Dorsal remains excluded from the nucleus since Toll is 
inactive in this region (Roth et al., 1989; Rushlow et al., 1989). Dorsal target genes 
have different affinity in their binding site for their transcriptional activation. Snail 
and twist, two of its ventral targets, require high levels of Dorsal since they have low 
affinity binding sites and they specify the cells of the future mesoderm. Genes that 
specify the ectoderm and extend dorsally have higher affinity binding sites for 
Dorsal. While a gene like rho expressed in the neuroectoderm still requires low 
levels of Dorsal to activate its expression (Ip et al., 1992), a completely dorsally 
expressed gene like zen is only expressed in areas of the embryo where Dorsal is not 
able to repress its transcriptional activation (Cai et al., 1996). Dorsal can repress 
transcription by interacting with other TFs (Dubnicoff et al., 1997). 
The mesoderm network which regulates the subdivision of the mesoderm into 
primordia of different muscle types is a multi-layered process, compared to the D-V 
process which occurs in a single epidermal layer. This network could be described as 
a TF cascade which is started by Twist which regulates the expression of many TFs 
such as Tinman and Mef2. Tinman further regulates a subnetwork that will define the 
dorsal mesoderm, while Mef2 activates the differentiation network for somatic 
muscle. The CRMs regulated by the TFs in this network integrate inputs from TFs 
and signalling cascades (Bonn and Furlong, 2008). Lameduck is a transcription 
factor found downstream of Twist, Tin and Mef2 and is expressed in precursors of 
the somatic muscle and the visceral muscle.  Enhancers bound by Lmd are cobound 
by the three others in a combinatorial manner to activate muscle precursor genes. 
Genes expressed both in FCMs and FCs, are co-bound by Lmd, Tin and Twi, while 
target genes exclusive to FCMs are co-bound by Lmd, Tin and Mef2. All four TFs' 
target genes are expressed predominantly in both myoblast types. These genes have a 
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diversity of expression pattern resulting from the diversity of transcriptional 
activators and their binding behaviour and no one interaction is sufficient to account 
for all features of FCM gene expression.  Enhancers of FCM-exclusive genes and 
genes expressed in both FCMs and FCs that are bound by Lmd and the other TFs 
show chromatin modification associated with active enhancers, specifically 
H3K4me1, H3K27ac, and H3K79me3 (Busser et al., 2012). Most of Lmd-bound 
CRMs are co-bound by Mef2 and the responses generated by these two transcription 
factors can be varied within the same cell type (Cunha et al., 2010). 
Myogenesis is a process of cell differentiation that consists of a stage of progenitor 
cells proliferation, followed by activation of muscle-specific genes that lead to 
differentiation of the myoblasts. These will later fuse into myotubes. In embryonic 
myogenesis the muscle fibres are derived from mesodermal structures that form the 
template for the subsequent muscle tissue. Myogenesis has represented a paradigm 
for cellular differentiation processes as it has offered insights into basic cellular 
mechanisms such as signalling, transcriptional and post-transcriptional control of cell 
fate, cell fusion and cell differentiation (Gunage et al., 2017). 
Many properties of the muscle differentiation process are shared between Drosophila 
and higher organisms. Drosophila is the model organism that has offered important 
advances in understanding the way myoblasts fuse, identification of muscle-specific 
promoters, the role of myonuclear positioning in myofibrialar function and 
mechanisms that lead to muscle formation. Drosophila larval muscles are formed by 
a single syncytial fiber, while adult muscles have multiple fibers. Vertebrates only 
contain multiple syncytial muscles (Bentzinger et al., 2012; Chaturvedi et al., 2017). 
Muscle tissue is derived from the mesoderm, a germ layer that together with the 
endoderm and the ectoderm give rise to all the tissues that form an organism. 
Myogenesis can be divided into several distinct phases: cells that will generate the 
muscle precursors start from mesodermal structures that under positive and negative 
external signalling activate a battery of transcription factors and chromatin 
remodelling factors. These factors translate this signalling into gene expression and 
microRNA programs that give myogenic identity to the muscle progenitor cells 
(Bentzinger et al., 2012). The mesoderm starts to form segments along the anterior-
posterior (A/P) and dorsal-ventral (D/V) axes and populations of muscle progenitor 
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cells are formed at specific locations. Within the muscle progenitor cells population 
individual cells become singled out compared to their neighbours and will form 
founder cells. The neighbours will become fusion-competent myoblasts that will fuse 
with a single founder cell to form a muscle fibre. Founder cells have a very important 
role in establishing the particular characteristics of different muscles fibres by 
activating specific muscle identity gene products. By fusing with competent 
myoblasts, mature syncytial myotubes are formed that will eventually attach to the 
epidermis. In more complex myotubes, primary fibres are formed that will fuse to 
secondary fibres while the muscle grows (Lemke and Schnorrer, 2017). 
Muscle formation is influenced by several signalling cascades, including Wnt, TGFβ 
and  Hedgehog family members (Baylies et al, 1998). Transcription factors like 
Twist (Baylies and Bate, 1996; Castanon and Baylies, 2002) and Mef2  (Bour et al., 
1995; Lilly et al., 1995; Ranganayakulu et al., 1995) are the key activators of muscle 
differentiation and of gene-specific programs. Their roles have been conserved from 
Drosophila to vertebrates. Mef2 promotes muscle differentiation and is present 
throughout the muscle differentiation process from early mesoderm to later stages 
where it remains detectable in all muscle types (somatic, visceral, pharyngeal and the 
heart musculature). Mef2 is activated early in development by Twist (Taylor et al. 
1995), which binds directly to its regulatory sequence (Cripps et al., 1998). 
The mef2 gene is first detected in the Drosophila embryo in the ventral furrow cells 
during gastrulation. Its expression is restricted to the mesoderm during germ-band 
extension and its expression matches the pattern of the twi gene.  Around stage 10, 
the mesoderm separates into two different cell layers in order to form the primordia 
of the visceral muscle and heart precursor cells in the dorsal mesoderm and the 
somatic musculture in the ventral mesoderm. The mef2 expression is present in all 
these precursors and its expression is maintained in later stages of embryonic 
development (Lilly et al., 1994; Nguyen et al., 1994). 
The Mef2 protein is first detected at stage 11 during germband expansion throughout 
the mesoderm. During the germband expansion process and in later stages of 
embryonic development, the Mef2 protein is observable in the visceral muscles, 
cardiac cells and in segmentally repeating clusters of the forming somatic 
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musculature. The localisation of the Mef2 protein is restricted to the nucleus of 
muscle progenitor cells and their differentiated derivatives (Bour et al., 1995). 
Mef2 protein in turn binds to the consensus regulatory sequence YTAWWWWTAR 
(Andres et al., 1995) and activates a large series of target genes with broad 
expression profiles (Elgar et al., 2008; Junion et al., 2005; Sandmann et al., 2006). 
Some of the first genes that were identified as direct target genes were Tropomyosin 
(Lin et al, 1996), β3-tubulin (Damm et al, 1998) and Paramyosin (Arredondo et al, 
2001), which are proteins involved in muscle structure, while Actin57B (Kelly et al, 
2001) is the major myofibrillar actin expressed in muscle during embryogenesis. 
Large-scale studies pinpointing Mef2 binding sites across the genome have shown 
that Mef2 can activate genes important in muscle differentiation both directly and 
indirectly (Elgar et al., 2008; Junion et al., 2005; Sandmann et al., 2006; Taylor and 
Hughes, 2017). 
The precursors of the adult muscles (AMPs) begin to form during the early stages of 
Drosophila embryonic development and commit to the muscle fate. Unlike other 
myoblasts around them which differentiate into larval muscles, they retain an 
undifferentiated state (Bate et al, 1991). It has been suggested that these cells activate 
a specific lineage program to maintain their identity, and simultaneously prevent 
their peer myoblasts from acquiring the same fate (Ciglar et al., 2014). 
Progenitor muscle cells begin expressing Mef2 long before they begin expressing 
early target genes and thereby enter the process of differentiating into muscles. One 
proposed explanation for this is that regulatory factors repress Mef2 and inhibit its 
activity. In vertebrates, two repressors of Mef2 are known among other candidates: 
Twist and class IIa Histone Deacetylases (HDACs). However, Twist in Drosophila is 
required for Mef2 expression in the mesoderm, which would contradict a 
simultaneous role as a repressor (Cripps et al., 1998; Taylor et al., 1995). 
Mef2 is expressed throughout the myogenesis process that generates muscles from 
the respective mesodermal cells both in muscle precursor cells and adult myocytes. 
Muscle development depends on Mef2 expression and a lack of this transcription 
factor results in failure of myogenesis (Bour et al., 1995). Both early and late muscle-
specific target genes are activated by Mef2 (Elgar et al., 2008; Junion et al., 2005; 
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Sandmann et al., 2006; Taylor and Hughes, 2017). In mef2 mutants, genes 
characteristic for founder cell are expressed, therefore FCs are formed and specified 
(Bour et al., 1995; Lilly et al., 1995; Ranganayakulu et al., 1995), but later stages of 
muscle development are impaired. Mef2 is required both for fusion and for activation 
of the genes involved in the differentiation process. 
1.7 Mef2 in Drosophila 
Early in Mef2 research, the role of the gene in muscle development at Drosophila 
embryonic level has been used to place this gene at the centre of muscle 
differentiation. Later work in Drosophila has established that Mef2 is involved in 
activation of transcription in other tissues (Blanchard et al., 2010; Clark et al., 2013). 
Mef2 is an important hub of a regulatory network that consists of intricate feed 
forward and feedback loops that integrate all types of regulation of a gene and its 
products. Regulation of Mef2 in Drosophila involves mechanisms that regulate its 
activity at transcriptional, translational, and post-transcriptional levels. 
To understand how Mef2 performs its function most of the studies looked at the 
activation of its target genes and how their transcription is activated. A large scale 
genomic study correlated the enhancer regions bound by Mef2 during embryonic 
muscle development with the expression profiles of the genes activated by these 
enhancers. This study identified at least 211 direct targets of Mef2 with three 
different temporal profiles: (1) enhancers bound continuously bound by Mef2 
(representing approximately half of the analysed enhancers), (2) enhancers bound 
early but not late by Mef2 (representing 21% of the enhancers), (3) enhancers bound 
late but not early (representing 32% of the enhancers). The expression of the target 
genes coincided with the incidence of a Mef2 binding event of their respective 
enhancer (Sandmann et al., 2006). Moreover, a study using an allelic series of Mef2 
mutants to profile gene expression of its targets has shown that the correct timing of 
their expression is correlated with the level of Mef2 protein. Target genes expressed 
earlier in development were shown to require lower levels of Mef2 proteins for their 
activation compared to genes expressed later in development. Overexpression of 
Mef2 at earlier time points in the muscle differentiation program coincided with an 
earlier onset of expression of late-expressing genes (Elgar et al., 2008). 
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The three groups of genes with different temporal profiles show differences in terms 
of the number of Mef2 regulatory sites present in their enhancers. Groups (1) and (3) 
showed enrichment of one or several Mef2 sites per fragment, while early-bound 
genes contain as many Mef2 sites as the rest of the genome (Sandmann et al., 2006). 
Certain genes have been shown to require the co-binding of tissue-specific 
transcription factors together with Mef2 at their CRM in order to fine-tune the timing 
of expression and levels of their genes. For example, the Act57B gene locus is part of 
the group of enhancers that are bound by Mef2. However, Act57B is expressed in the 
embryo as early as Stage 11 and its expression has been shown to require the 
presence of Mef2 for its activation at this stage of development (Elgar et al., 2008). 
Artificially increasing Mef2 levels at this stage was not sufficient to induce 
premature activation of this locus and only through the additive input of Mef2 and 
Lmd the Act57B expression was shown to be induced in stage 11 (Cunha et al., 
2010). Therefore, the way Mef2 is able to find specific DNA sites in order to elicit 
transcription of certain genes earlier in development must be through cooperation 
with other cofactors and TFs.  
The activation of Mef2 target genes seems to require a very fine balancing of Mef2 
levels, since mis-expression of Mef2 leads to defective phenotypes in the tissue it is 
active in. Loss-of-function mutants of mef2 do not form differentiated somatic 
muscle, despite the fact that muscle progenitors are able to develop, the fusion 
process and any further differentiation process fails (Bour et al., 1995; Lilly et al., 
1995; Taylor, 1995). When Mef2 is overexpressed in the mesoderm, the 
differentiation process of the heart, the somatic and visceral muscles is disrupted 
(Gunthorpe et al., 1999).  In the pacemaker neurons, reduced Mef2 expression causes 
loss of circadian rhythms due to dampening of the molecular rhythms, while 
overexpression of Mef2 desynchronises the pacemaker neurons resulting in longer 
and complex locomotor behaviours in adults flies (Blanchard et al., 2010). Based on 
the phenotypic responses observed in various tissues where Mef2 was mis-expressed, 
a particular aspect becomes apparent: there is a certain range of Mef2 levels that are 
compatible with normal progression of the molecular processes Mef2 is involved in. 
The regulation of Mef2 levels in Drosophila can manifest at transcriptional, 
translational and post-transcriptional level. 
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The regulation of Mef2 at gene level displays three types of activators: 1) Activators 
that turn on mef2 transcription and co-bind enhancers together with Mef2 to activate 
target genes (for example Twi, Lmd) 2) Activators that are a direct target of Mef2 
and in a feedback loop bind mef2 enhancers to increase Mef2 production (for 
instance CF2, Vg) 3) Mef2 acts as its own transcriptional activator. However, the 
regulation of Mef2 occurs at mRNA and protein levels as well. 
In Drosophila, Mef2 is part of a functional network with various proteins that 
modulate its activity at different molecular levels, often forming feed-forward and 
feedback looks. These network partners can be divided in 4 categories:  
1) Autoregulation of Mef2 of its own enhancer in late muscle differentiation.  
 
Mef2 protein is able to bind to a specific enhancer of the mef2 gene that is active in 
differentiated muscle cells (Figure 1.3A). The enhancer is active in all embryonic 
muscle tissues, with detection of expression at late stage 12 in longitudinal visceral 
muscle precursors, starting with stage 14 in myoblasts of somatic muscle. By stage 
16 this Mef2 enhancer showed strong activity in the visceral and somatic muscle, but 
not in the dorsal vessel. In third instar larvae the expression is maintained in the other 
muscles and also detectable in the dorsal vessel. The onset of activity of this 
enhancer resembles the mechanism of late differentiation of all the three muscle 
types: first the visceral muscles start terminal differentiation, followed by the somatic 
muscle cells and the dorsal vessel is the last to start differentiation.  The activity of 
this enhancer is only detectable in muscle cells, though it can be ectopically activated 
by transgenically expressed Mef2. In absence of the Mef2 site, overexpressed Mef2 
was unable to drive activation of the autoregulatory enhancer (Cripps et al., 2004). 
2) Mef2 levels can be modulated by the products of its own target genes. 
 
The Drosophila Chorion factor 2 (CF2) is a protein that collaborates with Mef2 to 
activate a number of structural muscle genes (e.g, Actin57B, TnI, mhc) (Gajewski 
and Schulz, 2010; Tanaka et al., 2008), while its own expression is dependent on 
Mef2 activation (Figure 1.3A). CF2 is detected in all types of muscle lineages in the 
embryo and its mRNA is not detectable in a null mutant of mef2 (Bagni et al., 2002), 
thus the CF2 gene expression is directly or indirectly regulated by Mef2. The model 
proposed for the interaction between the two proteins is the following: at stage 11 
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Figure 1.3: Modes of regulation of Mef2 activity 
(A) Regulation of Mef2 expression in muscle. Twist (Twi) initiates expression of 
Mef2. Later, both Twi and Lameduck (Lmd) are able to bind upstream of Mef2 and 
drive its expression. Mef2 target genes include Chorion factor 2 (CF2), which feeds 
back positively by binding enhancers of the mef2 gene to stabilise Mef2 levels. 
Together, Mef2 and CF2 activate target genes including structural muscle proteins. 
Mef2 also forms an autoregulatory feedback loop by binding its own enhancer. 
Another target, microRNA 92b, feeds back negatively onto Mef2 levels by 
repressing translation of mef2 mRNA. 
(B) Examples of interactions of Mef2 with other transcription factors during 
Drosophila development. Upper diagrams: Mef2 physically interacts with Twi, 
Vestigial (Vg) and Scalloped (Sd) on the vestigial adult muscle enhancer (vg
AME
). 
The interaction with Twi represses vg expression, while interaction with Vg and Sd 
synergistically enhances vg expression. Bottom diagram: Mef2 and Lmd co-bind a 
multitude of enhancers throughout the genome, leading to diverse target gene 
expression profiles within the same cell context. 
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(C) Responses of Mef2 activity to external stimuli. Upper diagram: In neurons, Mef2 
physically interacts with p300 and modulates specific target genes with effects on 
action potential firing depending on synaptic input activity. Middle diagram: Mef2 is 
the nuclear effector of salt-inducible kinase 3 (SIK3) for maintaining K
+
 and water 
homeostasis in glial cells. Histone deacetylase 4 (HDAC4) can translocate to the 
nucleus when it is unphosphorylated, and repress Mef2 protein from activating 
transcription. Bottom diagram: In fat body cells, infection signalling triggers 
dephosphorylation of Mef2, which can then bind TATA binding protein (TBP). This 
interaction leads to a switch in target genes. 
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mef2 transcription is activated by Twi and Mef2 is able to maintain its transcription 
in a Twi independent manner by binding to its own enhancer. At stage 12 the Mef2 
protein activates CF2 transcription, the protein in combination with Mef2 being able 
to activate expression of structural proteins and to maintain high levels of Mef2 in a 
CF2 concentration dependent manner. When CF2 was overexpressed in the muscle 
lineages, higher levels of Mef2 were detected, while when CF2 was knocked-down 
the Mef2 levels were reduced compared to the wild-type control, indicating a 
positive feedback loop (Arredondo et al., 2017).  
Another product of a Mef2 target gene that is able to regulate Mef2 activity is miR-
92b, a negative regulator of Mef2. Mef2 is able to activate expression of miR-92b by 
directly binding to its enhancers in the heart, somatic and visceral muscles, which 
present three Mef2-binding sites. Mef2 mRNA contains two targeting sites for miR-
92b in its 3’ UTR region which allow repression of the Mef2 translation process. 
When miR-92b is overexpressed, Mef2 mRNA and protein levels are decreased and 
defects in muscle attachment are observed. When miR-92b is deleted, Mef2 levels 
are elevated, leading to abnormalities in muscle development. In this case the 
interaction between miR-92b and Mef2 forms a negative feedback loop that is able to 
stabilise Mef2 levels in order to ensure the muscle development process can continue 
under normal conditions (Chen et al., 2012).  
3) Mef2 transcriptional activators that require collaboration with Mef2 protein to 
activate target genes.  
 
One protein in this category is Twist, the bHLH transcription factor that induces 
mesodermal cells down the path of myogenesis. Mef2 gene expression is only 
initiated via activation of Twist binding its enhancer region in the early stages of 
embryonic development. A significant part of CRMs bound by the Mef2 protein in 
early embryonic development (totalling 42%) is co-bound by Twist. Twist and Mef2 
have partial overlap in the timing of their expression during embryonic development 
(Adryan and Teichmann, 2010; Lilly et al., 1994) and the co-bound CRMs regulate 
genes involved in early mesoderm development. In contrast, Mef2 alone selectively 
drives expression of genes involved in aspects of later differentiation such as muscle 
attachment and sarcomere structure (Sandmann et al., 2006). 
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Twist protein is able to physically bind Mef2 protein via its C-terminal part and 
repress its activity (Figure 1.3B). The effects of this interaction can result in 
repression of the vg
AME
 enhancer, an element that is repressed in swarming myoblasts 
surrounding developing fibres in Drosophila pupae and is a direct target of Mef2 
during IFM differentiation. The vg
AME
 enhancer was not found among the embryonic 
CRMs bound by Mef2 during myogenesis.  Twist alone is not able to repress the 
expression of this enhancer in absence of Mef2 in S2 cells (Bernard et al., 2009).  
Lmd (Figure 1.3B, lower diagram) is a tissue-specific modulator of Mef2 activity in 
Drosophila embryogenesis at stages 10-13. Lmd binds a locus upstream of the Mef2 
gene and regulates its expression. The Mef2 protein co-binds 68.8% of the Lmd 
enhancers with a similar temporal profile and these direct target genes are also 
regulated by Mef2. The transcriptional behaviour of these genes is divergent to the 
regulatory effects of Lmd and Mef2, showing either an additive, cooperative or 
antagonistic response. The genes were separated into three clusters based on their 
changes in expression in lmd and mef2 loss-of-function mutants compared to 
wildtype controls. Cluster I contains genes that are downregulated in both lmd and 
mef2 mutants and consists mainly of structural muscle proteins. Cluster II genes have 
differential responses in the two mutants: upregulated in lmd mutants, but unchanged 
or slightly altered expression in mef2 mutants. Cluster III genes are decreased in 
expression in lmd mutants and have increased expression in mef2 mutants. The two 
TFs were overexpressed ectopically in the ectoderm in order to test by colorimetric 
fluorescent in situ hybridisation the transcriptional response of the shared target 
genes. When expressed ectopically in the ectodermal stripes, candidate genes from 
the three clusters had varied responses: cluster I genes were able to be activated 
ectopically by Mef2 alone and/or by co-expressing the two TF; cluster II genes were 
activated ectopically by overexpressing Lmd alone and/or by Lmd and Mef2 
together; cluster III genes were expressed in the ectoderm under Mef2 
overexpression, but their levels were attenuated when Lmd was co-expressed with 
Mef2, showing that the two TFs have opposing inputs on these target genes. 
Integrating this enhancer binding information with the transcriptional responses of 
target genes it becomes clear that there is flexibility in the way the two TFs activate 
transcription, inducing synergistic, additive or repressive effects (Cunha et al., 2010). 
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Interestingly, the lmd gene is directly regulated by Twi and its expression is 
dependent on Twi binding its enhancer (Bonn et al., 2012; Furlong et al., 2001; 
Zinzen et al., 2009). Enhancers found in somatic FCMs were bound by combinations 
of Twi, Lmd and Mef2, suggesting that Twi is able to start a series of feedforward 
loops in FCMs that are able to induce gene regulation by Mef2 and Lmd in these 
cells. These feedforward loops are able to offer spatiotemporal specificity to gene 
expression patterns (Busser et al., 2012). 
Scalloped (Sd) and vestigial (Vg) are two myogenic factors that physically interact 
with Mef2 both during embryonic muscle development and indirect flight muscles 
development (Bernard et al., 2009; Deng et al., 2009). The two factors have 
differential expression in the embryo, Sd being expressed in a subset of developing 
somatic muscles and in the dorsal vessel, while Vg is found only in the embryonic 
somatic muscle. The overexpression of the two myogenic markers in developing 
embryos of stages 12 - 15 can repress Mef2 target genes expression during 
embryonic muscle differentiation without affecting Mef2 protein levels. The Sd and 
Vg proteins can help modulate the activity of Mef2 in late-stage Drosophila 
myogenesis, with effects in specific cell types. It is important to note that vg and 
mef2 are co-expressed in progenitors of somatic muscles as early as stage 11, while 
Sd and Mef2 are present in cardiac muscle cells, where Vg is not expressed. The 
three proteins were shown to form a tripartite complex that is expressed in certain 
stage 16 somatic muscles (Deng et al,2009). During IFM development the three 
proteins are found throughout the differentiation process, from muscle progenitors to 
fully formed muscles. Vg is involved in both establishing IFM identity in myoblasts 
(Bernard et al., 2003; Sudarsan et al., 2001) and throughout the differentiation 
process (Bernard et al., 2006). Vg
AME 
is the enhancer that activates vg expression in 
adult muscles and is specifically active in unfused myoblast that undergo 
differentiation. Mef2 is able to bind this enhancer and activate its expression and the 
presence of Sd next to Mef2 can synergistically increase the activation of this 
enhancer in vivo (Figure 1.3B, middle diagram). When Vg is cotransfected with Sd 
and Mef2, the highest levels of activation of the Vg
AME 
are detected in S2 cells. The 
presence of Vg as part of the activation complex of its own transcription could show 
the presence of a positive feedback loop where Vg reinforces its own expression 
(Bernard et al., 2009). 
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4) Mef2 can influence responsiveness to signalling. 
 
In neurons, synaptic activity regulates the levels of expression of p300 (Figure 1.3C). 
At normal synaptic activity levels, p300 can repress Mef2 protein by binding it, 
independently of the p300 histone acetylase activity. Lower levels of this protein 
encountered under enhanced synaptic activity do not interfere with activation of 
expression by Mef2, allowing Mef2 to bind the enhancer of dpum and induce its 
transcription. The dPum protein is able to reduce action potential firing by repressing 
paralytic mRNA translation. This repression is required under enhanced synaptic 
activity to regulate the neuron's downstream signalling (Lin and Baines, 2019).  
The Salt-inducible kinase 3 (SIK3) is the central node that transduces the signalling 
pathway for K
+
 and water homeostasis in glial cells (Figure 1.3C, middle diagram). 
Knockdown of Mef2 or SIK3 in glial cells by RNAi causes a nerve swelling 
phenotype, which can be further exacerbated by nuclear HDAC4. Mef2 acts 
downstream of SIK3, since overexpressing Mef2 in SIK3 mutants rescues the 
swelling phenotype. When looking at the HDAC4 localisation in glial cells under 
mis-expression of SIK3, the subcellular localisation of HDAC4 is regulated by SIK3 
levels. When SIK3 is overexpressed, HDAC4 accumulates in the cytoplasm and the 
nerve swelling is supressed, while when SIK3 is downregulated, HDAC4 
accumulates in the nucleus and nerve swelling is exacerbated. The overexpression of 
a phosphorylation-defective form of HDAC4 in a SIK3 knockdown glial background 
exacerbates the swelling phenotype compared to when a wild-type form of HDAC4 
is overexpressed. Thus, SIK3 is able to supress the inhibitory role of HDAC4 in glial 
cells in order to maintain K+ and water homeostasis. Fray and drip, two Mef2 target 
genes with roles K
+
 and water homeostasis, were shown to be downregulated under 
Mef2 and SIK3 knockdown in glial cells. Overexpression of these genes in a SIK3 
mutant background is able to rescue the nerve swelling phenotype. Likewise, when 
larvae of SIK3 mutants are fed a pan-HDAC inhibitor diet, the nerve defects in these 
larvae are rescued. These genetic interaction experiments point to a model where 
HDAC4 is trapped in the cytoplasm of glial cells when phosphorylated by SIK3, and 
Mef2 in the nucleus is able to activate transcriptional programs that control water and 
K
+
 homeostasis. When HDAC4 is dephosphorylated, it shuttles to the nucleus, 
represses the activity of Mef2 is repressed and transcription of target genes does not 
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occur (Li et al., 2019). A potential way how HDAC4 is able to repress Mef2 activity 
is by direct protein-protein interaction via its conserved Mef2 binding site (Yang and 
Seto, 2008) and physically blocking its access to the DNA. HDAC4 has been shown 
to be able to change the distribution of Mef2 in the nucleus of neurons when 
overexpressed (Fitzsimons et al., 2013).   
In the Drosophila adult fat body, Mef2 acts as a transcriptional switch activating 
either a battery of genes involved in metabolic functions or a group of immunity 
proteins necessary to fight bacterial infections (Figure 1.3C, bottom diagram). In 
healthy flies, Mef2 is phosphorylated at T20 and activates the expression of anabolic 
enzymes. As flies get infected by gram-negative bacteria, Mef2 loses its T20 
phosphorylation which allows direct binding to TATA Binding Protein (TBP). Mef2 
and TBP bind enhancers of antimicrobial peptides necessary to fight the infection. 
When the switch is made from the phosphorylated to dephosphorylated state of 
Mef2, a reduction in anabolic enzymes is observed. Mef2 activity is critical in 
immunity activation, since when Mef2 is knocked down in the fat body and an 
infection occurs, those flies show reduced resistance. The loss of metabolic genes 
expression is mediated by the imd pathway signalling that occurs under Gram-
negative infection (Clark et al., 2013).   
Based on the multiple levels of regulation of Mef2 in Drosophila, it becomes 
apparent that protein interactions can account for specific outcomes of target genes 
expression and for different functions that Mef2 can fulfil in various tissues. There 
are distinctions in responses to Mef2 levels, activity and transcription not only 
between different cell types, but also within the same cell. Mef2 is able to activate 
batteries of genes under the impulse of diverse environmental signals and in order to 
ensure specificity for each context it cooperates with other interaction partners 
present in the nucleus to modulate gene expression. The interaction can be 
cooperative, additive, synergistic or even antagonistic. 
1.8 Mef2 in vertebrates 
Mef2 was first identified in mammalian cell culture (Gossett et al., 1989) and its 
target DNA element, an A/T rich sequence, was identified in nearly all known 
muscle genes in skeletal muscle (Black and Olson, 1998). Mef2 is part of the MADS 
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box family of transcription factors that are essential for muscle genes expression 
(Black and Olson, 1998; Taylor, 1995).  
The myocyte enhancer factor 2 (mef2) gene family in vertebrates has four members, 
denoted Mef2a, Mef2b, Mef2c and Mef2d which share over 65% identity in the 
Mef2 domain and 90% similarity in the MADS box (Breitbart et al., 1993; Chambers 
et al., 1992; Leifer et al., 1993; Martin et al., 1993; McDermott et al., 1993; Morisaki 
et al., 1997; Pollock and Treisman, 1991; Ticho et al., 1996; Wu et al., 2011; Yu et 
al., 1992), while only one mef2 gene is conserved in Drosophila (Bour et al., 1995; 
Lilly et al., 1995; Nguyen et al., 1994). The genes encoding these proteins are located 
on different chromosomes in the vertebrate genomes (Hobson et al., 1995; Martin et 
al., 1993; Wu et al., 2011). All of these proteins are expressed in a tissue-specific 
manner and can be alternatively spliced to form multiple isoforms with functional 
differences (Martin et al., 1994; Zhu and Gulick, 2004; Zhu et al., 2005). The four 
Mef2 proteins bind to a consensus DNA sequence as homo- or heterodimers by their 
MADS-box domain (Andres et al., 1995; Pollock and Treisman, 1991; Wu et al., 
2011). The Mef2-specific domain is adjacent to the MADS-box and allows high-
affinity DNA binding and interaction with other factors (McKinsey et al., 2002a). 
The expression patterns of the four vertebrate Mef2 proteins have partial overlap and 
regulate temporally and spatially gene expression in body development and 
maintenance (Black and Cripps, 2010; Edmondson et al., 1994; Potthoff and Olson, 
2007). 
The four Mef2 genes are involved in regulation of myogenesis where they interact 
with other transcription factors to achieve this role. The most well-known 
transcription factor interactors are the myogenic BHLH regulatory factor family 
(MRF) that consists of  MyoD, Myf5, Myogenin and MRF4 (Black and Olson, 1998; 
Molkentin et al., 1995; Ornatsky et al., 1997; Weintraub et al., 1991). Mef2 interacts 
with members of the MRF family in cell culture where synergistically muscle 
specific genes are activated (Kaushal et al., 1994; Molkentin et al., 1995). The four 
genes that encode the proteins Mef2a,-b, -c, -d  in vertebrates have a functional 
relationship with the MRF transcription factor family in myogenesis. The MRFs are 
able to convert fibroblast into myoblasts and the co-transfection of Mef2 can enhance 
this ability (Molkentin et al., 1995). In mammalian skeletal myogenesis, cellular 
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signalling activates the expression of MyoD and Myf5 that induce expression of 
Myogenin, the TF that will activate Mef2 expression (Wang et al, 2001). Myogenin 
and Mef2c can self-activate their own promoter and can bind their promoters 
reciprocally in order to maintain their expression levels (Edmondson et al., 1992; 
Ridgeway et al., 2000; Wang et al., 2001). Muscle differentiation occurs in 
vertebrates under the cooperation of Mef2 proteins with myogenic bHLH factors.  
The four Mef2 proteins have partially redundant functions during myogenesis, but 
not all of them are essential for myoblast differentiation. Mef2a is required for the 
differentiation process while Mef2b, -c and –d are dispensable. These proteins have 
redundant functions in myoblast development, but there are also particular gene 
programs regulated by only one individual of the Mef2 family. When knocking down 
a specific Mef2 isoform in C2C12 cells, certain groups of target genes are 
misregulated and their expression cannot be rescued by the overexpression of another 
isoform. In this study it was found that Mef2a regulates specifically the most 
abundant group of proteins, followed by Mef2b, -c and –d in a descending trend. 
Many genes are sensitive to the activity of two isoforms but very few genes were 
found to be dependent on all four isoforms (Estrella et al., 2015).      
Mef2 genes are able to modulate their own expression via a negative-feedback loop 
which involves activation of expression of HDAC9, a class IIa HDAC. During in 
vitro muscle differentiation, HDAC9 levels increase followed by a decline to a basal 
rate as the differentiation process continues and Mef2 protein levels reach a certain 
threshold. The decline in HDAC9 levels coincides with the increase in Mef2 levels 
(Haberland et al., 2007). HDAC9 is found to be expressed in skeletal muscle in mice 
during embryogenesis, but is downregulated postnatally (Zhang et al., 2001). When 
present in the nucleus, HDAC9 can repress the transcriptional activation via a direct 
protein-protein interaction with Mef2 (McKinsey et al., 2001). Signalling can induce 
HDAC class IIa phosphorylation by calcium dependent kinases that produce HDAC9 
nuclear export and removal of Mef2 activity repression (Chang et al., 2005).  
Mef2 modulates the expression of muscle specific microRNA, miR-1 and miR-133 
by inducing the activation of an enhancer located in a region separating the coding 
regions of these two genes. The two miRNAs have opposing roles: miR-1 inhibits 
myoblast growth, promoting differentiation, while miR-133 activates myoblast 
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growth and supresses differentiation (Chen et al., 2006). The miRNAs post-
transcriptionally regulate gene expression by disrupting the translation and stability 
of the mRNA (He and Hannon, 2004). HDAC4 is a target of miR-1 both during 
myogenesis and in chondrocytes, whose mRNA is targeted as part of a regulation 
mechanism to induce differentiation of muscle cells (Chen et al., 2006; Li et al., 
2014). Taken together, Mef2 is able to activate miR-1 that will repress HDAC4, a 
repressor of Mef2 transcriptional activity, thus creating a positive regulatory 
feedback loop to promote muscle differentiation (Potthoff and Olson, 2007).   
Mef2 can also interact with polyoma virus enhancer activator 3 (PEA3) in satellite 
cells to induce differentiation (Taylor et al., 1997). In Drosophila only recently a 
population of satellite cells have been described and in these cells Mef2 levels are 
repressed in order to repress muscle differentiation (Boukhatmi and Bray, 2018; 
Chaturvedi et al., 2017). The role of Mef2 in muscle development further involves 
cooperation with Homeobox proteins such as Tinman (Cripps et al., 1999), and 
GATA factors (GATA4) (Morin et al., 2000). The different Mef2 isoforms play roles 
in a variety of tissues including the nervous system (Shalizi and Bonni, 2005), the 
immune system (Rao et al., 1998), adipocytes (Sharma and Goalstone, 2005), the 
endothelium (Lin et al., 1998), chondrocytes (Arnold et al., 2007) and bones (Verzi 
et al., 2007). 
Mef2 activity can be also negatively regulated by interacting transcription factors. 
Mouse Twist binds to the Mef2 transcriptional activation domain and inhibits its 
activity (Spicer et al., 1996). In Drosophila, Twist is required for mef2 expression in 
the mesoderm, thus Twist is a positive regulator of mef2 in Drosophila (Cripps et al., 
1998; Taylor et al., 1995). 
Genomic studies in vertebrates to study Mef2 function and regulation have been 
performed in cell culture (Estrella et al., 2015), but not in vivo during embryonic 
development. Undertaking such studies in vivo are complicated by the fact that the 4 
genes have overlapping expression in multiple tissues. The direct interactors of 
Mef2c have been reviewed recently and several of these protein were found to be 
involved in the role of Mef2c in different cell types: development of muscle cells, 
endothelial cells, immune cell, neurocyte, chondrocyte and other interactors. These 
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totalled 30 distinct interaction partners and some of these also interact with the other 
isoforms (Dong et al., 2017). 
1.9 Aims and objectives 
Drosophila Mef2 is expressed throughout embryonic development by every type of 
muscle cell, both at early and late stages. Its gene regulatory activity contributes to 
many different processes in muscle development, ranging from cell differentiation to 
syncytial fusion and establishment of the sarcomere. Mef2 likely regulates the 
expression of at least 230 genes in Drosophila (Junion et al., 2005; Sandmann et al., 
2006). This variety of functions in various cell types must require regulatory systems 
that govern the activity of Mef2 itself in turn, ensuring that the appropriate subset of 
Mef2 target genes is activated while the rest remains inactive depending on the needs 
of each Mef2-expressing cell at different stages. Some aspects of how Mef2 is 
regulated are already known, such as its accumulation throughout myogenesis and 
the switching of target genes based on the level of Mef2 present in a cell (Sandmann 
et al., 2006). However, there are also several known examples of gene regulatory 
activity where Mef2 requires the physical interaction with one or more cofactors to 
induce expression of target genes, or where Mef2 is repressed by cofactors. Given 
the vast number of target genes, study approaches investigating individual candidates 
seeking to identify the regulatory programme that governs their response to Mef2 
activity are unlikely to be efficient to yield a comprehensive picture of Mef2 
regulation. It would thus be valuable to complement the existing genomic data on 
Mef2 DNA binding with proteomic data to identify the cofactors that confer spatial 
and temporal specificity to its function. 
Two large scale affinity purification studies have attempted to use Drosophila S2 
cells for genome-wide mapping of protein interaction networks (Guruharsha et al., 
2011; Rhee et al., 2014). While Guruharsha and colleagues focused on protein 
complexes derived from whole lysate extractions, Rhee and colleagues focused on 
transcription-related protein interactions, therefore only using nuclear extracts for 
purification experiments. Mef2 was used in both studies as a bait protein, among 
others. In both experiments a variant of Mef2 tagged with FLAG-HA was transiently 
expressed in S2R+ cells to identify interacting partners. The Mef2 list of interaction 
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partners derived from whole lysate S2 cells totalled 101 proteins (Guruharsha et al., 
2011). From the nuclear extracts a total of 681 unique bait-pray protein interactions 
were identified for Mef2 (Rhee et al., 2014). Only 67 proteins were found to interact 
with Mef2 in both of the studies. 
The experimental approach used in these studies has an important limitation in the 
fact that Mef2 was overexpressed for the purification experiments. In Drosophila, 
Mef2 expression and activity is very tightly regulated in time and space and the 
expression of its target genes is sensitive to particular levels of the protein.  
Therefore an overexpression of the protein could enrich for particular interactions 
that are susceptible to binding Mef2 when it is expressed at a particular threshold, 
especially at higher levels of expression. Moreover, the S2 cells might not express 
the most representative interactome for Mef2 since it is believed that these cells are 
likely derived from haemocytes. Mef2 is known to be expressed in different 
Drosophila cell types, primarily the muscle, neuronal and fat body cells.  
The current study was intended to identify interaction partners for Mef2 in 
Drosophila embryonic myogenesis. Cell culture is an attractive experimental set up 
for performing affinity purification studies that require a considerable amount of 
material. However the low expression levels of Mef2 in S2 cell (The modENCODE 
Consortium et al., 2010) would imply the necessity to overexpress the protein and 
one of the first aims of our study was to investigate Mef2 protein interactions at 
physiological levels. Moreover, studying the Mef2 interactome in embryos at 
different stages of development would allow to differentiate the dynamics of the 
Mef2 protein interactions at different time points. Mef2 is expressed at lower levels 
early in muscle development and at higher levels during late myogenesis (Sandmann 
et al., 2006). Different enhancers are susceptible to different levels of Mef2 proteins 
rather than different isoforms (Gunthorpe et al., 1999; Sandmann et al., 2006). 
Moreover, certain genes have been shown to require certain Mef2 levels to activate 
their own expression and to physically interact with Mef2 to turn on other target 
genes (Arredondo et al., 2017). Therefore, in order to get a clear picture of the Mef2 
interacting network in the muscle, the best experimental set up is to extract the lysate 
from the same particular tissue via a method that allows expression of the prey at 
physiological levels.  
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The present study therefore aimed to identify as comprehensively as possible the 
collective of proteins that interact with Mef2. Since Mef2 is a transcriptional 
activator, its full interactome might contain primarily proteins that interact with it to 
regulate its induction of gene expression, as well as potentially proteins that are 
directly regulated by Mef2 on the basis of a protein-protein interaction. This aim was 
tackled in three objectives, which reflect the three main chapters of this thesis. 
The first objective towards this aim was to perform protein purification experiments 
to extract Mef2 and proteins physically bound to it. The resulting extract could then 
be subjected to mass spectrometry to identify the proteins contained and create a list 
of candidate Mef2-interacting proteins. To implement this, a transgenic Drosophila 
line was used where Mef2 is endogenously fused to a GS-TAP tag. This tag contains 
specific sites that can be targeted using antibody- and streptavidin coated beads to 
bind and extract Mef2 from a protein extract. Using appropriate buffer conditions, 
the physical interactions between Mef2 and its binding partners can be maintained. 
This procedure is known as tandem affinity purification (TAP) and usually produces 
extracts of higher purity than single-step purification procedures such as co-
immunoprecipitation (Li, 2011). 
The second objective was to use bioinformatic methods to enrich the protein datasets 
obtained using TAP/MS with functional and contextual information such that 
meaningful conclusions can be drawn based on the presence of proteins in the 
extracts. This is necessary firstly as a quality control, because no purification is 
without contaminants that would lead to false conclusions if TAP/MS results are 
interpreted naively. Secondly, this objective takes advantage of the rich 
computational resources available for the Drosophila model organism, covering 
among others genome-wide screens of interactions between genes and proteins, 
functional annotations for many genes, and large-screen expression studies of mRNA 
and other gene products across development and across different tissue types. Using 
this wide array of data, rich information can be extracted when a meaningful list of 
protein candidates is analysed. 
The third objective was to study further at least one candidate Mef2 regulator 
identified by the proteomic study. The chosen candidate was HDAC4, which was a 
potential Mef2 regulator candidate not only based on the proteomics work but also 
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based on the role of its vertebrate homologues in vertebrate Mef2 repression. Having 
been identified by TAP, this candidate should physically interact with Mef2, either 
directly or indirectly as part of a larger protein complex. The aim of these molecular 
biological and genetic experiments was thus to determine whether HDAC4 plays a 
role in muscle development and whether it is associated with regulating expression 
of Mef2 target genes. If so, this would suggest that HDAC4 could act as a repressor 
of Mef2 in muscle development. 
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Chapter 2: Materials and methods 
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2.1 Fly rearing, fly strains and antibodies 
Experiments on Drosophila were performed at two locations: Cardiff University and 
EMBL Heidelberg. The flies used in the experiments were cultivated on fly food 
prepared from recipes specific for the location. All the fly stocks were kept at 18°C 
and flipped every four weeks. When making crosses the flies were kept at 25°C. All 
egg collections were made at 25°C for defined time points on a suitable food 
substrate consisting of apple juice agar plates for small scale collections and in 
population cages. All the plates were supplemented with a generous amount of 100% 
yeast paste placed at the centre of the plate. 
The fly food at Cardiff University was a mixture containing cornmeal, dextrose, 
yeast, nipagin and agar. The fly food at EMBL contained malt extract, corn powder, 
molasses, dry yeast, agar, soy powder, propionic acid and nipagin. 
When collecting flies for crosses, the stock tubes were amplified and kept at 25°C 
during the day and 18°C during the night to optimise female virgins collection. The 
laying cages were kept at 25°C for all experiments regardless of the size of the 
collection. Large scale collections were carried out for TAP purifications in 
population cages, while any other experiments were performed in small collection 
cages. In all experiments a wild-type control was used. 
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Table 2.1: Drosophila lines 
Name Genotype Source/Ref Experiment 
Oregon-R (OR) Wildtype Lab resource 
EMBL Fly 
Facility 
Resource 
TAP purification 
dHDAC4 
experiments 
Mef2GSTAP W*;Mef2GSTAP E. Furlong TAP purification 
 
UAS-dHDAC4 W*;;UASdHDAC4 WT E. Olsen Overexpression 
experiments in 
muscle for dHDAC4 
UAS-
dHDAC4ΔC 
W*;;UASdHDAC4ΔC E. Olsen Overexpression 
experiments in 
muscle for dHDAC4 
UAS-
dHSAC4SA 
W*;;UASdHDAC4 E. Olsen Overexpression 
experiments in 
muscle for dHDAC4 
UAS-hHDAC5 W*;;UASdHDAC5 WT E. Olsen Overexpression 
experiments in 
muscle for hHDAC5 
UAS- 
hHDAC5ΔC 
W*;;UAShHDAC5ΔC E. Olsen Overexpression 
experiments in 
muscle for hHDAC5 
UAS- 
hHDAC5SA 
W*;;UAShHDAC5SA E. Olsen Overexpression 
experiments in 
muscle for hHDAC5 
CPTI77 w1118,PBac{602.P.SVS-
1}HDAC4CPTI000077 
(Knowles-
Barley et al., 
2010) 
Colocalization of 
Mef2 and dHDAC4 
HDAC4 del6 PBac{RB}HDAC4
e04575/e02449
/FM
7 ftzlacZ 
J. Han, M. 
Taylor 
dHDAC4 LOF 
mutants 
HDAC4 del48 PBac{RB}HDAC4
e03932/e02449
/FM
7 ftzlacZ  
J. Han, M. 
Taylor 
dHDAC4 LOF 
mutants 
handGFP If/CyO;C3.1 hand-GFP (Sellin et al., 
2006) 
Positive control for 
dHDAC4/GFP 
expression 
DaGal4 w;;DaGal4 (Wodarz et al., 
1995) 
Rescue experiments 
for dHDAC4 LOF 
mutants 
Twiptwip-Gal4 w*; P{GAL4-twi.B}2 (Baylies and 
Bate, 1996) 
Gal4 for 
overexpression 
experiments in 
muscle 
Dp(1;3)DC266 w1118; Dp(1;3)DC266, 
PBac{DC266}VK00033 
Bloomington (# 
30383) 
Rescue experiments 
for dHDAC4 LOF 
mutants 
Dp(1;3)DC267 w1118; Dp(1;3)DC267, 
PBac{DC267}VK00033 
Bloomington (# 
30384) 
Rescue experiments 
for dHDAC4 LOF 
mutants 
 
  
 39 
 
Table 2.2: Antibodies 
Antibody Host Source Working 
dilution 
Experimental purpose 
Anti-TAP Rabbit Sigma 1/10000 or 
1/5000 
Detection of GSTAP-tagged 
Mef2 
Anti-SBP Mouse Santa Cruz 
Biotechnology 
1/500 Detection of GSTAP-tagged 
Mef2 
Anti-Mef2 (4 
different strains) 
Rabbit EMBL in house 
production 
1/1000 Detection of GSTAP-tagged 
Mef2 
Anti-GFP Mouse Abcam 1/100 Detection of a GFP-tagged 
protein used as control for 
Mef2 levels estimations  
Anti-Rabbit-
HRP 
Goat Santa Cruz 
Biotechnology 
1/1000 Secondary antibody 
Anti-Mouse-
HRP 
Goat Santa Cruz 
Biotechnology 
1/1000 Secondary antibody 
Anti- B3-tubulin Rabbit R. Renkawitz-
Pohl 
1/1000 Analysis of somatic muscle 
development during 
embryogenesis 
Anti-DIG-AP 
Fab fragments 
Sheep Roche 1/2000 RNA in situ hybridisation 
Anti-GFP Mouse Sigma 1/2000 Study of HDAC4 expression 
Anti-lacZ Rabbit Molecular 
probes, 
Invitrogen 
1/5000 Staining for FM7-ftzlacZ 
balancer in order to 
distinguish heterozygous 
from homozygous embryos 
Anti-Mef2 Rabbit Bruce Pearce 1/1000 Colocalization studies with 
HDAC4 
Anti-rabbit 488 
IgG 
Goat Molecular 
probes, 
Invitrogen 
1/200 Secondary antibody 
Anti-mouse 546 
Igg 
 
Goat Molecular 
probes, 
Invitrogen 
1/200 Secondary antibody 
Biotinylated 
anti-rabbit 
Goat Vector 
Laboratories 
1/200 Secondary antibody 
Biotinylated 
anti-mousee 
Goat Vector 
Laboratories 
1/200 Secondary antibody 
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2.2 TAP purification experiments specific methods 
2.2.1 Making Mef2 TAP purification compatible 
This study was intended to systematically identify the proteins that associate with 
Mef2 during Drosophila embryogenesis. For these purposes a Tandem Affinity 
Purification (TAP) experimental strategy was developed where a Drosophila line 
expressing a GSTAP tagged Mef2 was used as bait. The Drosophila line was 
prepared in the Furlong lab. The line was generated via homologous recombination. 
The transgenic line contained a knock-in of a GS-TAP at the C-terminus of Mef2 
(Figure 2.2), in frame with its 10
th
 exon (Figure 2.1). The tag contained two Protein 
G domains, two TEV-protease cleavage sites, and one streptavidin-binding peptide 
(SBP) moiety, placing the Protein G domains at the extreme of the C-terminus. The 
Mef2 protein itself weighs roughly 55 kDa, while the entire tag is estimated to weigh 
approximately 45.8 kDa. The SBP peptide has a molecular mass of 9 kDa, one TEV 
cleavage site has a molecular weight of 1.7 kDa and one Protein G domain weighs 
14.4 kDa. The molecular weights were estimated with ExPASy based on sequence 
analysis (Artimo et al., 2012). When performing experiments like Western blots the 
observed molecular weight may vary from the estimated one due to post translational 
modifications, relative changes or other experimental factors. The tag used is a 
variation of the original yTAP tag that has been shown to have better efficiency in 
purification experiments (Bürckstümmer et al., 2006). 
2.2.2 Drosophila large population maintenance 
Cages for Drosophila populations were plastic cylindrical tubes covered at every end 
with a mesh that did not allow the flies to escape. The mesh was secured on the tubes 
with rubber bands. For the rear part a shorter mesh, long enough to allow complete 
coverage of the circular area, was used. For the front part a longer, sleeve-like mesh, 
was used (Figure 2.3). The frontal mesh allowed handling of the food/egg collection 
plates in and out of the cage with minimization of the flies escaping. This mesh was 
knotted to avoid flies escaping. All population cages were kept in rooms that 
maintained a constant 25°C temperature and provided a day-night cycle. 
Prior to populations set-up, Drosophila were expanded in bottles and the adult flies  
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Figure 2.1: DNA Sequence of Mef2 exon X with inserted GSTAP-tag 
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Figure 2.2: Mef2GSTAP fusion protein structure 
Domain structure of GSTAP-tagged Mef2. Cleavage site for the tobacco etch virus 
(TEV) protease is labelled. SBP: streptavidin-binding peptide. 
 
 
 
Figure 2.3: A Drosophila population cage  
A population cage consisting of a cylindrical plastic tube which has the ends covered 
by mesh that impedes the flies from the population to escape. The larger mesh at the 
front that is knotted allows access to the inside of the cage for feeding  and eggs 
collections. 
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were transferred to the cage.  For the next cycles of Drosophila flies maintained in 
population cages the adult flies were collected from “larval boxes”. Before addition 
of the adult flies to the population cages, the flies were anesthetised with CO2 and 
poured into a conical shaped flask. The flies were weighted and added in sequential 
steps to the population cages until a maximum weight of 30 g of total flies/cage was 
added. The flies were allowed to recover and two apple-juice plates supplemented 
with yeast were added to the bottom of the tube. The two apple-juice plates had a 
double role: as the only food source for the flies inside the cages and as the collection 
plates for embryos.  
Once the flies were transferred into the cages, the population was maintained and 
expanded through alternating cycles of embryos collection for larval boxes set-up, 
growth of new adult flies in larval boxes that will be used to prepare new population 
cages. Each cycle of egg collection for larval boxes preparation did not last longer 
than 14 days and the cages were supplied with fresh food twice a day to avoid larval 
growth inside the population cages. 
2.2.3 Embryo collection from large collection plates for larval boxes set up 
In order to collect the embryos for larval boxes three large sieves having different 
mesh sizes were used. The top sieve had 710 µm mesh and did not allow any dead 
adult flies to go through, the intermediate one had a 356 µm mesh which did not 
allow fly heads, and potential larvae to go through, while the bottom one (112 µm) 
collected all the embryos. The use of the three sieves one on top of the other allowed 
to collect only the embryos and to wash off any debris such as yeast. Distilled water 
(dH2O) and brushes were used to allow transfer of the embryos from the plates to the 
sieves. The plates were apple juice agar plates supplemented with yeast where the 
females had deposited the eggs during collections. The cleaned embryos with dH2O 
were transferred from the bottom sieve to a cylinder and dechorionated for 2 min in 
50% bleach. A magnetic stir bar was used to mix the embryos during the 
dechorionation step. The dechorionated embryos were transferred back to the 112 
µm sieve and washed with dH2O to remove any traces of bleach. The embryos were 
then transferred to a cylinder in 1x PBS + 0.1% TritonX 100 (PBS-Tx). Using a filter 
pump to remove the PBS-Tx, the embryos were placed onto a filter paper. On the 
filter paper the embryos were washed once with 70% ethanol and once in 1x PBS-
 44 
 
Tx. The filter containing the embryos was placed in the larval boxes on top of the 
food and spread evenly on the food surface with a small amount of PBS-Tx. The 
layer of embryos transferred in one larval box did not exceed a height of 0.5 cm to 
avoid overcrowding the box.  
The larval boxes were plastic Tupperware boxes with the lid presenting a hole in the 
middle covered with mesh to allow oxygen flow without allowing the larvae to 
escape. Tupperware boxes were tightly sealed such that the larvae did not escape. 
The food was placed at the bottom of the boxes on a few layers of tissue paper. The 
larval boxes were shifted between 18°C and 25°C incubator to delay or speed up 
development such that the adult flies were synchronised for population cages set-up.  
2.2.4 Embryo staging and collection 
The correlation of desired developmental stages was transformed in time points of 
development at 25°C. Developmental 2 h windows were used to capture the most 
representative stages of muscle development in Drosophila embryos. The staged 
embryos were collected in two-hour windows of egg laying on apple juice-agar 
plates and then aged at 25°C until the desired age. The collected stages are described 
in Table 2.1. Each egg laying period for embryo collection was preceded by three 
consecutive 1 h prelays (1 h long egg-laying time points). The prelays allowed to 
collect any eggs that the flies did not manage to lay due to the overcrowding of the 
plates with eggs, therefore these eggs would be of unknown age and could have 
biased the experimental collection. After the two hour egg-laying period the plates 
were removed from the population cage and the embryos were allowed to develop 
until the desired age. O/N embryos collections were timed as 18h of continuous egg 
laying time, no separate aging step required. 
Table 2.3: Stages of embryos collected 
Stage Egg laying time 25°C Aging time 25°C 
4-6 h 2 h 4 h 
6-8h 2 h 6 h 
10-12 h 2 h 10 h 
11-13 h 2 h 11 h 
O/N (0-18 h) 18 h 0 h 
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2.2.5 Embryos preparation for TAP  
The stage collected embryos as described in section 2.2.4 were transferred from the 
plates into the three sieve system described in section 2.2.3 and thoroughly washed 
with dH2O to remove any debris. For chorion removal the embryos were transferred 
into a cylinder containing 50% bleach where they were incubated for 2 min under 
stirring. For washing off the bleach the embryos were transferred through a sieve 
which contained a detachable mesh of 112 µm pore size. This sieve allowed 
thorough washing of the embryos with dH2O in order to remove traces of bleach. The 
removable mesh containing the embryos was placed on a tissue paper to absorb 
excess moisture. The embryos were left to air dry for approximately 5 min. When 
suitably dry the embryos were transferred with a spatula into a 15 ml or 50 ml tube, 
weighed and snap frozen in liquid Nitrogen. The snap frozen embryos were stored at 
-80°C. 
2.2.6 Lysis of Drosophila embryos for TAP purifications 
All steps were performed at 4°C unless otherwise stated. The embryos were removed 
from the -80°C freezer and placed on ice to partially thaw. The ratio of lysis buffer 
volume to amount of embryos used was 1:3, meaning for 1 g of embryos to be lysed, 
3 ml of lysis buffer were used. The lysis buffer composition was the following: 50 
mM Tris pH 7.5, 125 mM NaCl, 1.5 mM MgCl2, 0.2% NP40, 5% Glycerol, 1 mM 
EDTA, 1 mM DTT, 10 ug/ml DNAse, 25 mM NaF, 1 mM Na3VO4 (phosphatase 
inhibitors), protease inhibitors mix (2 mM AEBSF, 40 µM E-64, 0.5 µM Aprotinin, 
1 µM Leupeptin, 60 µM Pepstatin A, 10 µM Bestatin (Sigma)). The EDTA, DTT, 
DNAse, protease and phosphatase inhibitors were added fresh before lysis. The 
buffer conditions were derived from Bürckstümmer et al and the protease inhibitors 
mix was based on a protocol routinely used in the Gavin lab (Bürckstümmer et al., 
2006; F. O’Reilley, personal communication). 
The partially thawed embryos were transferred to a 15 ml Wheaton douncer provided 
with two pestles, loose and tight. The loose pestle was used to break the cell 
membranes, while the tight pestle is used to mechanically disrupt/lyse the cells. The 
homogenisation was performed with 20x strokes with the loose pestle followed by 20 
strokes with the tight pestle. If the required volume of lysis buffer surpassed 8ml, the 
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homogenisation was done in subsequent steps. Another volume of lysis buffer was 
used to rinse all the tubes and the Wheaton douncer and 5 complete strokes with the 
loose pestle and 5 complete strokes with the tight pestle are used to homogenise any 
leftover material from the wall that was not homogenised.  
The homogenate was transferred to thick wall Beckham Polycarbonate Thick Wall 
centrifuge tubes and centrifuged at 100000 g/49000 rpm for 1 h in order to clarify it. 
A lipid layer was formed at the surface of the sample after the ultracentrifugation. 
The cytosolic fraction was carefully removed with a 1 ml syringe with an orange tip 
(25 G). The removal of lipids was done carefully to avoid mixing the clarified 
supernatant or to collect any debris from the pellet. To recover as much as possible 
from the cytosolic fraction that got mixed with the lipid layer, further centrifugation 
steps were applied. Three subsequent steps of centrifugation at 14000 rpm for 5 min 
of the mixed lysate, followed by needle extraction were performed. A new needle 
was used for each new extraction of the cytosolic fraction as the lipids tended to stick 
to the needle. The obtained cytosolic fraction was immediately used as input material 
for the TAP purification. 
2.2.7 GS-TAP purification  
This TAP purification protocol was adapted from a protocol from the Gavin lab that 
was described in several studies that were using proteins tagged with the yTAP as 
bait (Kühner et al., 2009; Puig et al., 2001; Rigaut et al., 1999). The modifications 
made to the protocol were taken from the Bürckstümmer et al study because we were 
working with a different tag, specifically the GSTAP (Figure 2.4) (Bürckstümmer et 
al., 2006). 
All steps were performed at 4°C unless otherwise stated. IgG-Sepharose (IgG 
Sepharose 6 Fast Flow, GE Healthcare) beads were washed twice in lysis buffer by 
mixing 400 µl of slurry (200 µl of actual IgG beads) with 1.5 ml 1x lysis buffer in a 
15 ml Falcon tube (Figure 2.4). The beads were spun down at 1800 rpm for 1 min 
and the buffer was removed. The cytosolic fraction of the Drosophila embryos was 
added to the washed IgG beads and incubated for 2h on a spinning wheel. The IgG 
beads bound by the bait protein were spun down at 1800 rpm for 1 min and the 
supernatant (biological material free of bait and associated proteins) was removed. 
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The bound IgG beads were resuspended in 400 µl 1x lysis and transferred to a small 
Mobitec (0.8 ml, M1002) column. An additional 1 ml of lysis buffer was used to 
rinse the falcon tube for any remaining beads left on the walls of the falcon tube. The 
beads in the Mobitec column were washed with 10 ml 1x lysis buffer followed by 4 
ml of TEV cleavage buffer (TEVcb, 10 mM Tris pH 7.5, 100 mM NaCl, 0.1% NP40, 
2 mM DTT) and the buffers were allowed to pass through the column by gravity 
flow. A mixture of 400 µl TEVcb and 21ul TEV protease (final concentration 0.05 
µg/µl) was added to cleave the bound bait protein off the beads. The cleavage was 
done by incubating the beads with the TEV protease for 1h at 16°C, while shaking at 
500 rpm in a thermoshaker.  
200 µl of Streptavidin Sepharose beads (Ultralink Immobilized  Sterptavidin Plus, 
Thermo Scientific) slurry (100 µl beads) were pipetted into a new Mobitec column 
and washed with a total of 3 ml TEVcb. The TEV cleavage product was directly 
eluted onto the new Mobitec column containing the Streptavidin beads. When 
everything was eluted, the column was sealed and incubated for 1h on a spinning 
wheel to bind the cleaved bait protein to the streptavidin beads. The buffer, now free 
of bait protein was allowed to flow through and the bound streptavidin beads were 
washed with 6 ml TEVcb. The bait protein was elute off the beads by incubating 
with 150 µl of 2 mM biotin (Sigma) for 5 min. The proteins were eluted off the 
column by gravitational flow into a 1 ml microcentrifuge tube, snap frozen in liquid 
nitrogen and stored at -80°C until required. 
Both extraction procedures that were used as a basis to develop the protocols for 
extraction of Mef2 interacting proteins are protocols optimised for purification of 
solubilised proteins from whole cell extracts (Bürckstümmer et al., 2006; Kühner et 
al., 2009). The Mef2 proteins that was used as bait is a nuclear protein and could be 
successfully solubilised using this procedure (see western blot results in Chapter 3, 
e.g. Figure 3.4). Therefore the procedure should extract both nuclear and cytosolic 
proteins that interact with Mef2 in Drosophila embryos.  
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Figure 2.4: Tandem affinity purification (TAP) procedure 
The cell extract is incubated with IgG beads that recognise protein G to isolate the 
bait and its interacting protein complexes. The beads are purified from the 
suspension and incubated with TEV to release the bait. The resulting solution is 
incubated with streptavidin beads to clean up the bait further and remove TEV 
protease. The beads are purified and incubated with biotin, which competes with 
streptavidin on the beads for binding to SBP. 
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2.2.8 Western blots  
2.2.8.1 SDS-polyacrylamide gel electrophoresis 
SDS-polyacrylamide gels were prepared fresh for routine western blot analysis of 
lysis samples or TAP purifications. For 1.0 cm thick gels a 10% resolving gel was 
prepared (375 mM Tris pH 8.8, 10% Acrylamide (30% acrylamide/bisacrylamide 
solution, Biorad), 0.1% sodium dodecyl sulphate (SDS), 0.2% ammonium persulfate 
(APS, Thermo Fisher), 0.5% Tetramethylethylenediamine (TEMED, Bio-Rad)) and a 
5% stacking gel (125 mM Tris pH 6.8, 5% Acrylamide, 0.1% SDS, 0.2% APS, 0.1% 
TEMED). For small gels a volume of 5 ml of 10% resolving gels and 3 ml of 
stacking gel were sufficient to obtain a 72 x 86 mm gel.  For large SDS-
polyacrylamide gels 50 ml of 10% resolving gel and 30 ml of 5% stacking gel were 
prepared to make a 594mm x 841mm gel. For small gels the maximum volume to be 
loaded per well was of 30 µl and for large gels of 100 µl. The PageRuler Prestained 
Protein Ladder (Thermo Fisher) was used as a reference for protein sizes both for gel 
analysis and western blots. The loading for Input samples and cytosolic fraction was 
done depending on total protein content as determined by Bradford assay not 
exceeding 20 µg of total protein loaded per lane. For other types of samples a 10% 
volume of the sample was loaded unless otherwise stated. For loading the protein 
samples, an in-house 4x SDS loading dye (200 mM Tris pH 6.8, 400 mM DTT, 8% 
SDS, 0.4% Bromophenol blue, 40% glycerol) was added to the samples that were 
denatured by boiling for 10 min at 100°C. The gel was run in Laemmli 
electrophoresis running buffer (25 mM Tris base, 192 mM Glycine, 0.1% SDS, pH 
8.8). For small gels the Mini Portean Casting and Electrophoresis (Biorad) system 
was used, while for casting and running the large gels an EMBL in house system was 
available. Precast gradient gels (4-20% Mini-PROTEAN TGX Gels, Biorad) were 
used for analysis of the TAP purification experiments and for preparation of eluted 
proteins for gel extraction before MS analysis. 
2.2.8.2 Protein transfer 
Following SDS-PAGE, the gels and membranes were equilibrated in transfer buffer 
(25 mM Tris, 192 mM Glycine, 20% (v/v) Methanol pH 8.3). The transfer of 
proteins was done on Nitrocellulose membranes (Thermo Fisher) via a semi-dry 
transfer method. The membrane, gel and Whatman papers (3 layers each side) were 
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thoroughly soaked in transfer buffer. The transfer was done overnight at very low 
voltage (25 mA, depending on the size of the membrane) due to improved resolution 
of the bands. 
2.2.8.3 Antibody incubation 
All the steps were performed at room temperature unless otherwise stated. After 
transfer, the membranes were washed 3 times 20 min in TBST (19 mM Tris base, 
137 mM NaCl, 0.1% Tween-20 (Biorad)), and blocked for 1 h in 5% milk (low fat 
powder diluted in TBST). The primary antibody was diluted appropriately in 
1xTBST+ 5% milk and incubated overnight at 4°C with shaking. The next day the 
membrane was rinsed 3 times in fresh TBST and washed 3 times 20 min in TBST 
while shaking. The HRP-conjugated secondary antibody was diluted in 1xTBST+ 
5% milk and incubated for 1 h at room temperature with the membrane. After 
incubation with the secondary antibody the membrane was rinsed 3 times followed 
by three 20 min washes in TBST.  
2.2.8.4 Signal detection 
The membranes were coated in Amersham ECL Detection Kit (GE Healthcare) and 
incubated in the dark for 5 min with the developing solution. The excess developing 
solution was removed, the membranes were covered with clear film and transferred 
to a film developing cassette that allowed transport of the membrane in darkness to 
the developing room. The signal detection was performed in the dark on film 
(Amersham Hyperfilm ECL, GE Healthcare) by exposing the film to the signal for 
various amounts of times: as short as 1 sec and as long as 30 min. The films were 
developed on a Kodak RP X-OMAT Processor Machine, Model M6B. 
2.2.9 Sample preparation and mass spectrometry analysis 
The sample preparation and mass spectrometry identification was performed by the 
Proteomics Core Facility at EMBL. The TAP purified proteins were loaded onto 
gradient SDS-polyacrylamide gels (4-20% Mini-PROTEAN TGX Gels, Biorad), run 
a few centimetres into the gel and stained by a Methanol free Coomassie Stain. The 
samples were prepared by in-gel digestion with trypsin, the peptides were extracted 
from the gel by incubation with acetonitrile and cleaned and eluted by ZipTip. The 
extracted peptides were loaded onto a Thermo Orbitrap Velos Pro and Q-Exactive 
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where they were analysed by a AmCit/β-Casein/MSA 1h method. The identified data 
was compared against the Drosophila sequence available in UNIPROT and the 
spectra were parsed using Scaffold. The reported outputs were the list of identified 
protein in each sample together with the number of unique peptides and the 
unweighted spectrum count (that show how often peptides belonging to a protein was 
selected for MS). The filters applied to compile the final list of data was the 
following: minimum 2 peptides per protein needed to be identified for that candidate 
to make it to the final list and a peptide needed to have a minimum Mascot score of 
20 such that the peptide is taken into account for a protein.  
2.3 Bioinformatic analysis specific methods 
2.3.1 Normalised Spectral Abundance Factor and estimation of contaminants 
The Normalised Spectral Abundance Factor (NSAF) was determined for each protein 
in each sample based on the total spectral counts identified by mass spectrometry. To 
calculate NSAF, first all proteins' total spectral counts were normalised to each 
protein's respective sequence length as reported on Uniprot, because larger proteins 
are more likely to generate more peptides that can be detected by MS  (Zybailov et 
al., 2006): 
                     
                     
                       
 
NSAF was then calculated by dividing each protein's size-adjusted counts by the sum 
of all size-adjusted counts in the sample: 
       
                     
                           
 
To classify candidate proteins as potential contaminants or specific bait-binding 
proteins, a ratio of vector magnitudes (α) was calculated to compare  NSAFs between 
purifications containing bait (TAP experiments on Mef2-GSTAP expressing 
embryos) and purifications containing no bait (TAP experiments on WT embryos). 
For each protein present in at least one of the included datasets, a vector was 
constructed, containing the respective NSAF values of that protein across the four 
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TAP datasets. These vectors were combined into a matrix such that each row 
represented one protein and each column represented one TAP experiments. The α 
coefficient was then calculated according to the formula (Sardiu et al., 2008): 
   
   
     
  
   
     
   
where xi1/2 = NSAF in Mef2-GSTAP embryos (ON and 11-13), and yi1/2 = NSAF in 
WT embryos (ON and 11-13). Proteins for which α > 1 were classified as potential 
contaminants. Proteins only present in control samples have xi1 = 0 and xi2 = 0, 
leading to a division by 0 and making the α coefficient invalid. These proteins were 
classified as contaminants by default. 
2.3.2 Data collection and identification of protein interaction networks 
To construct the Protein-protein interaction (PPI) network for the Mef2-interacting 
candidates the Drosophila Interaction Database (DroID) (Murali et al., 2011; Yu et 
al., 2008) version 2015_12 was used. The database included 561,842 interactions, 
experimentally detected in 3 yeast two hybrid studies, curated literature-derived PPI 
from other databases, two large scale coAP/MS studies, Drosophila interlogs 
predicted from experimental data in yeast, worm and human, genetic interactions, 
miRNA-gene interactions and transcription factor-gene interactions. 
TAP identified candidate proteins, Mef2 interacting proteins identified in a co-
affinity purification (CoAP) study in S2R+ cells (Rhee et al., 2014) and overlapping 
candidates have been used as starting proteins to generate interaction networks. The 
interaction network representation is based on graph theory, mathematical structures 
that are used to model pairwise relationships between objects. A graph consists of 
nodes and edges that connect these nodes. In a PPI, one protein represents one node, 
while an edge between the nodes signifies the existence of some sort of interaction 
between them. These networks represent the framework to assess if the identified 
candidates during the purification studies are functionally relevant. The proteins used 
to generate the networks will be referred to as seeding nodes (seeds). Two proteins 
are considered to interact in the generated network if there is any known association 
that can be derived from the DroID database.  
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The network was generated computationally via the DroID plugin compatible with 
the Cytoscape 2.8.3 software. This plugin allows to extract all the interaction data 
available in the DroID database connected to all the proteins provided as input nodes 
(seeds). The network building function ensures that there are no redundant proteins 
in the connected network. 
2.3.3 Identification of shared and unique seeds in the analysed samples 
The Mef2-interacting candidates shared among the different purification experiments 
were identified using the Draw Venn Diagrams web applications which compared 
the list of proteins and represented them as Venn Diagrams. 
2.3.4 Protein Identifiers 
Uniprot database (The UniProt Consortium, 2019) was used to map between 
UniPROTKB accession numbers, FlyBase gene identifiers and Gene Symbols. 
Flybase IDs that map the genes encoding the analysed proteins were used as the 
identifiers for PPI network generation and analysis. UniPROTKB accession numbers 
were used to compute functional similarity between proteins. Gene Symbols were 
used to map the proteins with RNAseq information for their transcript.  
2.3.5 Shortest distance derivation 
The shortest path between identified candidate proteins and Mef2 was calculated 
using the NetworkX 1.10 module in Python 2.7. The distance could take three 
values: 0 if there is a direct interaction with Mef2, 1 if another common interaction 
partner is present between Mef2 and the other seed and 2 if two intermediates stand 
between Mef2 and the analysed candidate. Based on the algorithm used to generate 
the PPI network, if two intermediate partners are required to connect one seed to 
Mef2, at least one of the interaction partners needs to be a seed. 
2.3.6 Expression data 
To identify potential Mef2 interacting candidate proteins acting in similar biological 
contexts at particular time points the expression of their analysis was performed. The 
genes encoding the proteins were classified based on the specificity of expression 
across developmental stages. RNA-Seq data from 30 developmental stages spanning 
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from Drosophila embryos to adult have been downloaded from the modENCODE 
project (Graveley et al., 2011). Based on their expression pattern across all 
developmental stages the proteins were classified as ubiquitous if they were 
expressed across all developmental stages, stage specific if they were expressed 
predominantly in one and no more than four consecutive stages and non-ubiquitous 
non-specific (NUNS) if a particular pattern could be identified. A specificity scale 
was devised to quantitatively classify the genes based on their expression pattern 
(Murali et al., 2014). 
2.3.7 Gene expression specificity scale 
The expression specificity (Esi) of a gene across developmental stages is a fraction of 
the total abundance of that gene across all the 30 developmental stages and was 
calculated as follows: 
    
                     
                           
 
Where                       is the raw expression of a particular gene at stage i. 
The values obtained will be between 0 and 1. The sum of all expression specificities 
for each gene across all developmental stages equals 1.  
Genes labelled as specific have Esi values of > =0.19; genes expressed across all 
stages and are labelled as ubiquitous have stage E i values >0.005 across all time 
points; NUNS were genes with nonzero Esi values  <= 0.005. Genes with 0 Esi  
values across all stages were labelled as not expressed. 
2.3.8 An expression filter to find genes active in particular contexts  
The expression filter was created on the hypothesis that a protein is more likely to be 
active at expression levels that approach its maximal level across developmental 
stages. Therefore a gene’s expression level was calculated at each stage as a 
percentage of the maximal expression value achieved across developmental stages. 
Each gene had one percent maximum (pmax) value for each stage. 
The pmax of a gene in stage i is calculated as follows: 
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Where                       is the raw expression of a particular gene at stage i 
and max RNA abundance is the raw expression of the genes maximal expression 
level. The values obtained will be between 0 and 1. The pmax of the developmental 
stage where the gene is maximally expressed equals 1. The RNA expression data was 
derived from RNAseq data from modENCODE (Graveley et al., 2011). 
A pmax value of above 0.45 is considered to give the highest confidence that the 
curated list of gene are active in a similar biological context. 
The connection between developmental stages and the pmax values of all the 
analysed proteins was analysed by creating a distance matrix and then clustering 
them hierarchically. The Morpheus platform was used to plot the values (Gould, 
2012). 
2.3.9 Gene ontology enrichment  
The candidate proteins were annotated functionally by gene ontology (GO) 
enrichment. The GO enrichment analysis was performed using BINGO (Maere et al., 
2005), a tool that determines overrepresented GO categories in a set of genes. 
BINGO version 3.0.3 compatible with Cytoscape version 3.3.0 was used. The Gene 
Ontology version 1.2, release 2016-04-20 associated with Drosophila melanogaster 
model organism was retrieved from the Gene Ontology Consortium website 
(Ashburner et al., 2000). The overrepresented GO categories were determined by a 
hypergeometric statistical test with a Benjamini and Hochberg False Discovery Rate 
correction. The Drosophila genes association with specific GO terms was 
downloaded from FlyBase (McQuilton et al., 2012) release 2016_02.  
2.3.10 Modular analysis 
Scale free biological networks are modular (Hartwell et al., 1999), many functionally 
related nodes tending to cluster together to perform a particular function (Davis et al., 
2015). The densely connected seed nodes of the network were analysed using the 
MCODE version 1.4.2 (Bader and Hogue, 2003) from Cytoscape. For MCODE 
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clustering the default parameters: degree cut-off value of 2, node score cut-off of 0.2 
and k-core clustering value of 2 were used.  
2.3.11 Functional similarity 
Functional similarity between proteins was computed based on a semantic measure 
of the GO terms associated with them. FunSimMat release 6.0 (Schlicker and 
Albrecht, 2008, 2010) was used to measure the functional similarity between each 
pair of proteins. For this analysis the proteins identified by their FlyBase IDs were 
mapped to UniProtKB accession numbers. If multiple UniProtKB entries were 
associated to a single initial gene, all the mapped entries were included in the 
semantic analysis where the maximum functional similarity obtained by any of them 
was considered for further exploration. The functional similarity is based on GO 
terms obtained from the Gene Ontology Annotation database release January 2012 
(Barrell et al., 2009). The functional similarity score obtained from summing up the 
score for each GO category (biological processes, molecular function, cellular 
component) was used as the criterion to construct a similarity network. The nodes in 
this network corresponded to proteins identified in the Mef2 interacting candidates 
and an edge was connecting two nodes if the functional similarity score was ≥0.7 
(Zanon et al., 2013).  
2.3.12 Pathway enrichment and ontology analysis 
The ClueGO plugin version 2.2.5 (Bindea et al., 2009) was used to analyse the 
clusters obtained for modular analysis of the networks derived for the study of Mef2-
interacting candidates. 
2.3.13 Data availability statement 
All supplemental data files can be found in the figshare repository at 
https://doi.org/10.6084/m9.figshare.12445634. In addition to tables S1 to S4, this 
provides: tables with overlap groups in Venn diagrams, pmax filter dataset (section 
4.2.10), Mef2 biological process GO terms and GO term clustering dataset (section 
4.2.11), functional similarity matrix (section 4.2.12). 
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2.4 HDAC4 as a potential Mef2 interactor specific methods 
2.4.1 Embryo collection and fixation 
The Drosophila strains used in Chapter 5 for embryo collections can be found in 
Table 2.1. Embryos were collected in small collection cages on fresh apple juice-agar 
plates supplemented with fresh yeast for 18h at 25°C to allow collection of an array 
of embryonic developmental stages. Embryos were transferred from the apple juice-
agar plate using a brush and water to a basket with a wire mesh base. The eggs were 
washed with water to clean the yeast away. A solution of 50% bleach was used to 
remove the chorion membrane (approximately 2 minutes). Dechorionation was 
monitored under a dissecting microscope and was allowed to proceed until the 
embryos became shiny and the dorsal appendages were removed. Dechorionated 
embryos were rinsed thoroughly with water, dried on tissue paper and transferred 
into a petri dish containing heptane and afterwards transferred to a 2ml tube 
containing a final volume of 1 ml heptane. Another 1 ml of 7.4% 
paraformaldehyde/PBS was added to the tube and embryos were then fixed for 20 
minutes under constant shaking. Afterwards, all embryos were resuspended into the 
heptane phase and the paraformaldehyde (lower phase) was removed using a glass 
Pasteur Pipette. A mixture of 1:1 of heptane and methanol was used to remove the 
vitelline membrane by vortexing for 30 s. The embryos were washed 3 times in 
methanol to remove any traces of heptane and were stored at -20°C in methanol until 
required. 
2.4.2 Immunohistochemistry – single antibody staining 
The immunohistochemistry protocol is derived from (Rushton et al., 1995). Fixed 
embryos were rehydrated using a 1:1 mixture of methanol and 1x PBS containing 
0.1% Triton X-100 (PBS-Tx), washed 3 times in 1x PBS-Tx and then blocked in 
PBS-Tx + 0.5% bovine serum albumin (BSA) (Sigma) for 30 minutes at room 
temperature. Embryos were then incubated under constant shaking overnight at 4°C 
with primary antibodies diluted in PBS-Tx (for working dilutions of specific 
antibodies used in Chapter 5 please see Table 2.2). All the primary antibodies used in 
Chapter 5 were preabsorbed against very young (0-2h) fixed OR embryos and these 
antibody stocks were diluted prior to incubation with fixed embryos. Embryos were 
 58 
 
washed 3 times with PBS-Tx for 10 min and incubated with a 1:200 dilution of 
biotinylated secondary antibodies (anti-mouse, anti-rabbit, all from Vector 
Laboratories) for one hour at room temperature with shaking. The signal was 
amplified using the reagents A and B from the Vectastain Elite ABC kit (Vector 
Laboratories) diluted 1:100 in PBS-Tx. This solution required 30 min pre-incubation 
at room temperature before adding it to the embryos to allow formation of the 
amplification system. Incubation of embryos with the A+B complex solution was for 
30 min at room temperature without shaking. The stain was then developed with 
0.5mg/ml 3,3'-diaminobenzadine-tetrahydrochloride (DAB) (Sigma) and 0.02% 
hydrogen peroxide and observed under a dissecting microscope. To stop the colour 
developing reaction, the DAB and hydrogen peroxide were washed away with PBS-
Tx. Embryos were mounted in 80% glycerol, staged and selected for microscopic 
analysis. OR embryos were stained in each case and used as wildtype controls. 
Embryos were viewed on a Zeiss Axioskop microscope in bright field. 
2.4.3 Immunohistochemistry - double antibody staining 
Double antibody stainings were performed as described in the previous section with 
the following modifications: When primary antibodies were raised in the same 
animal, embryos were incubated overnight at 4°C with the first (weaker) antibody 
and developed using nickel salts which give a dark coloration. Embryos were then 
washed, blocked with PBS-Tx + 0.5% BSA and incubated overnight at 4°C with the 
second primary antibody. This was developed the next day without nickel salts and 
resulted in a brown stain.  
2.4.4 Immunohistochemistry using  fluorescent antibodies 
For fluorescent double stainings, secondary antibodies conjugated with fluorescent 
dyes were used (Vector laboratories). In all cases, primary antibodies were raised in 
different animals (see Table 2.2) and incubation of embryos with primary antibodies 
was done as described in section 2.4.2. Embryos were incubated in the dark with the 
secondary antibodies at room temperature for 2 hours and, after washing, they were 
mounted in 80% Glycerol. Embryos were viewed on a Leica TCS SP2 AOBS 
spectral confocal microscope. 
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2.4.5 Larval muscle scoring and analysis 
Qualitative analysis of the effect on somatic musculature in the different experiments 
was performed by examination of the muscle pattern. Each of the 30 muscle was 
analysed systematically following specific criteria: presence/absence; shape. Based 
on the severity of the phenotype the effects were classified as: 1) wild-type - if no 
defects were observed; 2) weak – if the muscle pattern is wildtype and only a 
reduced number of muscles are misshapen; 3) moderate - most muscles are present 
and correctly shaped; 4) Severe- the muscle pattern is significantly affected, many 
muscles are misshapen or missing but a slight outline of the expected muscle pattern 
is still observable; 5) Extreme - no muscle is formed correctly. The wild-type muscle 
pattern was used as a reference for comparison. 
2.4.6 Hatching and survival assay 
Fly lines carrying a FM7 balancer with an ActGFP marker were generated for the 
potential HDAC4 null mutants (HDAC4 del6 and HDAC4 del48). Eggs were 
collected on apple juice-agar plates for 2h at 25°C and the obtained embryos were 
allowed to develop further for another 7h at 25°C. Embryos were observed under a 
fluorescence microscope and the embryos without GFP signal were selected. These 
embryos were homozygous for the generated deletion. 100 GFP negative embryos 
were aligned on a new agar plate and incubated for another 24h at 25°C.  At this 
stage any first instar larvae were collected and transferred to a new apple agar juice-
plate. The counting for second instar and third instar larvae was performed after 48h 
and 72 h at 25°C. Third instar larvae were transferred into tubes and allowed to reach 
pupal stage. As a control, 100 OR embryos were aligned on an apple juice agar plate 
and the hatched number of larvae was counted as previously described. 
2.4.7 Preparation of Digoxigenin-labelled RNA probe 
The DNA template for the HDAC4 RNA probe was a 5528bp cDNA derived from 
clone RE18386 ordered from the BDGP collection. Prior to transcription, DNA 
templates were linearised using a NotI enzyme, the reaction digest being incubated 
for 2h at 37°C. The protocol for synthesising DIG-labelled RNA probes from 
linearised DNA was adapted in the Taylor lab from protocols described by others 
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(Casey and Davidson, 1977; Urrutia et al., 1993). Transcription reactions were 
carried out in 50 µl tubes containing more than 2 µg of linearised template DNA, 1 
µl of 10X transcription buffer (Roche), 1µl  of DIGNTP mix (Roche), 0.5 µl of 
RNAse inhibitor (Roche) and 1 µl of T3 RNA polymerase (Roche) for the antisense 
probe, T7 RNA polymerase (Roche) for the sense probe. The final volume of each 
probe synthesis reaction was then adjusted to 10 µl with H2O. Reactions were 
incubated at 37°C for 2 hours. After transcription, the DNA template was removed 
by the addition of 1 µl of DNAseI buffer, 6 µl of H2O and 3 µl of DNAseI RNase 
free (10U/µl; Roche) and the mix was incubated at 37°C for 15 minutes. The RNA 
probes were fragmented by adding 80 µl of 125 mM sodium carbonate (pH 10.2), 
and incubating the probe at 60°C for 15 minutes in the hybridisation oven. The 
alkaline hydrolysis of the probes was stopped by adding a volume of 50µl 7.5M 
ammonium acetate and storing on ice. For RNA probe precipitation, the reaction was 
further mixed on ice, with 375 µl 100% ethanol for 10 min and centrifuged at 
maximum speed for 15 min. The remaining pellet was air dried, and resuspended in 
30μl TE:formamide (1:1). A spot test was performed in order to estimate the yield of 
the DIG-labelled RNA. A DIG-labelled control (Boehringer) of known concentration 
was used to determine the yield of the probe. Dilutions of both the control and the 
probes (all in RNAse-free H2O) were spotted and UC cross-linked in a UV 
Stratalinker to a positively-charged nylon membrane (Roche). The membrane was 
washed twice for 5 min in Blocking Solution (10 % blocking reagent from Roche 
dissolved in maleic acid buffer (100 mM maleic acid, 150 mM NaCl, pH 7.5)), 
followed by a 30 min blocking step. The membrane was incubated with an anti-DIG-
AP Fab fragment antibody diluted 1/2000 in blocking solution for 30 min at room 
temperature. There were two washing steps of 5 min in blocking solution, followed 
by two washes of 10 min in Washing Solution (100 mM Tris pH 9.5, 100 mM NaCl, 
5 mM MgCl2, 0.1% Tween). The spots were developed in a solution containing 4.5 
µl NBT and 3.5 µl BCIP per 1 ml of developing/washing solution, incubating in the 
dark for an appropriate time and the reaction was stopped by washing thoroughly 
with PBT. The yield was determined by comparing the intensities of the synthesized 
RNA probes with the control. Probes were diluted with TE:formamide (1:1) to  a 
final volume of 25 ng/µl  after the quantification procedure. 
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2.4.8 RNA In Situ Hybridisation 
In situ hybridisations were carried out according to standard protocol (Taylor, 2000) 
with the use of Digoxigenin-labelled RNA probes. Fixed embryos were stored at -
20°C in methanol and for RNA in situ hybridisation they need to be rehydrated. The 
rehydration process involves sequential replacement of methanol with 4% 
paraformaldehyde (PFA): 1) incubation of embryos for 2 min at room temperature in 
a mixture of 3:2 methanol to 4% PFA, 2) incubation of embryos for 5 min at room 
temperature in a mixture of 1:3 methanol to 4% PFA, 3) incubation of embryos in 1 
ml of 4% PFA for 10 min with gentle shaking. The rehydrated embryos were rinsed 
3 times and washed 3 times for 5 min in 1X PBS containing 0.1% tween-20 (PBT). 
Prehybridisation of the embryos at 55°C in a humidified chamber/hybridisation oven 
for 1 hour in hybridisation buffer (50% formamide (Fluka), 4X SSC (Sigma), 1X 
Denhardt’s solution (Sigma), 250µg/ml yeast tRNA (Invitrogen), 250µg/ml salmon 
testis DNA (Sigma), 50µg/ml heparin (Sigma), 0.1% Tween-20)) was necessary. The 
actual hybridisation of the embryos was done overnight at 55°C with 5 µl of 25 ng/µl 
DIG-labelled RNA probe in 0.5 ml hybridisation buffer, both the probe diluted in 
buffer and embryos being incubated at 55°C before mixing. The following day, 
embryos were washed 4 times in a washing solution at 55°C (50% formamide, 2X 
SSC, 0.1% tween-20). The first 3 washes lasted several hours during the day, the last 
wash was overnight. Prior to antibody detection, the embryos were rinsed once in 
PBT and washed in 1 ml PBT for 30 min under gentle shaking. For detection an anti-
DIG-AP FAB fragments antibody (Roche) diluted in PBT + 5% normal goat serum 
was used. Incubation of the embryos and antibody was done for 90 min at room 
temperature with gentle shaking. The embryos were then washed 4 times in PBT, 20 
min per wash. In order to prepare the embryos for staining development the embryos 
were rinsed twice and washed once for 5 min in AP buffer (100 mM Tris pH 9.5, 100 
mM NaCl, 50 mM MgCl2, 0.1% Tween). The colouring was developed in the dark 
in presence of 2.7 µl NBT (stock concentration of 9 µl/ml of 4-NitroBlue 
Tetrazolium Chloride Solution from Roche) and 2.1 µl BCIP (stock concentration 7 
µl/ml of 5-Bromo-4-chloro-3-indolyl-phosphate, 4-toluidine salt from Roche) diluted 
in 0.3 ml AP buffer. Embryos were washed thoroughly in PBT to stop the colouring 
reaction does not develop further than necessary and mounted in 80% glycerol. A 
Zeiss Axioskop microscope was used for observation of the stained embryos. 
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2.4.9 The GAL4-UAS Expression System 
The GAL4/UAS system was used to mis-express Drosophila HDAC4 and human 
HDAC5 in specific cells or tissues within the embryo. The system has two 
components: the GAL4 driver stock that expresses the yeast transcriptional activator 
protein under a tissue/cell specific promoter/enhancer, and the UAS stock that carries 
a transgene whose expression will be modulated by the GAL4 upstream activating 
sequence (UAS). In GAL4 and UAS crosses, the transgene is expressed in the same 
pattern and tissue as the GAL4 protein. The promoter that regulates GAL4 
expression can induce the ectopic expression of a transgene (Sonnenfeld, 2009).  
In the experiment used to observe the effects of overexpressing HDAC4 in muscle, 
females homozygous for the twi-Gal4; twi-Gal4 drivers were crossed with males 
homozygous for each UAS construct (see tables 2.1 and 2.4 for UAS constructs 
used). Crosses were set up in collection cages where flies were allowed to lay eggs 
on apple juice-agar plates at 25°C for 18h. These 0-18h collections contained 
embryos of stages 1-17. Stages 12 and 16 were identified by morphology and used to 
observe the effects of overexpessing different Class IIa HDAC constructs in muscle. 
Table 2.4: UAS-Constructs used to overexpress HDAC 
UAS construct Role 
UAS-dHDAC4 Construct allows overexpression of full length Drosophila HDAC4 
UAS-dHDAC4ΔC Construct allows overexpression of constitutively active Drosophila 
HDAC4, due to deletion of C-terminus including the HDAC domain 
UAS-dHSAC4SA Construct contains a Drosophila HDAC4 variant in which all the 
serine residues have been mutated to alanine. These Ser residues are 
important in the process involving shuttling of class IIa HDACs 
between cytoplasm and nucleus 
UAS-hHDAC5 Construct allows overexpression of full length human HDAC5 
UAS- hHDAC5ΔC Construct allows overexpression of constitutively active human 
HDAC5, due to the deletion of the C-terminus which includes the 
HDAC domain and NES 
UAS- hHDAC5SA Construct contains a human HDAC5 variant in which all the serine 
residues have been mutated to alanine. These Ser residues are 
important in  the process involving shuttling of class IIa HDACs 
between cytoplasm and nucleus 
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Chapter 3: Tandem affinity purification of Mef2 interacting proteins 
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3.1 Introduction 
Cell differentiation represents the core biological process to produce specialised 
tissues during development, and are implemented by molecular switches like 
transcription factors (TFs) that are able to activate batteries of genes. Uncovering the 
molecular mechanisms that lead certain central elements to coordinate the activation 
of specific genes via cis-promoters is considered essential for understanding how 
organisms develop (Britten and Davidson, 1969; Davidson and Britten, 1974; 
García-Bellido, 1975; Newman, 2020). Myogenesis represents a paradigm for the 
cell differentiation program and its gene expression program is regulated by key 
transcription factors like MRFs and the family of Mef2 genes in vertebrates and 
Twist and Mef2 in Drosophila (see Introduction). The Mef2 transcription factor 
family plays a pivotal role in muscle development both in Drosophila and vertebrate 
musculature where it partakes in TF cascades responsible to activate muscle specific 
genes (see Introduction sections 1.7 and 1.8 for specific examples) (Black and Olson, 
1998; Potthoff and Olson, 2007; Taylor, 1995). Drosophila has had a central role in 
uncovering the function of Mef2 in muscle development together with studies in 
mammalian cell culture (Taylor and Hughes, 2017). In mammals there are four 
closely related Mef2 genes (Mef2a, -b, -c, -d), while Drosophila has a single gene. In 
Drosophila, Mef2 null mutants are not able to form differentiated muscle - although 
specification occurs the progenitors fail to fuse (Bour et al., 1995; Lilly et al., 1995; 
Ranganayakulu et al., 1995) - while a loss of function study in vertebrates showed 
that MRFs require Mef2 to convert fibroblasts to myoblasts and C2C12 myoblasts 
fail to form myotubes in absence of Mef2 (Ornatsky et al., 1997; Snyder et al., 2013). 
Therefore, to understand muscle formation in Drosophila it is crucial to understand 
the function of Mef2 and of muscle specific proteins that interact with it during 
myogenesis.  
Genomic chromatin immunoprecipitation (ChIP) studies in Drosophila embryos 
have shown the broad role Mef2 plays in the orchestration of muscle differentiation 
(Junion et al., 2005; Sandmann et al., 2006). Hundreds of genes expressed at 
different time points during the differentiation program were regulated by Mef2 and 
showed differential transcriptional responses to different levels of Mef2 and to co-
activation by Mef2 and Lmd or Mef2 and Twi (Bernard et al., 2009; Cunha et al., 
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2010; Sandmann et al., 2006, 2007). In mammalian cell culture it was shown that the 
four Mef2 isoforms can activate separate gene groups and that very few genes are 
responsive to the activation of all the four Mef2 proteins (Estrella et al., 2015).  
Both in Drosophila and in mammals the activity of Mef2 is at the centre of a variety 
of biological contexts, where it coordinates specific gene programs based on 
signalling cues transduced to the nucleus by different kinases, or other activators and 
repressors. A selection of these partners have been found in muscle cells, while 
others interact with Mef2 in the fat body and the neurons. In Drosophila, Mef2 is 
present both in embryonic and adult muscle progenitor cells, hours before many of 
its target genes are expressed (Ranganayakulu et al. 1995; Taylor, 1995) and the 
activation of its target genes have been shown to require the presence of other TFs 
like Twist, Lmd, CF2, Sd and Vg for their activation. Some of these activation 
partners have been shown only to bind the same CRM to activate target genes, while 
other like Twist, Sd and Vg physically bind to Mef2 as proven by studies performed 
in S2 cells (Arredondo et al., 2017; Bernard et al., 2009; Cunha et al., 2010; 
Sandmann et al., 2007). Even in the same cell type, the Mef2 target genes have a 
range of expression profiles during the differentiation program (Elgar et al., 2008; 
Junion et al., 2005; Sandmann et al., 2006; Cunha et al., 2010) and Mef2 can interact 
differentially with its interaction partners in different muscle types (e.g. cardiac, 
visceral, somatic) which leads to varied transcriptional patterns (Busser et al., 2012; 
Deng et al., 2009). Mef2 is involved in adult neurons to regulate circadian rhythmic 
behaviour where its expression is regulated by the Clock and Cycle circadian 
transcription complex (Blanchard et al., 2010; Sivachenko et al., 2013). In the fat 
body Mef2 acts as a molecular switch for anabolic function and immune response 
depending on its phosphorylation state and the ability to bind TBP (Clark et al., 
2013). Moreover, the Mef2 family displays diverse functions in many mammalian 
cell types: muscle, nerve, vasculature, T-cells, chondrocytes (Potthoff and Olson, 
2007), with different Mef2 isoforms showing overlapping but also converging 
functions. Many of the proteins that directly interact with Mef2c in various biological 
contexts have been recently reviewed and they total 30 direct binding partners (Dong 
et al., 2017). Most of these proteins were identified through small scale studies where 
the interaction of each protein with Mef2 was assessed. Two large scale studies 
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performed in S2 cells provide lists of Drosophila Mef2 candidate direct interaction 
partners. 
Considering how complex the activity of Mef2 is in Drosophila and the diverse 
transcriptional responses it can generate, it is clear there are protein complexes that 
modulate the function of Mef2 in time and space in order to prevent early activation 
of genes in early muscle development, that regulate its activity during the 
differentiation program, as well as allow its activity in different cellular contexts 
required to regulate gene expression. Some of these direct protein interactions have 
been documented, however these are probably part of larger protein complexes that 
interact with Mef2 and are able to regulate its activity during muscle development 
(Guruharsha et al., 2011; Rhee et al., 2014). Considering the particular characteristics 
of the Mef2 behaviour in muscle cells, it becomes apparent that most of its 
interactions happen sporadically and in a context specific manner. Sometimes the 
interaction with the same protein can lead to opposing functions, either activating or 
repressing, most probably brought into effect by interaction with other proteins that 
can induce post translational modifications either to the two proteins themselves or to 
the chromatin surrounding the enhancers (Bernard et al., 2009; Busser et al., 2012).   
It was the aim of this study to identify Mef2-interacting proteins in muscle 
differentiation in embryos, preferably as part as distinct protein complexes that are 
able to effect a particular function.  Identifying and understanding the role of these 
proteins is of general importance since they represent an important part of the picture 
which describes the role of Mef2 in cell differentiation of muscle cells. Some protein 
interactions with Mef2 have been described, with little information about the role in 
development and the S2 large scale extractions cannot offer the resolution for a 
comprehensive screen of Mef2-interacting protein during development. 
3.1.1 Experimental approach 
Advances in complex protein purification approaches and subsequent identification 
of candidates by mass spectrometry have allowed systematic identification of protein 
complexes and networks (Köcher and Superti-Furga, 2007). Tandem affinity 
purification (TAP) represents the method of choice for proteome analysis when the 
subject of interest are long-range interactions, i.e. protein complexes consisting of 
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more than a bait (protein studied) and its direct interactor proteins, particularly when 
little prior information on expected interactors is available. The TAP method implies 
the fusion of the TAP tag with the targeted protein and its insertion into the host cell 
or organism. Cell extracts are prepared and the bait protein (TAP-tagged target 
protein) and its interaction partners are extracted via two subsequent steps of 
purification/elution. Compared to single-purification protocols, this usually reduces 
the amount of contaminating proteins. The TAP tag consists of two IgG binding 
domains from Staphyloccocus aureus Protein A, a TEV cleavage site and a 
calmodulin binding protein (CBP; Figure 2.2). This tag represents the canonical TAP 
tag and was initially developed in yeast (Rigaut et al., 1999). Both N-terminal and C-
terminal TAP tags are available, where the domains inversed such that Protein A is 
always located furthest from the target protein (Puig et al., 2001). This tag will be 
referred to as yTAP where “y” stands for yeast. The yTAP tag has been successfully 
used in yeast, bacteria, Drosophila and mammalian cell culture to purify protein 
complexes (Bouwmeester et al., 2004; Butland et al., 2005; Gavin et al., 2002; 
Veraksa et al., 2005). 
In the purification process Protein A binds strongly to an IgG matrix and requires the 
use of TEV protease to elute the bait protein and its interaction partners under 
physiological conditions. The eluted material is further bound to Calmodulin-coated 
beads in the presence of Ca
2+
, the following washing steps eliminating contaminants 
and remaining TEV protease. The bound material is eluted off the beads with EGTA 
under mild buffer conditions. This method allowed for purification of high-yield 
protein complexes under native conditions (Puig et al., 2001).  
Different version of the TAP tag have been developed to reduce the amount of 
necessary input material, reduce the percentage of contaminants and increase the 
overall yield. The more bait protein is recovered, the more associated partners are 
obtained. The new tags developed involved substitution of Protein A with Protein G 
and CBP with streptavidin binding peptide (SBP). Permutations of the mentioned 
components resulted in 4 different tags: a Protein A-CBP tag (the original yTAP), 
Protein G-CBP tag, Protein A-SBP tag and Protein G-SBP tag (GS-TAP). Of the four 
tags tested, the GS-TAP was shown to render the best results in mammalian cell 
culture. A 10-fold yield increase was observed for the GS-TAP tag compared to 
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yTAP (Bürckstümmer et al., 2006). The performance of the GS-TAP tag compared 
to yTAP was tested in the Drosophila system both in cell culture and embryos. The 
GS-TAP tagged protein expressed in Drosophila whole embryos gave a 3-fold higher 
elution yield compared to its yTAP tagged version. A lower load of contaminants 
was observed in the GS-TAP purification than in the yTAP purification. The use of 
additional TEV cleavage sites in the GS-TAP tag increased the cleavage time after 
the first purification step (Kyriakakis et al., 2008). 
The advantages offered by the GS-TAP tag for the purification procedure are the 
following: less input material is required, a reduction in contaminants left in the final 
elute is observable and the overall yield is higher than for TAP purification with the 
yTAP tag. The Furlong lab developed a line of C-terminally tagged Mef2. The GS-
TAP tag was knocked in frame with the Mef2 gene after its tenth exon. After the 
tenth exon the tag continues at the C-terminus with the SBP, two TEV cleavage sites 
and two Protein G domains. The knock-in was obtained by homologous 
recombination and the obtained stock was homozygous viable. The localisation of 
the protein in the cell was not affected by the tag. 
The modifications to the TAP purification procedure generated by the use of the GS-
TAP are the following: the first part of the purification step is the same (IgG beads 
are used to sequester the bait protein and the associated proteins from the lysate 
mixture, followed by the release of the bait by TEV protease cleavage), while the 
second step requires the use of streptavidin sepharose beads (instead of calmodulin 
beads) to bind the TEV-protease cleaved proteins and eluted with biotin (instead of 
EGTA). 
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3.2 Results 
3.2.1 Embryo collections for TAP purification 
Tandem affinity purification is a method to purify protein complexes in different 
model systems. Despite the wide range of applicability of this method in various 
organisms, the yield of the purified proteins is low. Therefore, a large quantity of 
biological input material is necessary to obtain a sufficient amount of eluted proteins 
to be detected by mass spectrometry (MS). In mammalian cells, the typical quantity 
of harvested cells for TAP purification amounted to 5x10
8
 - 1x10
9
 cells  
(Bürckstümmer et al., 2006). The range of quantities of input material used in the 
past to perform TAP purifications from Drosophila melanogaster embryos is very 
broad. The TAP purification of a nuclear protein used a nuclear extract from 30 to 40 
grams of embryos (Klymenko et al., 2006). Another study performing TAP 
purifications in Drosophila embryos both for cytosolic and nuclear proteins reported 
a range of 3-6 grams of embryos for an experiment (Veraksa et al., 2005). A study 
comparing the efficiency of the use of the GS-TAP tag to the classical yTAP 
reported that 5 grams of embryos were necessary for one TAP purification 
(Kyriakakis et al., 2008). 
Mef2, the target protein of the TAP purification, is known to be expressed very early 
in development and is present in the embryo until the end of embryogenesis. A 
combination of genetic and genomic studies have revealed that muscle genes 
regulated by Mef2 have a lower requirement of Mef2 activity if they are expressed 
early compared to the genes expressed at a later time point (Sandmann et al., 2006). 
A model in which Mef2 activity levels increase during muscle differentiation was 
proposed (Elgar et al., 2008), although without specifying whether "Mef2 activity" 
refers to levels of expression of the mef2 gene, or the fraction of Mef2 protein that is 
activating transcription of target genes. If the activity levels in this sense correlate 
with the amount of protein expressed, it is expected that Mef2 protein expression is 
lower in early development compared to late development (Figure 3.1A). Applying 
this hypothesis to TAP purification, one would expect that a lower amount of starting 
material is required for extraction from late stage embryos compared to earlier stage 
embryos. Taking these into consideration, embryos of 4 staging windows were 
collected of the Mef2-GSTAP line such that enough input material for 2-3 large scale  
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Figure 3.1: Collected embryos of Mef2-GSTAP line for TAP purifications that 
require large amounts of starting biological material  
A) Developmental timeline of Drosophila embryos at 25°C (Campos-Ortega and 
Hartenstein, 1997), highlighting expression of Mef2 and the mesodermal determinant 
Twist, which induces Mef2 expression. Collection of staged embryos was performed 
in 2 h windows that allowed to identify the most representative stages for Mef2 
activity during embryogenesis. The picture was adapted from (Zinzen et al., 2009)  
B) Total amounts of staged Mef2-GSTAP and wildtype (WT) collected embryos to 
cover large scale experiments of TAP purifications of the same stage. Wildtype 
embryos were collected as controls to identify non-specifically binding proteins. 
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TAP purifications was available (Figure 3.1B), although due to time constraints only 
the 11-13h staging window was analysed as a representative of muscle development. 
3.2.2 Detection of the tagged Mef2 bait 
To identify systematically the proteins that associate with Mef2 during Drosophila 
embryogenesis, the Mef2-GSTAP Drosophila line developed in the Furlong 
laboratory at EMBL was used. The transgenic line contained a knock-in of a GS-
TAP at the C-terminus of Mef2 (Figure 2.2), in frame with its 10
th
 exon (Figure 2.1). 
The tag contained two Protein G domains, two TEV-protease cleavage sites, and one 
streptavidin-binding peptide (SBP) moiety, placing the Protein G domains at the 
extreme of the C-terminus. Immunohistochemistry against the tagged Mef2 protein 
revealed that its expression recapitulated the expression pattern of the wildtype Mef2 
protein during embryogenesis (data not shown). The first step in adapting the TAP 
purification protocol for the tagged Mef2 protein (Figure 2.4) was to identify a 
method that allows tracking the extraction process at each step. For proteins, Western 
blot was the method of choice to assess the success of the optimisation steps, both in 
preparing embryonic protein extracts and during the TAP purification experiments. 
Both small and large scale experiments were performed.  
Western blot required an antibody that can specifically recognise Mef2 and 
distinguish the bands for tagged and untagged Mef2. To obtain this, four different 
bleeds of anti-Mef2 antibodies were tested (Figure 3.2). The antibodies were 
prepared in-house by the Furlong lab and previously used in ChIP and 
immunostaining. All antibodies were tested on the following biological materials: 
embryos from the Mef2-GSTAP transgenic line, wildtype Drosophila embryos 
(Oregon R), HeLa cells and S2 cells. Each sample was homogenised on ice with a 
Wheaton douncer in the trial lysis buffer 1 (TL1): 50 mM Tris-HCl pH 7.5, 100 mM 
NaCl, 10 mM KCl, 5% glycerol, 0.2% NP-40, 1.5 mM MgCl2, 0.2% IGEPAL, 1 
mM DTT, 0.001% DNase and protease inhibitors (Pefabloc/AEBSF 2 mM, E-64 40 
uM, Aprotinin 0.5 mM, Leupeptin 1 uM, Pepstatin A 60 uM, Bestatin 10 uM). All 
four antibodies produced a band close to 100 kDa in lysates of embryos collected 
overnight (O/N, 0-18h) from the Mef2-GSTAP line. A band close to 70 kDa was 
dominant in all other samples. This suggests the 70kDa band corresponds to 
untagged Mef2 and the 100kDa band to tagged Mef2. The DRC4 antibody (Figure   
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Figure 3.2: Identification of tagged Mef2 in the lysate of Mef2-GSTAP embryos 
Lysates from different biological samples were loaded onto a blot and incubated with 
four different anti-Mef2 antibodies raised against Drosophila Mef2. (A-D) show a 
blot of one antibody, each tested against the same set of lysates. The antibodies were 
grown in house at EMBL and the names were coded internally. Wildtype embryos 
were used as a control to distinguish the tagged from the untagged Mef2. HeLa cells 
extracts were included as a control for cross reactivity with human Mef2, while S2 
cells extracts were included as a potential negative control as no endogenous Mef2 
protein was reported in S2 cells so far. The yellow arrow indicates the tagged Mef2 
band. 
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3.2B) was able to recognise both variants of Mef2 with relatively low background 
signal, and was chosen for future use. "Anti-Mef2" in below sections refers to this 
antibody. 
3.2.3 Tracking Mef2 during TAP purification as influenced by the amount of 
solubilised bait 
It is important to be able to follow the bait protein during the purification process as 
problems during intermediate steps could affect the outcome of the procedure and 
affect the overall yield. The less protein is obtained from the TAP purification 
process, the less associated proteins the MS can identify. To track the Mef2 protein 
during the TAP purification process there were three possibilities: an anti-Protein G 
(anti-TAP) antibody, an anti-SBP antibody or an anti-Mef2 antibody. The anti-TAP 
antibody would only be useful to follow the bait before the TEV protease cleavage 
step, while an anti-Mef2 and anti-SBP antibody would be appropriate to observe the 
entire purification process. To test this hypothesis a lysate obtained from 500 mg of 
Mef2-GSTAP O/N embryos was split in half and one of the halves was incubated 
with TEV protease for 1h at 16°C. The lysates derived from Wildtype Drosophila 
embryos (WT) and HeLa cells were used as positive controls for the untagged Mef2 
and as negative controls for antibodies targeting the GSTAP tag. The anti-SBP and 
anti-TAP antibodies detected only a 96 kDa band in the uncleaved Mef2-GSTAP 
O/N embryos (Figure 3.3A & B, second lane). When the lysate from Mef2-GSTAP 
O/N embryos was incubated with the TEV-protease, the 96 kDa band disappeared 
and a shorter 19 kDa band appeared in the anti-TAP blot, consistent with the now 
cleaved tag, which is much smaller in size (Figure 3.3B, third lane). Similarly, in the 
anti-Mef2 blot, the upper band disappeared and the 77 kDa band became stronger, 
suggesting that Mef2 with the leftover SBP tag has a similar size as untagged Mef2 
(Figure 3.3C, compare second and third lane). The anti-SBP antibody was not able to 
detect the cleaved Mef2 (Mef2-SBP; Figure 3.3A, third lane), which made it 
inappropriate as an antibody for observation of the purification process. The anti-
TAP and anti-Mef2 antibodies were also tested on lysates from staged Mef2-GSTAP 
11-13h embryos, with essentially the same results (Figure 3.3D & E). 
Having identified a suitable antibody, the lysis method was the first step to optimise. 
Several lysis methods were tested for their ability to extract and solubilise the Mef2-
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GSTAP protein (Figure 3.4). Since just homogenising the embryos and clarifying the 
lysate proved to be quite inefficient, two new lysis methods were compared: longer 
incubation of the homogenate with the lysis buffer and a hypotonic extraction. For 
the standard lysis the embryos were resuspended in TL1, the tissues mechanically 
sheared with the loose pestle and the grinding process was finished off with the tight 
pestle. The loose pestle should break apart tissues while leaving most of the cells and 
nuclei intact, while the tight pestle should help the shearing of all the cellular 
components. The lysis buffer was designed to create an isolating and stable 
environment for the proteins of interest. This is of vital importance to the TAP 
purification procedure, because long range interactions between proteins are only 
maintained under close to physiological conditions. The modified procedure with 
extended incubation took advantage of additives contained in TL1, such as 
detergents, which should allow membranes to be disrupted more easily. After 
dissociating tissues using the loose pestle, the lysate was therefore incubated on ice 
for 30 min to partially lyse cells in this modified procedure. Subsequently, the lysate 
was ground with the tight pestle and clarified to solubilise the proteins. For the 
hypotonic extraction, a TL1 lysis buffer without NaCl was used during the two steps 
of mechanical shearing in pestles. After this, the salt was added and the lysate was 
incubated on ice for 30 min to allow the osmotic pressure created by the addition of 
salt to disrupt any unbroken cellular components. 
To quantify the amounts of Mef2 extracted by each lysis procedure, the total protein 
concentration of each lysate was determined using a Bradford assay and equal 
amounts were loaded onto a blot (see Methods). Additionally, a standard of known 
amount of GFP was loaded in serial dilutions (Figure 3.4A) and quantified by 
densitometry (Figure 3.4B). It was shown that regardless of the lysis method, the 
amounts of Mef2 that can be extracted from embryos varies by stage (Figure 3.4A & 
C). The comparison of the supernatant to the pellet has shown that the standard lysis 
procedure had the highest recovery rate of solubilised bait (Figure 3.4D & E). The 
hypotonic extraction was slightly more efficient than the lysis with extended 
incubation, though overall the initial lysis method was the most efficient and the least 
time consuming.  
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Figure 3.3: Options for observing the Mef2-GSTAP bait during TAP 
purification  
Western blots testing three methods to detect Mef2-GSTAP during the purification.  
The antibodies were tested on overnight (O/N) collected Mef2-GSTAP embryo 
lysates that were incubated with or without protein TEV protease. The lysates of 
HeLa cells and WT embryos were used as negative control. Yellow arrow indicates 
the tagged uncleaved bait, pink arrow indicates the Mef2 protein after tag cleavage, 
blue indicates the cleaved Protein G domains. 
A) Anti-SBP antibody that should detect the SBP in the tag before and after cleavage 
by TEV protease 
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B) Anti-TAP/ Protein G antibody that can detect the tagged bait when uncleaved or 
the cleaved Protein G domains of the bait 
C) Anti-Mef2 antibody that can detect both the cleaved and uncleaved bait.  
D&E) Extracts of 11-13 h staged Mef2-GSTAP embryos were used to confirm 
results of the anti-TAP (D) and anti-Mef2 (E) antibodies.  
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Figure 3.4: Testing different lysis methods to optimise the recovery of tagged 
Mef2 protein for use in TAP purifications 
The three different lysis methods were liquid homogenisation (labelled A on the 
blots), liquid homogenisation with extended incubation (labelled B on the blots), and 
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hypotonic shock extraction (labelled C on the blots). Each lysis methods was applied 
to embryos staged 4-6h, 6-8h and 10-12h. Bradford assays were used to determine 
total protein concentrations of each sample such that equal amounts could be loaded. 
A) To determine the amounts of clarified Mef2-tagged protein contained in each 
lysate, a western blot detected by the anti-Mef2 antibody was prepared in correlation 
with a serial dilution of a purified GFP of known concentration.  
B) Densitometry-based analysis to determine amounts of Mef2 extracted in the 
different homogenisation methods. A correlation between amount loaded and signal 
detected was determined based on GFP quantification and a similar correlation was 
used to determine the Mef2 bait extracted at different stages. 
C) Efficiency of the methods was determined by comparing the signal in the 
supernatant containing the solubilised protein that can be used in TAP, and the pellet 
that contains unextracted bait. 
D) Densitometric quantification of the relative Mef2 content of supernatant and 
pellet in each lysate. 
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3.2.4 TAP purification of Mef2-GSTAP and associated complexes from 2 g of 
O/N embryos 
The first large scale TAP experiment was realised starting from 2.366 g of O/N 
Mef2-GSTAP embryos using a procedure adapted from a TAP purification protocol 
used in the Gavin lab to purify yTAP-tagged proteins from Mycoplasma cells. Since 
the second part of the purification using the GSTAP tag required the use of 
Streptavidin beads rather than Calmodulin beads, this part of the purification 
protocol was adapted from the method described by Kyriakakis et al. (2008). In this 
study, the streptavidin-coated beads were boiled in SDS-loading buffer to release the 
bound purified complexes from the beads. The Bürckstümmer et al. (2006) study, 
which reported on the different TAP tag variants and their efficiency on purifying 
complexes from mammalian cells, used a 1 mM biotin solution to elute proteins from 
streptavidin beads instead. According to personal communication, others performing 
the biotin elution method with other tags have used a variety of biotin concentrations 
ranging from 2 mM to 10 mM. To perform the elution of Mef2-GSTAP and 
associated proteins, the streptavidin beads were therefore incubated in 150 µl of 2 
mM biotin solution (1.5 times beads volume) for 5 min at 4°C and eluate was 
recovered by gravitational flow. A control experiment of the same TAP protocol was 
performed on wildtype embryos.  
To observe the evolution of the TAP purification process, analytical fractions were 
collected throughout the procedure (Figure 3.5A). The fractions were analysed by 
Western blot and densitometry to determine the efficiency of each intermediate step 
and identify bottlenecks. The aliquots were taken at the following step: input extracts 
before clarifying the sample (Input); supernatant containing solubilised protein 
(cytosolic fraction, CF); supernatant after incubating the CF with the IgG beads (IgG 
flow-through, FT); uncleaved bait protein left on the IgG beads after incubation with 
TEV protease (IgG beads); bait protein cleaved by TEV protease (TEV eluate); flow-
through after incubating the streptavidin (SA) beads with the TEV eluate 
(Streptavidin FT); bait protein not eluted off the streptavidin beads (Streptavidin 
beads); final bait eluted with biotin that was used for MS analysis (Final eluate). 
Note that any protein detected in the IgG FT, IgG beads, SA FT and SA beads 
fractions represents protein lost in the purification procedure. 
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Densitometry was performed on the relevant bands obtained on the Western blot 
(Figure 3.5C). This refers to the bands for uncleaved Mef2 (100kDa) up to the TEV 
cleavage step, and the lower band for cleaved Mef2 (70kDa) after the cleavage. Both 
bands were quantified in the IgG beads fraction to assess the performance of TEV 
cleavage itself. The obtained densitometry values were corrected by the specific 
portion of each purification step loaded on the gel. 93% of the bait was solubilised 
(Figure 3.5B, CF vs. Input, normalised by amounts loaded). This solubilised bait is 
considered 100% of bait to be purified (Figure 3.5C), of which 27% bound to IgG 
beads as suggested by the 73% found in the IgG FT. After washing the beads and 
adding TEV protease, 3.3% of the initial bait remained in total. This estimate is the 
sum of 1.2% uncleaved bait (IgG beads, 100kDa band), 1.3% cleaved bait remaining 
bound to beads (IgG beads, 70kDa band) and 0.8% recovered bait (TEV eluate). This 
suggests that up to 23.7% of bait was lost in the washing steps before TEV cleavage. 
After the incubation of the TEV eluate with the streptavidin beads, washed with 6 ml 
cleavage buffer and eluted with biotin, only 0.27% was eluted in the final fraction, 
which amounts to 1/3 recovery of bait from the TEV eluate. 
For the MS analysis both purified samples (100 µl eluate each from O/N Mef2-
GSTAP or WT embryos) were concentrated with Amicon centrifugal filters with a 
10k cut-off to a volume of 30 µl. The samples were run a few centimetres into a 4-
15% Biorad gradient gel and the lane was cut out entirely and processed for analysis 
by the Proteomics Core Facility at EMBL. Running the samples so shortly into the 
gel allowed reducing the amount of gel needed to extract the peptides from the gel. 
Even though no bands were visible by Coomassie staining (Figure 3.5D), three 
proteins were identified by MS in the Mef2-GSTAP sample: Mef2, Hsc70-3 (a heat 
shock protein) and Actin 5C. The most abundant was Mef2 (the bait). In the WT 
control, one protein was identified, which was also among the proteins in the Mef2-
GSTAP sample (Actin 5C). The high abundance of the bait in the sample shows that 
the purification procedure was successful. However, the amount of bait was not 
sufficient to permit detecting many associated proteins. The two proteins pulled 
down are often regarded as contaminants in other pull down studies (Veraksa et al., 
2005), but have been shown to interact with Mef2 in other organisms (Sala et al., 
2014; Sonnemann et al., 2006; Yang et al., 2009).   
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Figure 3.5: TAP pilot experiment with 2g of O/N embryos expressing Mef2-
GSTAP 
A) Illustration of the aliquots collected during the purification procedure to observe 
the loss of bait at each crucial step of the purification: Input, input extracts before 
clarifying the sample; clear cytosolic fraction (CF), solubilised proteins fraction; IgG 
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FT (flow through), flow through after incubating the CF with the IgG beads, any 
detected protein is lost protein; IgG beads, uncleaved bait protein left on the IgG 
beads after incubation with TEV protease; TEV elute, cleaved bait protein by TEV 
protease; Streptavidin F, flow through after incubating the streptavidin beads with 
the TEV elute; Streptavidin beads, bait protein not eluted off the streptavidin beads; 
Eluate, final bait eluted with biotin that was used for MS analysis.  
B) Western blot of the aliquots collected during purification, stained against Mef2. 
Yellow arrow: the band corresponding to uncleaved Mef2 (100k) is not present in the 
supernatant after bead purification. Pink arrow: Band corresponding to cleaved Mef2 
(70k). 
C) Quantification of the Mef2 bait identified in each analytical fraction in B) based 
on densitometry after correction by the relative amount loaded onto the gel. CF, IgG 
FT and IgG beads 100k quantify the upper band of uncleaved Mef2 near 100kDa, all 
others quantify the lower band of cleaved Mef2 near 70kDa. 
D) Coomassie stained gel of the proteins purified by TAP. The control sample was 
extracted from WT embryos. The lanes marked were cut out from this gel for 
analysis by mass spectrometry (MS). Even though no bands were visible, a small 
number of proteins were identified by MS. The results from this experiment are in 
Table S1 ("ONMEF 2g pilot" column), see data availability statement in section 
2.3.13). 
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3.2.5 TAP purification of Mef2 complexes from 2 g of 11-13 h embryos 
The second TAP experiment was performed on 11-13 h staged embryos, collected 
from the Mef2-GSTAP or WT lines. Based on the first experiment, a higher amount 
of bait was desired. However, a much larger amount of bait protein per gram of input 
embryos was expected compared to the O/N embryos based on the previous 
experiments for optimising the lysis procedure. A similar quantity of embryos was 
therefore used as input material to prepare the lysate (~2 g of embryos). In the first 
TAP experiment, a large amount of bait remained on the IgG beads after TEV 
cleavage, with only 0.8% of bait being recovered in the TEV eluate. The 
concentration of TEV protease was therefore increased from 0.05 µg/µl as in the 
Gavin Protocol to 0.1 µg/µl as in the Kyriakakis study in order to increase the 
removal of the bound bait from the IgG beads. 
The analytical fractions were collected during the TAP purification procedure as in 
the first experiment and were analysed by western blot (Figure 3.6A) and 
densitometry. The recovery of bait after solubilisation was 79%, lower than 93% 
solubilisation in the first experiment. The fraction of bait bound to IgG beads was 
20% and in the TEV eluate 0.9%, while 1% was cut but remained stuck on the IgG 
beads and 0.8% was uncut by the TEV protease (Figure 3.6B). The ratio of total 
cleaved to uncleaved bait was therefore changed from 1.7 in the previous purification 
from O/N embryos to 2.5 in the staged embryos. The final percentage of bait purified 
was 0.35%, a slightly better yield than the first experiment (0.27%). Considering that 
the absolute amount of protein was higher in the 11-13h embryos as input, a much 
larger amount of bait should be present in this final eluate.  
The MS results suggested that indeed more bait was present, since more co-purified 
proteins were identified. While previously only 3 proteins were detected in the O/N 
embryos (bait and two candidate proteins), 56 proteins were identified in the 11-13h 
embryos (Mef2 bait and 55 candidate proteins). Only 5 proteins were detected in the 
11-13 h WT control.  
To compare in more detail the improvements brought by the use of more TEV 
protease to cleave the Mef2-GSTAP off the IgG beads, the analytical fractions of the 
O/N and 11-13 h experiments obtained after the incubation with the protease were 
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Figure 3.6: TAP pilot experiment with 2g of 11-13 embryos expressing Mef2-
GSTAP 
A) Aliquots were collected during the purification procedure and analysed by 
Western blot to observe the loss of bait at each crucial step of the purification: Input, 
input extracts before clarifying the sample; clear cytosolic fraction (CF), solubilised 
proteins fraction; IgG FT (flow through), flow through after incubating the CF with 
the IgG beads, any detected protein is lost protein; IgG beads, uncleaved bait protein 
left on the IgG beads after incubation with TEV protease; TEV elute, cleaved bait 
protein by TEV protease; Streptavidin F, flow through after incubating the 
streptavidin beads with the TEV elute; Streptavidin beads, bait protein not eluted off 
the streptavidin beads; Eluate, final bait eluted with biotin that was used for MS 
analysis. 
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B) Quantification of the Mef2 bait identified in each analytical fraction in (A) based 
on densitometry after correction by the relative amount loaded onto the gel. CF, IgG 
FT and IgG beads 100k quantify the upper band of uncleaved Mef2 near 100kDa, all 
others quantify the lower band of cleaved Mef2 near 70kDa. 
C) Comparison of the efficiency of Mef2 cleavage off the IgG beads in the 2g O/N 
TAP experiment compared to 2 g of 11-13 h embryos. 
D) Ratios between the full length tagged bait (100 kDa band) and the cleaved bait 
(70 kDa band) or between the eluted cleaved protein and the bait remaining on the 
IgG beads. The total amount of cleaved bait is the sum of the lower band in the IgG 
beads and TEV elute lanes, adjusted by amount loaded. The total amount on beads is 
the sum of the two bands in the respective IgG beads lane of (C). 
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loaded on a Western blot (Figure 3.6C) and analysed by densitometry. The 
comparison of the cleaved to the uncleaved Mef2 showed that the increased 
concentration of TEV protease was able to cut a larger proportion of the tagged bait 
protein, however the yield obtained in the eluate was not significantly larger (Figure 
3.6D). Despite this, the amount of bait and associated proteins in the 11-13 h eluate 
was sufficient to cross the detection threshold for MS and return a more appropriate 
number of identified proteins. Given that the change in TEV protease concentration 
did not impact the fraction of recovered bait substantially, this improvement is likely 
owing to a higher absolute amount of bait in the 11-13 h embryos. 
3.2.6 Improving bottleneck steps of TAP purifications 
Based on these two experiments, the main bottlenecks impacting the amount of bait 
(and bound proteins) available for MS were identified as the following: 1) the 
amount of input bait; 2) the efficiency of the bait binding to the IgG beads (70-80% 
of bait lost); 3) the recovery of cut bait after TEV cleavage (75% of remaining bait 
lost). The binding efficiency of the bait to IgG beads could be increased by using a 
larger amount of beads to achieve saturation during the incubation with the lysate. To 
improve recovery of the cleaved bait, a different elution method was chosen. The 
elution of the cleaved protein from the IgG beads so far was done by gravitational 
flow, which did not prove the most efficient.  
To test the impact of the amount of IgG beads on the recovery of bait in subsequent 
steps, a small scale experiment focussing on the first part of the TAP purification 
procedure was designed (Figure 3.7A). 2 g of O/N Mef2-GSTAP embryos were used 
as input material for the experiment and lysed using the standard procedure. 5 ml of 
cytosolic fraction were obtained and divided into four fractions of increasing volume: 
500 µl (1xCF), 1 ml (2xCF), 1.5 ml (3xCF), and 2 ml (4xCF). Each fraction was 
incubated with 20 µl of IgG beads to assess the binding capacity of the IgG beads 
from an increasing amount of Drosophila embryo lysate. The beads were recovered, 
washed twice and incubated with TEV protease to cleave and release the bait. The 
cleaved bait was eluted twice, first by centrifugation at 400 g for 2 min and again by 
washing the beads in 100 µl of cleavage buffer (TEVcb), followed by centrifugation.  
Analytical fractions of each step were analysed by Western blot as previously, 
though additional samples from washes were included (Figure 3.7B).  
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Figure 3.7: Optimisation of the first steps of TAP purification 
A) 2 g of O/N embryos were lysed and split into four fractions of increasing volume, 
each to be incubated with the same amount of IgG beads. The aliquots therefore 
receive decreasing concentrations of beads. 
B) Detection of bait in aliquots taken during incubation with the IgG beads and 
release of the bound bait by TEV protease cleavage. IgG FT, bait not adsorbed by 
IgG beads; LB wash, wash of bait-coated IgG beads with lysis buffer; TEVcb wash, 
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wash of bait-coated IgG beads with TEV protease cleavage buffer; IgG beads, left-
over bait on the IgG beads after washes and TEV protease cleavage (obtained by 
boiling beads after elution; typically some bait stays uncleaved and some cleaved 
bait also remains); TEV elute, cut bait protein eluted off the beads by centrifugation; 
TEV elute wash, 100 µl wash of post-cleavage IgG beads in TEV cleavage buffer 
prior to boiling, collected with centrifugation. An equal volume of corresponding 
analytical fractions was loaded, e.g. for TEV elute, 4 µl was loaded from the 1xCF 
TEV elute, 4 µl from 2xCF TEV elute etc. The cleaved Mef2 band is near 70kDa, the 
uncleaved Mef2 near 100kDa. 
C) Quantification of (B), highlighting distribution of bait across the different 
fractions. For each sample (1xCF, 2xCF etc.), the total bait detected across the 
different analytical fractions was measured. Each bar represents the respective 
fraction of this total. 
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The distribution of bait across the different fractions was similar regardless of the 
ratio of lysate to beads (Figure 3.7C), indicating consistency of the extraction 
procedure during these steps. To assess the efficiency of bait binding to IgG beads, 
the densitometry values of bait detected in the IgG FT were compared to the total 
amount of bait detected in the input. If the binding capacity of the beads exceeded 
the amount of bait, the efficiency should be unaffected by the amount of lysate. For 
1xCF and 2xCF, 91% and respectively 81% of the bait bound to the beads, while 
only 69% was bound in the 3xCF and 51% in the 4xCF samples, indicating that the 
binding capacity of the beads was saturated, potentially already in the 1xCF sample. 
The increasing amount of contaminants (blot signal outside of the 70kDa and 
100kDa bands, Figure 3.7B) suggests that additionally to lower efficiency of binding 
the bait, the beads were increasingly binding other proteins unspecifically. After 
TEV cleavage, approximately 35% of the bait was successfully eluted off the beads 
in the first two more concentrated samples, and approximately 25% in 3xCF and 
4xCF. Increasing the amount of IgG beads used for bait capture should therefore 
improve bait binding and yield. 
3.2.7 TAP purification of Mef2 complexes from 7.7 g of O/N embryos 
Taking into account the conclusions derived from the previous experiments, the GS-
TAP purification protocol was modified to improve the steps that have an important 
impact of the overall yield of the purification process. This third TAP purification 
experiment used 7.73 g of O/N Mef2-GSTAP embryos (and in parallel 7.5g of WT 
embryos as a control sample) as input as the previous optimisation test suggested that 
a higher input amount is a simple way of obtaining more bait for elution and 
interaction capture. The following additional modifications to the previous protocol 
were made: 1) The quantity of IgG beads was increased from 200 µl to 400 µl in 
total to increase binding capacity, and the lysate was split into smaller fractions to 
improve the exposure of the lysate to the bead surface area during the incubation. All 
the beads were then collected into the same Mobitec column; 2) For washing the IgG 
beads after binding the bait, the ratio of lysis buffer to TEV cleavage buffer was 
increased from 2.5:1 to 4:1; 3) To increase recovery of bait after the TEV cleavage, 
the elution from the IgG beads was done by a short centrifugation at 400 g, followed 
by a wash (Maeda et al., 2014). The concentration of TEV protease was maintained 
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at 1 µg/ µl as used for the 11-13 h purification. All other steps were performed and 
analytical fractions were collected as described previously. 
The analytical fractions in this experiment produced an untidy blot with strong signal 
for all the samples even at very low film exposure (1 s; Figure 3.8A), indicating high 
total protein concentrations. The blot was analysed by densitometry where possible 
(Figure 3.8B). The quantification showed the following: 16% of the bait was 
successfully bound to the IgG beads, 0.9% was eluted after TEV protease cleavage 
and 1.7% was cut by the TEV protease, but was not recovered from the IgG beads. 
The final eluted bait amounted to 0.45%. This yield of the TAP purification was 
sufficient to identify a substantial number of proteins by MS, 310 in total. In the 
control TAP purification performed on 7.5 g of WT embryos, 121 proteins were 
identified. The proteins were also visible by staining with Coomassie blue on the gel 
before extraction for MS analysis (Figure 3.8C). A full list of all proteins identified 
by MS can be found in Table S1 in the Figshare repository (see data availability 
statement, section 2.3.13). 
The overlaps between proteins identified in the different MS runs are illustrated in 
Figure 3.8D and E. The majority (56%) of the 310 proteins identified from O/N 
Mef2-GSTAP embryos (O/N MEF) were not found in any of the other samples, 
while only a quarter (27%) of the 56 candidates identified in 11-13 h embryos (11-13 
MEF) were unique to that sample. Only 5 proteins were found in all four samples; 
the same 5 that were present in the sample purified from 11-13 h staged wildtype 
embryos. The O/N wildtype embryos (O/N CTRL) revealed 3 unique proteins (2% of 
121 total), indicating that the proteins purified when no GSTAP tag is present in the 
sample are not simply a subset of unspecifically eluted, i.e. contaminant, proteins 
from a GSTAP sample. A more in-depth bioinformatic analysis was therefore carried 
out.  
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Figure 3.8: Final TAP experiment with 7.7g of O/N embryos expressing Mef2-
GSTAP 
A) Anti-Mef2 treated Western blot of the aliquots collected during the purification 
procedure to observe the loss of bait at each crucial step of the purification: Input, 
input extracts before clarifying the sample; cytosolic fraction (CF), solubilised 
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proteins fraction; IgG FT (flow through), flow through after incubating the CF with 
the IgG beads, any detected protein is lost protein; IgG beads, uncleaved bait protein 
left on the IgG beads after incubation with TEV protease; TEV elute, cleaved bait 
protein by TEV protease; Streptavidin F, flow through after incubating the 
streptavidin beads with the TEV elute; Streptavidin beads, bait protein not eluted off 
the streptavidin beads; Elute, final bait eluted with biotin that was used for MS 
analysis. 
B) Quantification of the Mef2 bait identified in each analytical fraction of A) based 
on densitometry. The values were adjusted by the respective amount of each fraction 
loaded onto the gel and refer to the band of uncleaved Mef2 (near 100kDa) before 
TEV cleavage, and respectively the band of cleaved Mef2 (near 70kDa) after 
cleavage. The IgG beads fraction contained both cleaved and uncleaved Mef2, which 
was separately measured and represented on the plot (100k and 70k). 
C) Coomassie stained gel of the proteins eluted from the TAP purification. O/N (0-
18h) samples are from the final purification experiment using roughly 7 g of Mef2-
GSTAP (O/N MEF) or WT (O/N CTRL) embryos, while the 11-13 h samples are 
from the previous purification experiment using roughly 2 g  of Mef2-GSTAP (11-13 
MEF) or WT (11-13 CTRL) embryos (section 3.2.5). The lists of proteins pulled 
down in each sample and total spectral counts can be found in Table S1 in the 
Figshare repository (see data availability statement, section 2.3.13). 
D) Overlap of the Mef2 interaction candidates identified from the samples in (C). 
Lists of genes in each overlap category can be found in the Figshare repository (see 
data availability statement, section 2.3.13). 
E) As (D), but also showing overlap with the sample purified from 2 g O/N Mef2-
GSTAP embryos in the first TAP experiment (O/N MEF 2g). 
  
 94 
 
3.3 Discussion 
3.3.1 Input material required 
The creation of the yTAP tag and the development of the TAP method has 
contributed to significant advances in the identification of protein complexes in a 
systematic manner. By taking advantage of the GSTAP tag introduced by 
Bürckstümmer et al. (2006) it was possible to identify candidate proteins that interact 
with Mef2 during Drosophila embryogenesis. The tag is supposed to require 
relatively low input biological material for performing tandem affinity purifications 
(Bürckstümmer et al., 2006). However, a small amount of input material still requires 
large scale collections of Drosophila embryos to provide enough bait for the TAP 
purification, such that the bait and co-purified proteins could be identified by MS. 
The collection of embryos required cycles of population expansion and eggs 
collections and several batches of collected embryos needed to be collated for one 
experiment. Over a 2 hours time window, one collection provided on average 250 
mg, therefore even for a relatively small scale TAP experiment (e.g. 2 grams of input 
embryos) several collection rounds were required. Four different specific 
developmental time points were collected, as well as 18h unstaged collections that 
were labelled as O/N embryos. The collections required coordination of two different 
large Drosophila populations: the Mef2-GSTAP line, as well as the control wildtype 
embryos from the Oregon R (OR) line. Only collection of the input material required 
a solid 3 months-worth of egg collections and a well-defined collections schedule 
since only one collection of each stage was possible to achieve per day during a 14 
days collection time window.  During each cycle at which the fly population was in 
the correct laying stage, embryos had to be collected for different purposes as 
follows: 4 different specific developmental time points, O/N embryos and collection 
for population maintenance and expansion. In itself the collection of the required 
input biological material is a significant time investment.  
3.3.2 Tracking Mef2 during TAP purification 
By taking advantage of the properties of TAP and the GSTAP tag, the study was 
focused on purifying a tagged Mef2 protein from Drosophila embryos. Since no 
specific antibody was known for the GSTAP tag, a series of rabbit anti-Mef2 
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antibodies were tested on Drosophila embryos extracts for identification of Mef2 on 
western blots. The different bleeds were generated in house by the Furlong lab and 
were tested, which had previously been used in other types of assays (ChIP, 
immunohistochemistry).  All the tested bleeds showed on the Western blots a 
specific band of 96 kDa for the GSTAP-tagged Mef2 and a 76 kDa band for the 
untagged Mef2 protein as determined by densitometric analysis. All reported Mef2 
protein isoforms have molecular weights around 55kDa (see section 2.2.1), however 
there are no reports of the apparent molecular weight of Mef2 on Western blots when 
extracted from Drosophila embryos. This discrepancy could be due to post-
translational modifications. Despite this, the 76kDa band was consistent between 
wildtype and TEV-protease treated Mef2-GSTAP extracts. Additionally, the 96kDa 
band only appeared in Mef2-GSTAP extracts that had not been treated with protease, 
and was the only band appearing with the anti-TAP antibody, indicating that the 
bands correspond respectively to GSTAP-tagged Mef2 and wildtype or cleaved 
Mef2. The anti-Mef2 antibody chosen for further experiments was DRC4 3
rd
 since it 
gave the least amount of background. A 76 kDa band was also identified in S2 cells. 
The expression of Mef2 in HeLa cells was shown in other studies (Ornatsky and 
McDermott, 1996; Perry et al., 2009), but in S2 cells only studies with Mef2 that was 
transiently expressed through expression of exogenous constructs were done 
(Guruharsha et al., 2011). The background observed during incubation with the anti-
Mef2 antibodies could be due to the use of β-mercaptoethanol in the gel sample 
buffer, an artefact which was observed in other cases (Hanukoglu, 1990). Other 
causes could be that an excessive amount of lysate loaded onto the gel may cause 
extra bands or a result of protein aggregation that could not be resolved by SDS and 
boiling. 
To be able to observe the Mef2-GSTAP dynamics during the TAP purification two 
antibody options were available: antibodies against the tag or against Mef2. There is 
an anti-Protein G antibody that could be used to observe the cleavage of the tag in 
the initial steps of the purification. However, it could not be used to observe the 
TEV-cleaved Mef2 because the Protein G domains of the tag are distal to the TEV 
cleavage site. Another option to target the tag was an anti-SBP antibody that should 
be able to identify both the full length tag as well as the cleaved tag, since the SBP 
domain is proximal to the TEV cleavage site. The anti-Mef2 antibody would be a 
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feasible option, however previous testing showed that it gave some unspecific 
background. The antibodies targeting the tag recapitulated the 96 kDa band 
representing the tagged Mef2 as previously identified by the Mef2 antibodies. The 
anti-Protein G antibody was able to identify both the Mef2-GSTAP protein, as well 
as the part of the tag cleaved off by TEV protease. Despite offering a very clean 
signal, this antibody could not be used further due to the inability to observe the 
cleaved bait during the second part of the TAP purification. The anti-SBP antibody 
was not able to detect the bait after cleavage, even though the SBP moiety is not 
cleaved off by TEV protease, and the successful purification of bait by streptavidin 
beads in the downstream steps confirms that the SBP moiety remained on the bait. 
For these reasons all further investigations performed by Western blots were done by 
incubating with the anti-Mef2 DRC4 3
rd
 antibody. The inability of the anti-SBP 
antibody to recognise the cleaved peptide could be due the cutting of the tag 
changing the structure of the recognised epitope, or the binding of the SBP peptide is 
too close to the end of the peptide chain which makes the interaction with the 
antibody inefficient. 
It is common practice for Western blots to include staining for a loading control, 
particularly when protein quantities are compared between bands on the blot. A 
common choice is to stain actin or tubulin, under the assumption that their expression 
would be more or less uniform between samples in different lanes and their bands 
should therefore be equal sizes if the blotted gel was loaded properly. This has been 
omitted in this study because to serve its purpose of standardising a blot, the protein 
chosen as a loading control needs to be consistent across lanes. In this study, the 
different lanes in most blots contain samples from different stages of the purification 
procedure, and therefore by their nature contain varying amounts of various types of 
proteins. There are no proteins which could reasonably be expected to be present in 
all samples, let alone in consistent amounts. The purpose of most blots in this study 
was to assess the relative amount of bait present in each volume of liquid produced 
during the purification procedure. Similar studies have likewise omitted loading 
controls for TAP analytical fractions (Kyriakakis et al., 2008). The more important 
step to provide relevant quantifications was therefore to normalise the band 
intensities as determined by densitometry to the fraction of the total experimental 
volume that the band represented. Where this reasoning did not apply, a GFP 
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standard was instead included on the blot to ascertain loading consistency. No 
Western blots were performed for the WT control purifications because staining 
these for wildtype Mef2 (or any other) protein would not provide relevant 
information on purification quality. 
3.3.3 Optimisation of protein extraction from embryos prior to purification 
To homogenise the embryos, a mixture of mechanical shearing and chemical lysis 
was used. However, the amount of solubilised protein can vary depending on the 
lysis method. The lysis buffer was designed such that the isolated proteins were 
maintained under stable conditions and the compatibility with the first part of the 
TAP purification procedure was maintained. Tris base was used as the desired 
buffering system due to its compatibility with many proteins that were purified by 
TAP. Other additives were used to increase the stability of the isolated proteins: 
DNase was added to the lysis buffer to decrease viscosity of the lysate due to the 
release of the nucleic acids, NP40 was added to enable membrane disruption, DTT to 
deter oxidative damage, EDTA to chelate metal ions from proteases, Mg
2+
 and 
glycerol for stabilisation and protease inhibitors to protect the extracted proteins. No 
protease inhibitors were used in the TEV cleavage step to avoid inhibition of the bait 
cutting process. 
Three different methods of lysis were tested using this buffer: 1) Liquid 
homogenisation, very quick homogenisation of the embryos resuspended in lysis 
buffer using a Wheaton douncer followed by immediate clarifying of the extract by 
ultracentrifugation; 2) Liquid homogenisation with incubation, an additional 30 min 
incubation on ice after homogenisation, before clarifying the extract by 
ultracetrifugation; this modification is often seen in published studies (Kyriakakis et 
al., 2008); 3) Hypotonic shock extraction. The aim of this step was to optimise the 
amount of solubilised bait extracted from the embryos. The lysis buffer already 
contained additives meant to improve the lysis process. For the third lysis option the 
incubation with a hypotonic version of the lysis buffer was intended to swell the cells 
and make them burst more easily under osmotic pressure, while the addition of high 
salt was meant to extract the proteins, in particular the nuclear ones. The hypotonic 
method was more efficient than liquid homogenisation with extended incubation as 
shown by the ratio of bait contained in the final lytic pellet to solubilised bait in the 
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supernatant. However, liquid homogenisation without extended incubation was 
favoured because it was equally efficient as hypotonic shock extraction, but also less 
time consuming.  Using this method reduced the time required for the procedure by 
half compared to the other extraction methods, which could be a significant factor in 
maintaining physiological binding of Mef2 with its interacting proteins. 
All three extraction methods showed that the amount of Mef2-GSTAP extracted 
from 10-12h embryos was many folds higher than in equal amounts of earlier staged 
embryos (4-6h and 6-8h). The Mef2 extracted from 4-6 h embryos was slightly more 
than from 6-8h samples. This aspect showed that for earlier staged embryos more 
input material was required for a TAP purification compared to a later staged one. It 
was assumed that O/N embryos would represent a rough average of the Mef2-
GSTAP protein expresssion across time. Considering the difference of Mef2-GSTAP 
expression across the stages, the input required for a TAP purification from staged 
embryos should therefore be different from the amount of O/N embryos required. 
Earlier stages should require more input than O/N because of the lower Mef2 
expression, while later stages should require less input than O/N. 
3.3.4 TAP purification of Mef2-GSTAP and associated complexes from 2 g of 
O/N embryos 
The first TAP purification was performed on 2 grams of O/N Mef2-GSTAP 
embryos, an amount of starting material on the lower scale of what was reported in 
previous TAP studies in Drosophila (Kyriakakis et al., 2008; Veraksa et al., 2005). 
The goal of this experiment was to identify a minimum amount of starting material 
required, to enable economical use of the collected material and keep enough 
available for repeat experiments. 
The lysis was performed as described, however the binding of Mef2-GSTAP to the 
IgG beads was extremely low as estimated by densitometry. The low binding of the 
Mef2-GSTAP to the IgG beads could be due to saturation of the IgG beads, either 
because more bait than the maximum binding capacity of the beads was available or 
because other proteins present in the lysate were able to non-specifically interact 
with the IgG beads such that the majority of them were masked for binding by the 
tagged Mef2. An important conclusion from this initial test was that despite having 
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an efficient cleavage of the bound bait, the elution of the cleaved bait, i.e. separating 
the cleaved bait from the IgG beads, was also a limiting step.  
The ability of mass spectrometry (MS) to identify Mef2 as the most abundant protein 
in the elute sample showed that in principle the purification protocol worked for 
extracting Mef2 and associated proteins. Additionally, this result also suggested that 
the amount/number of Mef2-associated proteins that can be identified by MS is 
proportional to the bait eluted after the purification. A sufficient amount of bait needs 
to be pulled down to have proteins above the detection threshold of MS. The main 
two strategies on how to obtain more bait were to increase the amount of input 
embryos from which to extract bait, as well as to improve the intermediate steps of 
the purification procedure such that more bait and associated protein is extracted at 
each step to obtain the best possible overall yield. 
The extraction from wildtype (WT) embryos as a control sample was intended to 
identify the most abundant proteins in the Drosophila embryos that are able to bind 
non-specifically to the beads and can withstand the different binding/elution steps as 
well as the washes. The proteins most commonly identified as probable contaminants 
of TAP purification are abundant cytosolic proteins such as myosins, heat shock  
proteins, actins and ribosomal proteins (Veraksa et al., 2005). The MS results of the 
WT embryos was very clean, only Actin5C was identified. However, in the Mef2 
sample both an actin and a heat shock protein were detected. This is consistent with 
the tissue of interest being muscle, a cell in which myosin, actins and other generally 
abundant proteins are present and functionally enriched (Uhlen et al., 2015). The 
result therefore highlights a difficulty in the interpretation of the Mef2 sample 
compared to the WT sample. Due to its role in muscle development, Mef2-associated 
proteins are likely to be muscle-enriched. However, once developed, muscles are a 
large protein reservoir in the embryo and are also a significant source of contaminant 
proteins in purification studies. Most proteins commonly considered contaminants 
may as a consequence be purified both specifically as Mef2-associated proteins, and 
unspecifically from WT embryos. Proteins found in both samples can therefore not 
necessarily be excluded, but rather may be valid interactor candidates. 
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3.3.5 TAP purification of Mef2 complexes from 2 g of 11-13 h embryos 
The first experiment using 2 grams of O/N embryos as starting material for TAP 
purification showed that this amount of embryos was not sufficient to detect Mef2-
associated proteins by MS. To assess if using more input bait was able to improve 
the detection rate while maintaining a low total sample volume, 2 grams of 11-13h 
staged embryos were used for the second experiment. These embryos were expected 
to yield more bait than a similar amount of O/N embryos because of the higher 
expression of Mef2 during these late embryonic stages. The amount of Mef2 
extracted from 10-12h embryos in the previous lysis optimisation also suggested that 
the 11-13h sample should provide increased amounts of Mef2 bait. Also, an 
increased concentration of TEV protease was used to enhance the cleavage of the 
bait off the beads and thus increase the amount of eluted cleaved Mef2-GSTAP. A 
direct comparison of the ratios of cleaved to uncleaved Mef2 of the two experiments 
showed that using more TEV protease did substantially improve cleavage efficiency. 
Despite this, the relative percentage of eluted cleaved Mef2 was only slightly larger 
than in the previous TAP experiment from 2 grams of O/N embryos. Due to the 
larger absolute amount of bait in the 11-13h staged embryos, the final yield of 
obtained bait was sufficient to allow detection of 55 associated proteins. 
It is important to note that despite having a similar amount of embryos lysed for the 
input material, the biological background is very different between the O/N embryos 
and 11-13h staged samples. While the 11-13h time point enriched for proteins 
involved in terminal muscle differentiation, the O/N embryos contain an average 
overview of Mef2 associated proteins, most probably complexes that interact with it 
throughout development. Depending on the proportion between proteins that 
specifically interact with Mef2 during late stages of myogenesis and the fraction of 
the O/N samples constituted by embryos from those stages, late-stage complexes 
might still be identified from O/N embryos. It is more likely that complexes that 
overlap between the two samples are involved in interactions with Mef2 for a longer 
time during development, rather than only towards the end of embryogenesis. The 
control sample was quite clean, only 5 protein were identified: Actin5C (which was 
also detected in the first TAP purification experiment), heat shock protein, two 
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vitellogenin proteins and elongation factor 1-alpha. This last detected protein is not 
one of the standard proteins classified as TAP contaminants. 
3.3.6 Improving bottleneck steps of TAP purifications 
In both TAP experiments the binding of Mef2-GSTAP to the IgG beads was quite 
inefficient although the amount of total protein should have been within the 
recommended range. A recommended starting point was to incubate 100 mg of total 
protein lysate with 150 µl IgG beads (Kaiser et al., 2008). The total protein detected 
in the clarified lysates for both the O/N embryos and 11-13h embryos was below the 
recommended starting incubation amounts, therefore there should have been enough 
beads available to allow efficient binding of the entire Mef2 bait to IgG beads. This 
suggests that the more likely problem was non-specific binding of other proteins to 
the beads, hindering binding of the bait. To test this hypothesis, another 2 grams of 
O/N embryos were lysed and the cytosolic fraction containing 6.8mg of total protein 
was split into four fractions of increasing size (500 µl, 1 ml, 1.5 ml, 2 ml), each to be 
incubated with the same amount of IgG beads (20 µl). Considering that an amount of 
10 mg of total protein was recommended as suitable to be incubated with 15 µl IgG 
beads (Kaiser et al., 2008), 20 µl of beads should have been sufficient to bind most if 
not all of the bait present in the cytosolic fraction in total, and even more so when 
split into smaller fractions where the largest fraction contained only 3.4 mg of 
protein. 
The experiment showed almost full binding of bait in the small volumes of cytosolic 
fraction (500 µl, 1 ml), while less than 70% were successfully bound to the beads in 
the larger volume fractions. IgG bead binding efficiency therefore did not depend on 
the total amount of protein, as the smaller fractions contained less total protein. 
Rather, considering that the amount of beads was kept constant, these fractions had a 
higher ratio of beads to protein, both bait and non-specific proteins. Consequently, 
this experiment suggests that with a lower bead-to-protein ratio, non-specifically 
binding proteins are able to attach to the IgG beads during incubation, thus 
interfering with the affinity binding of the tagged bait. This aspect was particularly 
observable in the wash aliquots where the Mef2 antibody was able to detect 
nonspecific proteins removed during the washes. The blots obtained for the 1xCF 
and 2xCF samples were much cleaner than the ones of the 3xCF and the 4xCF. This 
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could be a direct consequence of an increased amount of non-specifically bound 
proteins extracted with the beads and then eluted off them in the subsequent steps. 
Their detection on the blot additionally suggests that the proteins that interact non-
specifically with the IgG beads also cross-react with the Mef2 antibody. 
Considering the above, a more efficient and clean option for binding Mef2-GSTAP 
to the IgG beads was to increase the amount of beads as well as to incubate the beads 
with less volume of cytosolic fraction such that the ratio of non-specific proteins to 
IgG beads was kept at a minimum. 
3.3.7 TAP purification of Mef2 complexes from 7.7 g of O/N embryos 
The use of almost 8 grams of O/N embryos was successful in providing a large set of 
Mef2-associated proteins that were identified by MS and had a significant amount of 
spectral counts associated with each protein, thus the amounts of co-purified proteins 
were in quantities above the detection threshold. A total of 121 proteins were 
identified in the control experiment and 310 in the Mef2-GSTAP samples. The 
binding efficiency to IgG beads was lower in this experiment than the previous runs. 
This was despite the modifications to the protocol, such as incubating the lysate in 
smaller fractions and with more beads, that should have improved this according to 
the optimisation tests. A possible explanation for this could be that even though the 
amount of beads was doubled, this larger amount of input embryos may have 
required even more IgG beads to provide efficient binding. However, the practical 
restrictions of the downstream steps, in particular the size of sample containers, 
limited the amount of beads that could be used. However, despite the relatively low 
yield of individual steps of the purification, the overall yield of the purification was 
sufficient to provide information on candidates interacting with Mef2. 
Taking into account all the steps taken to improve the yield obtained by purifying 
Mef2 by tandem affinity purification and the reduced effects registered for each 
modified strategy, it appears that it is quite difficult to standardise the TAP 
purification protocols. The primary requirement of any TAP purification experiment 
is to provide sufficient amount of bait protein such that the final elute target protein 
and associated peptides are above the detection threshold of the MS. The protein 
composition given by the biological context of the analysed Drosophila sample and 
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the amount of eggs required to provide a sufficient amount of bait are the two main 
characteristics that influence the outcome of the TAP experiment. Therefore, 
selecting a generous amount of starting material and of IgG beads can ensure that the 
TAP experiment will have the highest chances of success. Using the detection by 
Coomassie of the eluted proteins represents a crude, but quite reliable measure in 
assessing the ability to detect the purified proteins by MS, as previously found by 
others (Kyriakakis et al., 2008).  
3.3.8 Purification yield  
The GSTAP tag was initially used in mammalian cell culture and was reported as 
giving ten-fold improvement in yield compared with the canonical yTAP tag 
(Bürckstümmer et al., 2006). For Drosophila embryos, a three-fold increase in yield 
compared to the yTAP tag was reported (Kyriakakis et al., 2008). In this study 
Kyriakakis et al. tested both tags in S2 cells and 0-6h Drosophila embryos. The 
yTAP and the GSTAP tags were used to extract a cytoplasmic protein as bait for co-
purification. In their analysis, they reported a 2.7% yield for the yTAP tag, and 
respectively 8.4% for the GSTAP tag when extracting from Drosophila embryos. 
The test performed in S2 cells showed a similar relationship between the two tags but 
with lower overall efficiency (8.1% GSTAP vs. 6.8% yTAP). In the present study, 
the best yield achieved despite many adjustments of the protocol and several 
optimisation trials was 0.45%, a 1.7-fold improvement from the 0.27% yield of the 
first TAP experiment. However, this yield was still substantially lower than in 
reported studies. A possible explanation for this is that the bait used here was a 
predominantly nuclear protein, which can interfere with purification unless very 
large amounts of input material are used, or specific steps are taken to first isolate 
nuclei. Drosophila embryo collections at such a scale were not feasible for this study. 
Yet, the relative fraction of bait extracted does not reflect the absolute amount of bait 
present, which was nevertheless sufficient to identify proteins interacting with Mef2 
both from the 2g 11-13h extraction and the 7g O/N extraction. The yield also has no 
impact on the quality of the data obtained using MS or the confidence in the 
identified proteins as specific interactors of Mef2. The primary drawback of low 
yield efficiency is that very large amounts of input material are needed to extract a 
high enough absolute amount of protein for detection by MS.  
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Chapter 4: Bioinformatic analysis of Mef2-associated proteins as 
determined by proteomics studies 
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4.1 Introduction 
Transcription factors sit at the core of differentiation processes and usually they are 
involved in complex protein-protein interactions (PPI) and protein-DNA interactions 
in order to govern the different gene expression programs. The identity of the 
specific regulatory networks active in a particular cell or tissue defines much of that 
system's phenotype. Large-scale purification studies to extract systematically the 
molecular interactions that take place in such networks have created a wealth of 
available experimental data. Due to the increasing popularity of specialised databases 
on model organisms and the standardisation of the different available datasets it has 
become more easily accessible to extract experimental data performed in other 
biological systems and correlate it to customised tasks.  
The advances of complex protein purification methods coupled with Mass 
Spectrometry (MS) allow to systematically identify protein complexes and protein 
networks. While experimental approaches like the yeast two-hybrid system, affinity 
purifications, chemical cross linking, chemical foot printing, protein arrays and 
fluorescence resonance energy transfer are helpful in determining PPIs, 
computational approaches are necessary to estimate which connections are the most 
reliable. Through the use of databases such as STRING (Search Tool for the 
Retrieval of Interacting Genes/Proteins) (Franceschini et al., 2013; von Mering et al., 
2005), DIP (Database of Interacting Proteins) (Salwinski et al., 2004) and 
Predictome (Mellor et al., 2002) one can easily derive associations between proteins. 
Usually the interactions between proteins coming from such databases means a 
functional relationship between the two connected proteins, but not necessarily an 
actual physical interaction. 
The Mef2 TAP purification performed in Chapter 3 revealed tens to hundreds of 
candidate proteins that interact with Mef2 in Drosophila embryogenesis. Mef2 is 
active in a lot of biological contexts and is responsible in activating genes with 
diverse expression profiles. Understanding how Mef2 is regulated is of particular 
interest as the protein was identified to be expressed throughout embryogenesis, 
therefore being active both in undifferentiated cells and fully differentiated tissues. 
The protein has been associated with a wide diversity of functions ranging from 
cellular functions such as the regulation of gene expression and nucleic acid 
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metabolism or biosynthesis to more complex, tissue relevant processes like 
mesodermal and muscle development, locomotion, and immune response. 
4.1.1 Experimental approach  
In this study the candidates identified by TAP/MS as Mef2 binding proteins are 
bioinformatically screened as interactors that form a connected network. The proteins 
identified by MS are expected to contain: 1) false positives, i.e. contaminants that do 
not interact with Mef2; 2) direct interactors of Mef2; 3) as the aspect unique to TAP, 
indirectly interacting proteins pulled down as part of Mef2 protein complexes. To 
increase our understanding of Mef2 regulation through PPIs, two bioinformatics 
approaches were chosen. Such analyses have been shown to be useful in 
understanding the quality as well as the functionality of the experimental data 
(Guruharsha et al., 2011; Murali et al., 2014; Rhee et al., 2014). 
The first approach is based on the spectral counting method, in which the data is 
treated semi-quantitatively in that the total number of peptides identified for a protein 
by MS is interpreted as a reflection of the abundance of that protein in the sample. 
This analysis then assumes that proteins detected in wildtype samples are 
contaminants and compares the abundance of each protein in the Mef2-GSTAP 
datasets with their abundance in wildtype datasets to classify all candidates as 
binders or contaminants (section 4.2.3). The next step then aims to narrow down the 
list of candidates or to rank candidates and identify the most promising Mef2 
interactor candidate for further study (section 4.2.4). This analysis thus minimises 
false-positives while having to accept false-negatives (ignoring potentially valuable 
candidates). Integrated with literature background, this analysis yielded HDAC4 as a 
promising candidate Mef2 interactor during muscle development, which was further 
studied in Chapter 5. 
The second approach was based on network models and investigated the functional 
relatedness between candidates. This was intended firstly to validate the 
experimental success of the extraction, but also aimed to identify potential functional 
modules, i.e. clusters of proteins that might form complexes with Mef2. This 
approach takes into account that proteins that can be unspecifically extracted from 
wildtype embryos through TAP could nevertheless be Mef2 interactors. Thus, the 
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analysis considers all candidates to have equal probability of being a real interactor 
from the start. It aims to minimise the loss of information by not discarding potential 
false-negatives and instead integrates the datasets with published data of PPIs 
(sections 4.2.6 to 4.2.9), gene expression (section 4.2.10) and functional annotations 
(sections 4.2.11 and 4.2.12).  Using the paradigm of "guilt by association", the better 
characterised a relationship between proteins is, the stronger their association in the 
network becomes. Similarly, correlations in gene expression and functional 
annotation imply a higher probability that proteins are part of shared molecular 
pathways or physically interact with each other. By integrating these data, we can 
validate the quality of the extraction since it should be reflected in shared annotations 
between the pulled down proteins, and gain a deeper understanding of the biology 
reflected in each dataset.  
Mef2 was endogenously GSTAP-tagged in Drosophila embryos, purified by tandem 
affinity purification (TAP), and the eluate was analysed by mass spectrometry (MS). 
Parallel negative control purifications were performed from wildtype (WT) 
Drosophila embryos of equivalent age using the same TAP protocol and analysis. 
These controls are aimed to help distinguish contaminants from specific binders 
among the proteins identified by MS in the purified samples. The bioinformatic 
analyses in this chapter also considered as positive controls Mef2 interactors 
identified in published studies that used other affinity purification methods analysed 
by MS (Rhee at al., 2014; Guruharsha et al., 2011). The published controls are meant 
to test the validity of the two approaches selected to interpret the Mef2-TAP 
purifications results.  
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4.2 Results 
4.2.1 Datasets of candidate Mef2-interacting proteins to be investigated 
The TAP process is a two-step extraction method where protein complexes 
containing the GSTAP-tagged Mef2 are pulled down from whole cell lysates of 
Drosophila embryos and analysed by MS. The datasets of candidate proteins 
obtained and their biological sources are listed in Table 4.1 and are described in more 
detail in section 4.2.2. A total of 328 unique candidate proteins were identified from 
Drosophila embryos across all TAP samples, of which 3 were unique to WT 
embryos and another 118 were found both in WT and tagged-Mef2 purified samples. 
Two other datasets were used in the analyses, both resulting from single-step affinity 
purifications of FLAG-HA tagged Mef2 expressed in S2R+ cells analysed via MS. 
The Guruharsha et al. (2011) purifications were performed on S2R+ whole cellular 
lysates, while Rhee et al. (2014) used the same cell lines but extracted protein from 
nuclear fractions only. Both affinity purifications were performed as part of large 
scale studies and the elimination of false positive results was assessed via a statistical 
approach which accounted for protein abundance and consecutive observations in 
sequentially performed experiments. The Guruharsha study reported a total of 101 
unique Mef2-interactors (DPiM), while 681 were described in the other study (S2-
CoAP).  
The candidate proteins reported in the two published studies were identified via their 
Flybase gene identifiers. The lists of candidate proteins from TAP purifications were 
mapped to Flybase gene identifiers via their UNIPROT identifiers. To allow 
comparison between all the datasets, the protein identifiers of all candidate proteins 
used in these analyses were converted to Flybase gene identifiers according to 
database release 2016_02. These identifiers are compatible with the Drosophila 
Interaction Database (DROID) version 2015_12 which represents the basis of 
building PPIs for the network analysis approach. 
4.2.2 Experimental characteristics of candidate datasets 
Mef2 like many transcription factors is able to activate or repress transcription 
through binding DNA at specific locations. In order to regulate cellular processes it   
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Table 4.1: Protein datasets 
Label  Description Size 
Mef2GSTAP Datasets   
ONCTRL 0-18h embryos, whole cells, negative (WT) purification 121 
ONMEF 0-18h embryos, whole cells, Mef2GSTAP purification 310 
11-13CTRL 11-13 h embryos, whole cells, negative (WT) purification 5 
11-13MEF 11-13 h embryos, whole cells, Mef2GSTAP purification 56 
External datasets   
S2-CoAP S2R+ cells, nuclear extracts, Mef2-FLAG-HA purification 681 
DPiM S2R+ cells, whole cells, Mef2-FLAG-HA purification 101 
Derived datasets   
ON/S2-CoAP Overlap between ONMEF and S2-CoAP candidates 102 
11-13/S2-CoAP Overlap between 11-13MEF and S2-CoAP candidates 29 
ONMEF* ONMEF candidates classified as specific by spectral counting 227 
11-13MEF* 11-13MEF candidates classified as specific by spectral counting 50 
Combined datasets   
Mef2 candidates Union of all Mef2GSTAP datasets and S2-CoAP candidates 888 
interacts with other proteins such as other transcription factors, chromatin modifiers 
and other cofactors. These interactions are crucial for gene expression modulation 
and they define the outcome of cell differentiation. 
Three TAP experiments (detailed in chapter 3) were performed to identify candidate 
proteins that interact with Mef2 in Drosophila embryos to modulate muscle tissue 
development. The proteins extracted by TAP were identified using mass 
spectrometry (MS). There were two bulk collections in which embryos of all 
development stages were collected overnight (O/N) and subjected to the TAP 
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protocol. Overnight collections contain embryos of ages in the range 0-18h, and thus 
span all stages of embryonic development. Besides various adaptations to the 
purification protocol, the main difference between the two experiments consisted in 
the amount of embryos used as input: 2 g of O/N embryos in the first and 
respectively 7 g in the second. Since only 2 proteins were identified in the TAP 
purification from 2g of O/N embryos, this sample was not studied further in this 
chapter. In the third experiment, candidate proteins that are potential interactors of 
Mef2 during late embryonic myogenesis were identified by purification of proteins 
from 11-13h staged embryos. By this stage, the embryos have completed 
development of the larval musculature. Additionally to the collections from Mef2-
GSTAP expressing embryos, each of the three experiments was accompanied by a 
parallel extraction from equally collected (O/N or 11-13h staged) wildtype (WT) 
embryos, where no bait is present and thus any identified proteins passed through the 
purification by non-specific binding. The data derived from WT embryos will be 
treated as an internal control for the experimental purification procedure. 
The list of proteins for each sample returned by the proteomics facility at EMBL 
contained the following information: Description of the protein identified, the 
UNIPROT accession number, the protein's predicted molecular weight as derived 
from the sequence available in the database, and number of spectral counts. Two 
separate protein lists were rendered for each sample, containing total spectral counts 
and unique spectral counts respectively. The database used to identify the peptides 
rendered from the sample was UNIPROT, restricted to Drosophila melanogaster 
sequences.  
Prior to mass spectrometric analysis, trypsin is used to digest the proteins into 
smaller peptides of 7 to 11 amino acids length. The resulting peptides are broken 
down by the mass spectrometer and the fragmentation spectra are recorded. These 
spectra are afterwards matched to a database which contains sequence specific data 
of known model organisms. Mass spectrometry detection of peptides does not 
provide chemical sequencing of these proteins, but uses the recorded spectra for each 
peptide and an algorithmic comparison with a databases of proteins to match the 
sample peptides to known proteins. Some fragments can match the sequence of more 
than one protein. Spectra that can be matched to only one specific protein are 
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classified as unique spectral counts.  The total spectral count for a protein thus 
contains both its unique spectral counts and those spectra that were matched to it but 
could also have been derived from a different protein.  
To test the validity of the obtained data, we tested the range of spectra obtained in 
other studies where Mef2 was bait. The Drosophila Protein Interaction Map (DPiM; 
Guruharsha et al., 2011) was built from clones transiently expressing FLAG-HA 
tagged Drosophila proteins in S2R+ cells. Using co-affinity purification, the proteins 
that interact with the tagged proteins were extracted and identified via tandem MS. 
Mef2 was one of the tagged protein that was successfully expressed and its 
interaction partners were identified. The spectral counts of these proteins were 
reported and were used as a quality control for the present Mef2 TAP purification 
results. A single purification experiment for the Mef2 dataset was reported in this 
study and we are not aware if the raw data reported is the consequence of several 
biological or technical replicates. A total of 101 unique proteins were identified in 
the affinity purification of FLAG-HA-Mef2 from whole lysates of S2R+ cells 
expressing transiently the tagged-Mef2. This dataset will be referred to as "DPiM". 
Rhee et al. (2014) used a similar FLAG-HA tagged Mef2 clone taken from the 
Universal Proteomics Resource (Yu et al., 2011), a part of the Berkeley Drosophila 
Genome Project (BDGP) to build transcription factor networks in Drosophila. The 
FLAG-HA tagged Mef2 was transiently expressed in S2R+, nuclear extracts of these 
cells were obtained and single-step affinity purification with Mef2 as a bait was used 
to extract the nuclear interactome of Mef2 in S2R+ cells. To analyse the purified 
proteins, the sample was trypsin-digested and the peptides obtained were analysed by 
tandem MS and mapped to a database. Due to the similar way of analysing the data, 
the spectral values reported in this study were used as a control for the spectral 
counting methodology that was applied to semi-quantitatively analyse the candidate 
proteins obtained in our TAP experiments (see section 4.2.3). 643 unique bait-prey 
interactions and two replicates were reported for the Mef2 clones. The published data 
include only total spectral counts for each candidate protein. The second replicate 
identified only 215 proteins, all of which were also present in the first replicate and 
therefore represent a 32% consistency between the two replicates. This dataset will 
be referred to as "S2-CoAP". 
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4.2.3 Classification of candidate proteins based on spectral counts identified by 
MS 
The higher the number of matched spectra for a protein, the higher the likelihood of 
the identification being valid, however a minimum of 2 spectra per protein is 
expected before a protein is considered to be identified with confidence.  The number 
of matched spectra for a protein can be considered an indication of its concentration 
in the sample, however in order to make estimations of relative concentrations of 
different proteins, each protein should have at least above 4 spectral counts for a 
minimum of reasonable linearity. It is important to note that if a protein has 0 
spectral counts in a sample, it is not possible to conclude that this protein is absent 
from the sample. Besides an actual concentration below the detection threshold of 
MS, it is for example also possible that all peptides detected for a protein fall below 
the confidence cutoffs that are applied when mapping detected spectra to the protein 
database. Spectral counting is therefore a semi-quantitative way to estimate amounts 
of proteins in the analysed samples and it is mostly reliable if we compare the 
different proteins in the same sample. 
The overnight collections of Drosophila embryos were subjected to TAP purification 
and the eluate was analysed via tandem MS. WT embryos were used as control for 
the purification procedure and were treated in parallel to the Mef2-GSTAP 
expressing embryos. The resulting MS datasets were labelled ONCTRL (for the WT 
embryos) and ONMEF (for the Mef2-GSTAP embryos) and a total of 121 proteins, 
respectively 310 proteins were matched during MS analysis. Only one MS run was 
performed per sample. It is important to note that the purification is based on 
antibodies against Protein G, and a streptavidin-binding moiety, neither of which are 
present in WT Drosophila embryos. Proteins identified in the WT sample are 
therefore expected to be contaminants of the purification process that are able to bind 
unspecifically to the antibody-coated and the streptavidin-coated beads, and could 
not be removed during the various washing steps of the protocol. 
The staged Mef2-GSTAP embryo collections (11-13MEF) were treated in a similar 
manner as the overnight collections and a WT staged collection (11-13CTRL) was 
purified in parallel as a control. The purification process of 11-13CTRL and 11-
13MEF resulted in 5 proteins identified in the control sample and 56 proteins 
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identified in the Mef2-GSTAP expressing embryos. The Mef2-interacting candidate 
proteins identified in these samples should show a snapshot of the complexes that 
interact with the transcription factor towards the end of the larval muscle 
developmental process. 
The range of spectral counts of all the TAP purifications and the two published 
studies was compared. The samples expressing Mef2-GSTAP (ONMEF, 11-13MEF) 
were the only ones having proteins with total spectral counts for any protein higher 
than 100. To estimate the abundance of proteins semi-quantitatively based on total 
spectral counts, a minimum threshold of 4 total spectral counts was considered. 
While proteins can be confidently identified with fewer spectral counts than this, 
such low numbers of spectral counts are very unreliable estimators of the 
concentration of the protein in the analysed sample.  Only the overnight samples had 
more than half of the proteins with spectral counts above this threshold (66% of 
ONMEF and 60% of ONCTRL). In all other samples, the majority of proteins had a 
spectral count of 4 or lower. Only 26% of the 11-13MEF proteins had 4 or more 
counts, while only one protein in the 11-13CTRL reached the 4 total spectral counts 
threshold. Of the proteins in the published studies, 38% (S2-CoAP) and respectively 
28% (DPiM) of the proteins met the threshold. 
The length of a protein can influence the number of spectra obtained for it in the MS 
analysis, generally the longer the protein the more spectra are available. Therefore a 
protein that is larger can seem more abundant than a smaller one due to the 
possibility of generating more spectra corresponding to the larger number of peptides 
per molecule after tryptic digestion. To compensate for the effects protein length has 
on spectral counts, a normalised spectral abundance factor (NSAF) was created 
(Zybailov et al., 2006). NSAF is calculated for each protein in a sample by dividing 
the total spectral counts (TSC) by the protein’s length (L), this ratio being further 
divided by the sum of all TSC/L of all the proteins in that particular sample. The 
numbers obtained for NSAF are between 0 and 1 and the closer the NSAF of a 
protein is to 1, the more abundant the protein is. NSAF allows to compare the 
abundance of the different proteins in the same mixture and to compare the 
abundance of various proteins in different samples (Paoletti et al., 2006).  
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To be able to compare the spectral counts of the identified candidates, the NSAF of 
each protein was calculated. All the studies included in this analysis involved 
purification of proteins where Mef2 acted as a bait except for the wildtype controls 
where no bait was expressed. Therefore, Mef2 is expected to be enriched in all 
datasets where it acted as bait, and should be among the most abundant proteins if 
the purification procedure was successful and specific. When ranked by NSAF, Mef2 
was the most abundant protein in 11-13MEF and the second most abundant in 
ONMEF. In S2-CoAP, Mef2 ranked 40th (top 7%), while in DPiM it ranked 29th 
(top 29%). Therefore, for the TAP purifications, Mef2 was among the first proteins 
while in the single-step purifications from the published studies it was not among the 
most abundant proteins. There were only 2 proteins that were identified in all 
samples (including controls) and only 4 proteins that were present in all samples 
except controls ("Mef2 samples"; 4 including the bait). The 2 proteins that were 
identified in all the samples had ranks relatively close to the bait, while the 3 non-
bait proteins that are only found in Mef2 samples have very low ranks compared to 
the bait. One of the 3, RpS3A, is a ribosomal protein which was more abundant than 
the bait in DPiM, while it is less abundant in S2-CoAP. In the TAP purifications this 
protein is significantly less abundant compared to the bait. Since the values of NSAF 
for the same protein differ significantly between samples, it is difficult to estimate 
the stoichiometry of these protein in relation to Mef2. The 2 proteins that are found 
in controls and samples are Act5C and Hsc70-4, two housekeeping genes, and their 
abundance is very close to the bait during TAP experiments and more abundant than 
the bait in FLAG affinity purifications. Since very few proteins are found in all 
samples, and due to the inconsistency of relative abundances between samples, only 
comparing the NSAF values or ranks of proteins with samples and between samples 
does not present a reliable method to prioritise the list of candidate proteins. 
The separation between specific and nonspecific binders is essential to distinguish 
likely Mef2-interacting candidates from contaminants.  The NSAFs of proteins 
purified by TAP were therefore used in a second approach, whereby statistical 
analysis is used to compare specific (bait-containing) purifications with control (bait-
less) purifications. The detected proteins were represented as vectors containing the 
respective NSAF values of each protein across the four TAP datasets. These vectors 
were used to build a matrix where the rows represent proteins and columns represent 
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experiments. The experiments include both control experiments where WT embryos 
were subjected to TAP purifications and the specific samples extracted from Mef2-
GSTAP expressing embryos. To determine if a protein was a contaminant, a ratio of 
vector magnitudes (α) was calculated as follows:  
   
   
     
  
   
     
   
where xi1/2 = NSAF in Mef2-GSTAP embryos (ON and 11-13), and yi1/2 = NSAF in 
WT embryos (ON and 11-13). Proteins for which α > 1 are considered contaminants 
(Sardiu et al., 2008). The published studies were not included in this analysis since 
there were no negative controls available to be contrasted against as the described 
method requires. Note that proteins only present in control datasets have no α 
coefficient because xi1 = 0 and xi2 = 0. Such proteins are instead classified as 
contaminants by default. 
The ratio of vector magnitudes was calculated for all candidate proteins in the TAP 
experiments. Based on this α coefficient determination, the candidates were then 
classified as below or above 1. Of the total 328 potential candidates, 83 candidates 
had an α coefficient larger than 1, and were thus classified as unspecific binders. 
Since the α coefficient is a cross-dataset measure, we tested how many proteins in 
each dataset had been classified as a contaminant. All 83 contaminants are present in 
the ONMEF dataset. In the 11-13MEF sample, 6 proteins were identified as 
contaminants, 4 of which were proteins also present in the 11-13CTRL dataset, while 
the remaining 2 were also present in ONCTRL. The 3 proteins present uniquely in 
ONCTRL were regarded as contaminants by default and removed from further 
analysis. 
Based on this algebraic analysis of NSAF abundance, 6 proteins were classified as 
contaminants in 11-13MEF, while 50 were regarded as specific Mef2-binding 
proteins. ONMEF has 227 proteins considered specific binder, while 83 were 
contaminants. These specific binders were grouped into two new datasets and were 
used further in the following network analysis model to contrast how the network 
behaviour changes when potential contaminants are removed. The two new datasets 
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are denoted as ONMEF* which includes the 227 specific interactors, respectively 11-
13MEF* has 50 proteins. 
4.2.4 Identification of best candidates for Mef2 regulation during myogenesis 
The aim of the proteomic study is to identify candidates that regulate Mef2 activity 
to activate target genes. In this first approach, we aim to identify the most promising 
individual Mef2 interactor candidates for further study (Figure 4.1A). The second 
approach in the following chapters instead aims to identify potential protein 
complexes or functionally cohesive groups of proteins from a systems-level point of 
view.  
Many studies show that Mef2 is able to cooperate with other proteins in a context 
dependent manner that will create a variety of transcriptional responses. The most 
promising candidates for further study should thus be found in 11-13MEF*, since 
proteins bound to Mef2 during this stage would most likely be interacting with it in 
the context of myogenesis. Since the two large scale studies performed in S2 cells 
and ONMEF* contain proteins that interact with Mef2 respectively in a non-muscle 
cell type and in non-specific developmental stage contexts, we used them here to 
narrow down the shortlist of candidates to those that are specific for the 11-13h 
staging. Thus the datasets 11-13MEF* and ONMEF* were compared and the 
proteins only found in the specifically timed sample were extracted. This reduced the 
list of 50 proteins down to 15 proteins found only in 11-13MEF*. These proteins 
were further shortlisted by comparing the 15 proteins with the Mef2 specific 
interactors extracted in the DPiM and S2-CoAP studies. None of the 15 proteins left 
in the 11-13MEF sample were found in the DPiM study, while 7 proteins were pulled 
down together with Mef2 in the S2-CoAP study. Therefore the final list of candidates 
comprises 8 proteins specifically found in the 11-13h embryos. The other proteins 
were eliminated from further analysis. Since these proteins were found interacting 
with Mef2 in more than one experimental setup, they are likely true interactors of 
Mef2, though potentially not specific to myogenesis. The list of 8 candidates was 
analysed for known associations using the STRING database (Szklarczyk et al., 
2019) and the network showed that 6 of the proteins are likely to be part of a muscle 
specific complex (Figure 4.1B). The 2 remaining proteins were dHDAC4, a class IIa 
HDAC that modulates gene expression together with transcription factors and 
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Brahma, an ATP-dependent helicase, a subunit of the Brahma complex that acts as a 
transcriptional activator. 
To assess whether any of the final 8 candidates is already known to participate in 
muscle development, we cross-referenced this list with a Drosophila RNAi screen 
where 10461 genes were specifically silenced in muscle using a Mef2-Gal4 driver 
(Schnorrer et al., 2010). The primary screen in this study assessed viability, posture, 
locomotion and ability to fly of flies expressing each RNAi construct in their 
muscles. The secondary screen assessed the morphology of the larval body wall 
muscle under RNAi targeting 436 genes that showed embryonic or larval lethality. 
The observed phenotypes were categorised either as muscle morphology defects 
(missing muscles, rounded muscles, split myofibril) or as sarcomeric organisation 
defects (fading Z, spotty Z, clumpy Z). This study will be further referred to as 
"muscleRNAi". 
Most of the genes corresponding to the short-listed proteins in dataset specific for the 
11-13h embryos (7/8) were also examined in the muscleRNAi primary screen (the 
gene up was not screened). Only 3 of the genes were part of the secondary screen for 
larval wall musculature defects. Five of 7 genes were lethal, of which one also 
showed a larval muscle morphology defect (wupA), and two showed a sarcomere 
defect (sls and tm2). The other two were not screened for muscle phenotypes (zip and 
jar; see Table 4.2). These five, together with up, form the group identified by the 
STRING database as a muscle-specific complex and the proteins they encode are 
also well-known and central building blocks of the sarcomere in muscles (Vigoreaux, 
2001). Since sarcomeric proteins should be localised in the cytoplasm, and Mef2 as a 
transcription factor should be nuclear, we obtained the gene ontology annotation for 
these genes to asses their cellular component (localisation) and molecular function 
(Table 4.2). Two of the sarcomeric proteins were already annotated with both 
cytoplasmic and nuclear localisation (wupA and sls), suggesting that presence in the 
nucleus might be a general feature of sarcomeric proteins. 
The only genes that were not associated with lethality in the muscleRNAi screen 
were dHDAC4 and Brahma, both localised to the nucleus and involved in 
transcriptional regulation according to their gene ontology annotation. Out of all the 
8 candidates, these two proteins are likely to interact with Mef2 to regulate gene   
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Figure 4.1: Determining the best candidate for biological testing 
(A) Workflow to narrow down candidate list to identify proteins that interact with 
Mef2 specifically during myogenesis. 
(B) STRING database network for 8 myogenesis-specific candidates. Connections 
between proteins include experimentally validated physical and genetic interactions, 
but also predicted relationships inferred from orthologues. 
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Table 4.2: Shortlist of candidates for Mef2 regulation during myogenesis 
Gene/Protein MuscleRNAi 
pheneotype 
Gene Ontology  
Cellular component 
Gene Ontology Molecular 
function 
wupA/ 
Troponin I 
Lethal 
(rounded 
muscle) 
Cytoplasm (striated muscle 
thin filament)/nucleus 
Actin binding  
ATP binding 
sls/Titin Lethal (spotty 
Z) 
Cytoplasm (striated muscle 
myosin thick 
filament)/nucleus 
Actin binding 
Protein binding 
Structural constituent of 
muscle 
Tm2/ 
Tropomyosin2 
Lethal (spotty 
Z) 
Cytoplasm (actin binding) Actin filament binding 
zip/Myosin II Lethal  Cytoplasm Myosin light chain binding 
Protein binding 
jar/Myosin VI Lethal Cytoplasm Calmodulin binding Actin 
binding 
Myosin light chain binding 
Protein binding 
up/ 
Troponin T 
n.d. Cytoplasm (striated muscle 
thin filament) 
Calcium ion binding 
Tropomyosin binding 
brm/Brahma Wildtype Nucleus Transcription factor binding 
Transcription coactivator 
binding 
Protein binding 
dHDAC4 Wildtype Cytoplasm/nucleus Histone deacetylase activity 
Protein deacetylase activity 
 
target activation in the nucleus. Interestingly, the STRING database predicts a 
functional link between these two proteins based on co-expression and biochemical 
data from orthologues. Brahma is a very promising candidate and two other subunits 
of the Brahma complex were pulled down from the extracts of 11-13h embryos 
(moira and Bap55). These proteins had been removed from the shortlist because they 
were also identified as Mef2 interactors in the S2-CoAP study. dHDAC4 was the 
only candidate out of the 8 proteins that seemed to act independently and not part of 
a bigger complex. Additionally, in vertebrates, class IIa HDACs have been shown to 
interact with Mef2 in muscle cells to regulate transcription. HDAC4 was thus 
selected as a candidate for further study to test whether the function of class II 
HDACs in myogenesis might be conserved in Drosophila. 
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4.2.5 Overlaps between TAP and published datasets of Mef2 interactors 
After the analysis of the TAP results and the other Mef2-interacting candidate 
datasets by spectral counting, we looked into characterising the likelihood of the 
proteins interacting with the transcription factor based on network models. While the 
prioritising approach of the previous analysis is useful to guide future experiments, 
this second approach should give a more general view on the type of protein 
complexes Mef2 comes in contact with in Drosophila. Most of the datasets of 
proteins pulled down by Mef2 in different experimental set ups have identified some 
candidates also found in the other datasets and some candidates that are specific to 
that particular sample. To identify the overlap between the different datasets and the 
degree of divergence between lists, a comparison of the candidates based on Venn 
diagrams was performed. It is important to note that the comparison of dataset was 
based on the presence or absence of a candidate in each sample and not on a 
protein’s abundance. 
The analysed datasets were the staged TAP purifications performed on 11-13h 
embryos (11-13MEF – data from Mef2-GSTAP embryos, 11-13CTRL – data from 
wildtype [WT] embryos) and the O/N embryos extracted from over 7 grams of input 
material (ONMEF - data from Mef2-GSTAP embryos, ONCTRL – data from WT 
embryos). The protein sets from the samples, respectively controls, have been 
analysed for any overlap in the proteins they contained (Figure 4.2A-C). All datasets 
overlapped at least partially with every other dataset. It is noticeable that the proteins 
recovered in the ONCTRL and 11-13CTRL samples overlapped completely with the 
data from Mef2-GSTAP embryos, except for 3 proteins that were unique to 
ONCTRL (Figure 4.2B, top diagram). 49 of the 56 proteins in 11-13MEF were also 
found in ONMEF. 
Almost 1/3 of the proteins in the ONMEF sample were also identified in the Rhee et 
al. (2014) CoAP/MS study where Mef2 associated proteins were co-purified from S2 
cells (S2-CoAP), and 50% of the 11-13MEF candidates overlapped with the S2-
CoAP dataset (Figure 4.2D-E). It was assumed that the presence in both datasets 
would suggest a higher confidence of a protein specifically interacting with Mef2. 
Therefore, the intersection of the TAP Mef2 samples with the Rhee CoAP/MS 
derived data was calculated and two new datasets were generated for later use to  
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Figure 4.2: Overlap between different datasets of candidates of Mef2-associated 
proteins obtained by affinity purification studies 
Supporting files listing protein IDs in each Venn diagram can be found in the 
figshare repository (see data availability statement, section 2.3.13). 
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A) Overlap between all datasets derived from purification experiments: 11-13CTRL 
(11-13h staged wildtype embryos), 11-13MEF (11-13h staged Mef2-GSTAP 
embryos), ONCTRL (overnight wildtype embryos), ONMEF (overnight Mef2-
GSTAP embryos), S2-CoAP (FLAG-HA tagged Mef2 overexpressed in S2 cells, 
(Rhee et al., 2014)). 
B) Overlap of candidate proteins between ONCTRL and ONMEF, respectively 11-
13CTRL and 11-13MEF, or ONCTRL and 11-13CTRL 
C) Overlap between the three samples purified from tagged-Mef2 expressing 
biological systems: ONMEF, 11-13MEF and S2-CoAP 
D) Overlap between the samples purified from overnight collected embryos: 
ONMEF, ONCTRL, S2-CoAP and ON/S2-Co-AP (intersection between ONMEF 
and S2-CoAP datasets) 
E) Overlap between the samples purified from staged collected embryos: 11-13MEF, 
11-13CTRL, S2-CoAP and 11-13/S2-CoAP (intersection between 11-13MEF and 
S2-CoAP datasets) 
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generate network models. These overlap datasets are denoted ON/S2-CoAP (overlap 
between ONMEF and S2-CoAP) and 11-13/S2-CoAP (overlap between 11-13MEF 
and S2-CoAP) respectively and are illustrated in Figure 4.2D & E. The overlap 
between the 11-13MEF candidates and the DPiM dataset (Guruharsha et al., 2011) is 
very low since only 8 proteins overlap. The ONMEF has only 15 proteins overlap 
with the DPiM dataset, it was unlikely that integrating these data would allow more 
insights into the TAP datasets, and relevant aspects of Mef2 function during 
development might be obscured rather than reinforced. Hence, this control was not 
studied any further via the network model approach. 
The datasets ONMEF* and 11-13MEF* which contain all the specific binders as 
identified by the spectral counting method represent 73% of the candidates for 
ONMEF, respectively 89% of the 11-13MEF dataset. The ONMEF* and 11-
13MEF* were compared with the 11-13/S2CoAP and ON/S2CoAP datasets and a 
number of 18 proteins were found in all the sets. Only 50% of 11-13MEF* were 
found in 11-13/S2CoAP, while only 80 proteins were common between ONMEF* 
and ON/S2CoAP.  
4.2.6 Connectivity between nodes depends on annotation level of the input 
proteins 
Protein Interaction Networks are a straightforward way to visualise lists of proteins 
and the connections between them. For the lists of Mef2 interactors each protein-
protein interaction network will be prepared starting from the list of candidate 
proteins and the connections between these proteins will be added based on 
information derived from a database which compiles information based on 
experimental, biochemical and genetic data available. In this way of visualising lists 
of candidates, each protein becomes a dot and if two proteins have a functional 
connection their dots are link together by a line. If two candidates and Mef2 are 
known to interact among each other, then our network would have three dots 
representing the proteins and three lines representing the functional relationships 
between each pair of proteins. This triangle would be found in the network 
representation of two separate lists of Mef2 candidate interactors, if these candidates 
were found in both of the lists. If there are candidates that are found only in a 
specific list, the dots of these unique candidates are linked with Mef2 only in the   
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Figure 4.3: Analysis of PPI networks of the datasets generated based on DroID 
derived data  
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A) Schematic representation of a protein-protein interaction (PPI) network based on 
graph theory, where the nodes are proteins and the edges are known associations 
stored in the DroID database. 
B) Representation of how the DroID Cytoscape plugin retrieves the information 
concerning a given protein used as input. The plugin receives a list of seeds 
(candidate proteins). For each seed, it retrieves a list of known interaction partners 
and the binary interactions stored for each seed-partner pair from the DroID 
database. 
C) Schematic how the DroID Cytoscape reading algorithms merges information 
retrieved for every protein provided as input node (seed). If two seeds (yellow) have 
a common interaction partner, the seeds will be connected through that intermediate 
partner (blue). If the DroID database contained a known interaction between two 
seeds, the two nodes will be directly connected in the PPI network (not illustrated). 
D) Overlap of the PPI networks obtained using each labelled dataset as seeds for the 
DroID plugin: 11-13CTRL (11-13h staged wildtype embryos), 11-13MEF (11-13h 
staged GSTAP embryos), ONCTRL (O/N wildtype embryos), ONMEF (O/N Mef2-
GSTAP embryos), S2-CoAP (Mef2 overexpressed in S2 cells, (Rhee et al., 2014)). 
Note that the number of identified interaction partners is several folds larger than the 
number of seeds (compare with Figure 4.2). Supporting files listing protein IDs in 
each Venn diagram can be found in the figshare repository (see data availability 
statement, section 2.3.13). 
E) Overlap of the PPI networks obtained for ONMEF, 11-13MEF, S2-CoAP, 
ON/S2Co-AP and 11-13/S2Co-AP. The 11-13MEF* and ONMEF* networks are 
omitted due to practical constraints of displaying Venn diagrams but are explained in 
the main text. 
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network representation of the list it was originally found in. Therefore, overlapping 
candidates between two datasets have the ability to give a similar topology of the 
network of the two list, while the unique candidates should give divergence to these 
networks since new functional relationships are added. 
The model used to construct the protein-protein interaction (PPI) network (Figure 
4.3A) for each considered dataset was based on the DroID Cytoscape Plugin which is 
able to retrieve information regarding a set of input proteins (referred further as 
seeds) from the DroID database. The information retrieved includes binary physical 
PPIs derived from various yeast two hybrid studies, physical PPIs derived from co-
immunoprecipitation studies, literature-curated genetic interactions, transcription 
factor-gene relationships, miRNA-gene interactions and predicted protein 
interactions derived from data in human, yeast and worm. Based on the obtained 
information from the database, the algorithm adds to the list of seed proteins the 
identified interaction partners and registers all seeds and interaction partners as nodes 
in a network. Any known association between two proteins is registered in the 
network as an undirected edge between the two proteins' nodes, regardless of the 
nature of that association (Figure 4.3B). Thus, if two seeds have a known association, 
they will be connected by an edge. If two seeds interact with the same non-seed 
protein, a network path is created between them through this common protein/node 
(Figure 4.3C). 
Each obtained PPI network contains two categories of nodes: nodes derived from 
seed proteins ("seeds") and nodes derived from interaction partners of seed proteins 
as identified by DroID ("interaction partners"). The connectivity (number of edges) 
of a node derived from a seed protein is influenced by the number of different known 
associations of that protein. The connectivity of a node representing an interaction 
partner depends on the number of seeds that interact directly with that protein. Some 
nodes derived from seeds can have low connectivity if they have a low number of 
known associations; this is typically the case for proteins with little literature 
background. A node from an interaction partner can have a high connectivity if it is 
linked with several seed proteins. Proteins from the datasets for which DroID 
returned no known association in the database are not included in the network. Note 
that the interaction partners for seeds as identified by DroID were only used to 
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determine how well-characterised the proteins in the different datasets were and how 
well-connected the respective PPI networks were (this section and the one 
following). After this step, all further analysis considered only the seeds, i.e. 
candidate Mef2-interactors, themselves, and the interactions (connections) between 
them that were found in the DroID database. 
To test if the seed proteins in our datasets were well characterised, the connectivity 
of nodes derived from them (Figure 4.4A) was compared to the connectivity obtained 
using random lists of proteins (Figure 4.4B), whereby the random lists had the same 
number of proteins as the datasets tested. From Figure 4.4, it is observed that the 
proteins in all the datasets have a high number of neighbours (more than 10 for 
almost all seeds, mean connectivity above 200 interaction partners per seed). The 
WT control samples each had a slightly higher mean connectivity than the 
corresponding sample derived from embryos expressing tagged Mef2. The proteins 
extracted in the staged samples had a greater connectivity than overnight samples. 
The fact that the proteins used as input are well connected signifies that the proteins 
of interest are characterised and there is enough biological background available to 
assess the validity of the data obtained using functional relatedness and network 
modelling.  
Using the DroID plugin, one PPI network was generated for each dataset, where two 
proteins were connected if there was any known biological interaction between them 
(genetic interaction, PPI, TF-gene relationship, binary interaction derived from yeast 
two hybrid studies, or predicted from other organism; Figure 4.3B-C). For each 
dataset, all candidates contained in the dataset were used as seeds to query known 
interaction partners and generate the respective network. This resulted in a total of 9 
networks. The networks are denoted by the same name as the dataset they are derived 
from (S2-CoAP, ONMEF, 11-13MEF, ONMEF*, 11-13MEF*, ON/S2-CoAP, 11-
13/S2-CoAP, ONCTRL, 11-13CTRL). The number of nodes in the experimental 
datasets' PPI network are illustrated in Figure 4.3D. 
Since the derived datasets (the two datasets of non-contaminant Mef2-interactors as 
determined by the NSAF α coefficient, and the two overlap datasets) are subsets of  
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Figure 4.4: Numbers of detected interaction partners in DroID for each 
candidate protein in the starting datasets 
A) Number of interaction partners identified per seed by DroID for each of the 9 
datasets used for network analysis. 
B) Distribution of the interaction partners identified by DroID using random lists of 
proteins as seeds. For each dataset, ten lists of proteins chosen randomly from the 
Drosophila genome were generated, where the number of proteins on each list 
corresponded to the number of proteins in the respective dataset. 
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ONMEF and 11-13MEF respectively, also the PPI networks derived from them are 
subnetworks of the ONMEF and 11-13MEF networks. Consequently, neither of the 
overlap samples have any unique nodes (Figure 4.3E). It is striking to note that even 
though the overlap between the datasets, i.e. the seed proteins, was minimal 
(compare Figure 4.2A), the vast majority of nodes in the PPI networks were shared 
between several networks (Figure 4.3D & E). Correspondingly, most datasets contain 
a substantial number of unique proteins (Figure 4.2A), but only very few nodes in the 
PPI networks are unique to any network (Figure 4.3D & E). Those seeds which were 
shared between datasets necessarily also lead to all of those seeds' interaction 
partners identified by DroID being shared. However, those seeds which were not 
shared might have been expected to result in divergent additional interaction 
partners. This striking overlap suggested that the proteins pulled down in the 
analysed samples were able to identify, partially overlapping parts of a closely 
connected larger genetic network. 
There were overall 1042 nodes/proteins that were shared between all 9 PPI networks. 
Another 678 proteins appeared in all networks derived from the 7 Mef2 datasets but 
not in ONCTRL and 11-13CTRL. This includes both physically interacting proteins, 
but also proteins otherwise included in the network as implied by the different types 
of connections that DroID queries (see above). 93% of the proteins in these groups 
had direct connections with Mef2. Only the S2-CoAP network had a substantial 
number of nodes that could not be found in the networks generated by any other 
dataset (Figure 4.3D). 
The comparison between networks around different samples of Mef2 interactors 
allows to assess how distinct the candidates extracted in each case are and if they 
capture very distinct parts of the Mef2 interactome. The high numbers of known 
interactions show that the proteins that were co-purified with Mef2 are well 
characterised proteins. Yet, while there is only partial overlap between different lists 
of candidates, the overlaps between the networks were very large, indicating that the 
unique candidates seem to connect to Mef2 via a common set of links. Since these 
common connections were present in datasets representing different biological 
contexts, these proteins could be part of a core biological network in which Mef2 is 
embedded across time and cell types. The large subnetwork that was unique to S2 
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cell data and not present in the Drosophila networks may reflect the different 
biological context of Mef2 in cultured cells. Similar subnetworks unique to the 
Drosophila sets, though very small, were also present and could reflect different 
Mef2 contexts during development. 
4.2.7 All candidate proteins are closely associated with Mef2 
To determine if the seed proteins in each dataset are indeed part of the same network 
component with Mef2, the network distance from each seed to Mef2 was analysed. 
For each dataset containing Mef2 as a seed (all sets, except ONCTRL and 11-
13CTRL), the shortest path network distance (ND) within the PPI networks 
generated by DroID of each seed to Mef2 was computed. The highest ND to Mef2 
found in any network was 2. ND can therefore take up three distinct values: 0 
corresponds to direct interactions between Mef2 and a candidate protein (Figure 
4.5A), 1 indicates the presence of one intermediate in the shortest path (Figure 4.5B), 
2 indicates two intermediates in the shortest path (Figure 4.5C). Since the ND is 
determined within the DroID networks, intermediate nodes in this case can be either 
other seed proteins or interaction partners identified by DroID. Note that for ND=2, 
at least one of the intermediates must be another seed (Figure 4.5B). In the control 
datasets (11-13CTRL, ONCTRL) the seed list did not contain Mef2. However, the 
PPI networks generated by DroID contained Mef2 as an interaction partner of some 
of the seeds. Therefore the analysis of shortest distance for each candidate to Mef2 
was calculated for the controls as well. Figure 4.5G shows the ND for all seeds and 
datasets. 
The first important observation was that all proteins had a path to Mef2 within their 
respective PPI network, indicating that none of the networks contain any fully 
separate subnetworks without connections to the rest. This confirms that all proteins 
identified by mass spectrometry as Mef2 interactors are already known to be directly 
or indirectly connected to Mef2. Most of the proteins are connected to Mef2 through 
another intermediate protein (ND=1, Figure 4.5G). In all samples except 11-13MEF 
and 11-13CTRL, over 70% of the seeds require a different protein as an intermediate 
to connect to Mef2. Only very few seeds require more than one intermediate to link 
to Mef2 (ND=2): 2 seeds in S2-CoAP, 3 seeds in 11-13CTRL and 10 seeds in 
ONCTRL. The ratio between indirect (ND=1) to direct (ND=0) interactors of Mef2  
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Figure 4.5: Number of intermediate proteins between Mef2 and associated 
proteins present in each PPI network 
Diagrams of network distance between Mef2 and other seed proteins when Mef2 is 
either a seed or an interaction partner in the PPI. With Mef2 as a seed, each other 
seed (seed X) can have A) a direct interaction/no intermediate proteins, B) 1 
intermediate protein, which can be another seed or an interaction partner identified 
by DroID, C) 2 intermediate proteins, of which necessarily at least one must be 
another seed. 
When Mef2 is not a seed but was itself identified by DroID as an interaction partner, 
each seed (seed X) can have D) a direct interaction / no intermediate proteins E) 1 
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intermediate protein, which must be another seed, F) 2 intermediate proteins, of 
which at least one must be another seed. 
G) Distance of Mef2 to each seed in the PPI networks generated from the 9 datasets. 
ND, network distance. Network distances larger than 2 are possible in theory but 
were not found in any of the datasets analysed.  
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was roughly 1.5 in networks generated from datasets derived from staged Drosophila 
embryos (11-13MEF, 11-13MEF*, 11-13CTRL), while in the overnight samples the 
ratio is above 3. This suggests that in overnight samples Mef2 is involved in more 
indirect connections than in the 11-13h staged context. 
The networks created to analyse the relationship between candidates in the datasets 
and Mef2 consist of both Mef2 interactor candidates identified via protein 
purification and other proteins that are predicted to be part of the PPI network since 
they have direct functional connections with candidates. These common 
“intermediate” proteins allow to create a path within the network between any two 
candidates considered. Many proteins have a direct link to Mef2, but the majority 
require an intermediate protein to connect to it. However, only the CTRL and the S2-
CoAP networks have third-order candidates (2 proteins distant from Mef2), and none 
are further apart than this, indicating that all networks are densely centred around 
Mef2. 
The identification of both direct and indirect links to Mef2 suggests that all the 
datasets have identified proteins that are either direct interactors, or part of a complex 
that works together with Mef2. This is most striking for the CTRL datasets, since 
these would normally be assumed to be contaminants that should not interact with 
Mef2. Since all networks form a single connected component it can be assumed that 
these networks are densely packed with connections and that focusing only on the 
connectivity among seed proteins will highlight which complexes they are part of in 
their interaction with Mef2.  
4.2.8 Connectivity between candidate proteins 
The seeds were found to form either direct or indirect connections to Mef2 in the 
analysed networks. The connectivity of the seeds with regards to other seeds and 
Mef2 was investigated in order to determine if they form a connected subnetwork. 
This analysis is similar to the previous step analysing network distances in the 
concept of connectivity, but it selectively analyses seeds and disregards all 
interaction partners added by DroID to test whether seeds are well-connected 
between themselves. To achieve this purpose, all non-seed interaction partners were 
removed from the 9 PPI networks, leaving behind only the seed nodes and the 
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connections between them. The seeds were then classified into different levels: 0 
level seeds had direct connections with Mef2, 1
st
 level proteins interact with Mef2 
through 0 level seeds, 2
nd
 level proteins need two other seeds to interact with Mef2 
(seeds from levels 0 and 1; Figure 4.6A). Next, the connectivity (number of edges) 
between all seeds on each respective level was computed (within-level connectivity). 
Subsequently, the connectivity between each two levels was computed, i.e. the 
number of edges from seeds on the upper level to seeds on the level below (between-
level connectivity). 
For all 9 datasets except 11-13CTRL, most of the seeds had a direct or indirect 
connection to Mef2 through other seeds (Figure 4.6B). Indeed, the overall distances 
of seeds from Mef2 when only connections between seeds are taken into account are 
quite similar to the distances in the full networks that include all interaction partners 
identified by DroID (compare Figure 4.6B with Figure 4.5G). However, in the seeds-
only subnetworks, a small number of seeds are not connected to Mef2 at all (Figure 
4.6B, grey bars), indicating that these seeds depended on a non-seed interaction 
partner to be connected to the full PPI network. These proteins do not form a 
separate connected group among themselves, but are isolated both from the seeds 
subnetwork and the other seeds in this category. 
The great majority of the seeds are either direct interactors of Mef2 or on level 1, 
followed by level 0 proteins. The number of level 2 proteins is very low in all the 
samples. The low number of unconnected and level 2 seeds strengthens the previous 
finding that the candidates contained in the datasets are part of a highly connected 
network with many known interactions. 
Additionally to their distance to Mef2, the connectivity between the seeds classified 
as level 0, 1 and 2 was studied in all the datasets (Figure 4.6C). This was done to 
compare the connectivity of seeds with Mef2 to their connectivity with each other, as 
a way of assessing how central Mef2 is within the network. The connectivity in this 
case is the number of connections within or between the respective levels, 
normalised by the number of potential connections (Figure 4.6C, labelled as 
"MAX"), which depends on the number of seeds on the respective level (compare to 
Figure 4.6B). This normalisation is necessary because large networks naturally are 
likely to contain a larger absolute number of connections, and the sizes of the  
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Figure 4.6: Classification of Mef2 associated proteins on levels depending on 
their distance to Mef2 in seed-only subnetworks 
A) Schematic representation of a small PPI subnetwork formed by Mef2 and other 
seeds that are connected to it and to other seeds.  The seeds are classified as 0 level if 
they interact directly with Mef2, level 1 if another seeds sits between the two, level 2 
 136 
 
if two other seeds are required to connect to Mef2. The seeds on the same levels or 
adjacent levels can be interconnected. 
B) Distribution of seeds on levels in each dataset. 
C) Relative connectivity between seeds within each level and between levels. 
Connectivity is the number of connections of each seed divided by the maximum 
possible connections, which in turn depends on the number of seeds on the same 
level (respectively the level below). MAX, maximum potential connections per seed 
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different subnetworks diverge substantially. Comparing absolute numbers of 
connections would thus not provide much information except that one subnetwork is 
larger than the other. 
In all the samples that have level 2 seeds, these proteins have reduced connectivity 
among themselves and with level 1 proteins, making them the least connected seeds. 
Level 1 and level 0 proteins tend to have the highest connectivity between the seeds. 
In all datasets except the overlap-sets (S2-CoAP, ONMEF, 11-13MEF, ONMEF*, 
11-13MEF* and ONCTRL) the trend of the connectivity between seeds showed the 
following pattern: direct interactors of Mef2 are the most interconnected seeds 
among themselves. The connectivity of level 1 proteins to direct interactors was the 
second-highest, and level 1 proteins were the third-most connected group of seeds. 
This pattern indicates networks which are centred on Mef2 and gradually become 
less connected the further away from Mef2 nodes are. The S2-CoAP subnetwork 
derived from the published study contained only level 0 and level 1 proteins, but 
their connectivity followed the same pattern. 
However, in the overlap datasets ON/S2-CoAP and 11-13/S2-CoAP, the pattern was 
reversed, the level 1 proteins being the most interconnected while Mef2 direct 
interactors are the third-most connected group. This indicates the opposite, i.e. 
networks where nodes further away from Mef2 become gradually more 
interconnected. This suggests that the candidates that are shared between the TAP 
purification datasets (ONMEF and 11-13MEF) and the published study (S2-CoAP) 
are less likely to contain complexes that directly include Mef2 and instead may be 
enriched for long-range interactors that can be pulled down with Mef2 e.g. through 
adapter proteins. Furthermore, the consistency of this trend also in ONCTRL 
indicates that this control sample is also Mef2-centred, even though Mef2 was only 
added to the network as an interaction partner identified by DroID. This suggests that 
the control samples primarily contain Mef2 interaction partners of interest, even 
though the proteins in these samples were purified due to unspecific binding to the 
purification columns and not due to specific binding to Mef2. Consistent with this, 
11-13MEF* and ONMEF* ONMEF*, which were filtered as likely specific binders 
based on the CTRL datasets, have a very similar behaviour as the networks that still 
contained seeds categorised as potential contaminants (as determined in section 
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4.2.2). This means that the potential contaminants are not distinguishable from 
specific binders based on their connectivity characteristics both towards Mef2 and 
between each other, which argues against the assumption that they are contaminants. 
The previously identified trend of more connectivity with Mef2 in staged samples 
(11-13MEF and 11-13MEF*; Figure 4.5G) is also maintained when intermediate 
interactor proteins are removed from the networks and only the connectivity of seeds 
with Mef2 and between seeds is taken into account. These samples had a larger 
fraction of seeds on level 0 (direct connection to Mef2; Figure 4.6B), and their level 
0 seeds also had nearly twice the relative connectivity between each other compared 
to level 0 seeds in other datasets (Figure 4.6C). This further increases the confidence 
that these datasets contain complexes that directly interact with Mef2. 
Overall the samples display a strong connectivity which seems to indicate the 
extracted candidates are part of well characterised networks that are able to indicate 
the biological processes that Mef2 is involved in during Drosophila development. 
The characteristic that stands out from the connectivity among seeds in all these 
networks is that there is an intense crosstalk between different potential candidates 
and it is connectivity information alone does not make it possible to extract 
information about certain proteins that could form distinct protein complexes. 
Together with the previous observation that the extended networks for each dataset 
form roughly the same connected component suggests that Mef2 is involved in an 
intricate regulatory network that is present around it in most contexts. Some of these 
candidates were also identified in control experiments and these proteins are often 
regarded as contaminants in purification experiments and are discarded from further 
analysis. Interestingly, when looking at their connectivity, Mef2 is one potential 
protein that links these together as an intermediate protein. Also, most unique 
candidates were introduced in the network of another list as intermediate proteins by 
the DROID algorithm. This suggests that these unique candidates are likely present 
in the other biological contexts where they haven’t been identified by MS, but they 
were not pulled down due to dynamics in concentrations or differences in 
experimental conditions which are able to preserve better certain types of interactions 
compared to others. 
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The fact that the proteins are very well interconnected makes further bioinformatic 
analyses possible, and suggests that the candidates can form modules that cluster 
together to perform a function. It is impossible to estimate from a network model if 
these networks represent protein complexes that interact with Mef2 at the same time 
or physically, but these analyses can provide important directions for further 
experiments. 
4.2.9 Topological evaluation of protein-protein interaction networks 
The final aim of the network analysis was to use a network cluster detection 
algorithm to identify cohesive subgroups within a network of all available 
candidates. If such groups are identified, these could be Mef2-interacting protein 
complexes. However, the clustering algorithms could be impacted by the presence of 
contaminants, since these could interconnect otherwise discrete subgroups of the full 
network. The previous analysis of interconnectivity in DroID-generated PPI 
networks suggested that the control samples purified from WT embryos (ONCTRL 
and 11-13CTRL) contain a substantial portion of potential Mef2-interacting 
candidate proteins and it would thus be preferable to retain them for further analysis 
to identify potential Mef2-interacting complexes. We thus wanted to assess how the 
seeds in the CTRL datasets and the connections between them influence the 
networks of non-CTRL datasets. Seeds from all datasets were pooled for this 
purpose, resulting in the "Mef2 candidates" dataset containing 888 candidate proteins 
(not counting Mef2 itself). 
As previously, known interactions / connections between seeds were extracted from 
the DroID database, resulting in a large network containing one node for each seed 
and edges between nodes according to the PPIs stored in DroID. Two networks were 
derived from this. First, control connections were identified, i.e. connections between 
two seeds, where both seeds were present in either of the control datasets (ONCTRL 
or 11-13CTRL). The first derived network ("Without CTRL edges") was created by 
removing all control connections from the large network. The second derived 
network ("CTRL only") was created by removing all connections except those where 
at least one of the two seeds was present in a control dataset. This was intended to 
test whether the seeds from control samples connect into a network of different 
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character than seeds not present in controls. The resulting networks are characterised 
in Table 4.3. 
The control connections that were removed to create the first derived network 
constituted 26.5% of all edges. Along with these edges, 13.6% of seeds were 
eliminated (becoming entirely unconnected to the main network). Even though such 
a large number of edges was removed, the network metrics were only marginally 
different, meaning that the overall layout of the network was conserved. In contrast, 
the network composed only of CTRL-adjacent edges contained only 26.7% of the 
original edges. Despite this drastic reduction, the network retained 88.6% of all 
seeds, a similar amount of seeds as the "without CTRL" network.  The characteristics 
of this network were markedly different, reflecting a substantially less connected 
network. Besides the reduced density and increased heterogeneity, nodes in this 
network had substantially fewer neighbours (also reflected by the reduced number of 
nodes with higher degrees). The network was also less centralised, reflected in 
reduced clustering coefficients, a higher diameter and radius, and higher shortest path 
lengths. These differences suggest that the control-adjacent network does not 
conserve the centralisation on Mef2 that is typical of the other PPI networks. In 
contrast, removing control-only edges did not disturb this centralisation, suggesting 
that control-only edges were peripheral in the network relative to Mef2. Overall, 
these results suggest that the presence of seeds that are also contained in control 
datasets, or the PPIs associated with them, do not substantially impact the network 
and thus it should not be necessary to remove either of them for the downstream 
analysis. In the interest of avoiding false negatives (excluding proteins that are 
genuine Mef2-interacting proteins), the complete network was therefore used in the 
following step (Figure 4.7A). 
Based on the "guilt by association" paradigm, an identification of potential cohesive 
subunits of the main network was attempted. In principle, highly-connected 
subnetworks could reflect biologically relevant groups of genes, such as regulatory 
networks that act together at particular times or in particular biological contexts. To 
identify potential subnetworks, the MCODE plugin was used in Cytoscape to extract 
clustered groups of nodes. Running MCODE on the complete network of Mef2 
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candidates identified 10 clusters (Figure 4.7B). However, without further analysis, it 
was not possible to interpret whether any of these clusters were biologically relevant. 
To test whether proteins contained in each cluster were associated with coherent 
biological contexts or functions, a gene ontology (GO) enrichment analysis was 
carried out for each cluster using the ClueGO plugin for Cytoscape. This showed that 
the clusters were diverse in functions (representative GO network of the first 
MCODE cluster in Figure 4.7C), and they were therefore not analysed further. To 
test the previous hypothesis that removing control-only edges had no significant 
effect on the functional characteristics of the network, the same analysis using 
MCODE and ClueGO was carried out for the two networks derived earlier ("without 
CTRL" and "CTRL only"). The same cluster as shown in Figure 4.7C was found in 
all cases. However, no other clusters or their functionality were maintained. 
Therefore, even though the network characteristics were maintained when removing 
CTRL edges, the functional assessment of the network was impacted. This 
corroborated the previous decision to retain seeds from control samples and their 
edges, as removing either of them changed the functional characteristics of the 
network. Furthermore, the cluster that was retained was characterised as related to 
ribosome and translation. Proteins of this category of function are often considered 
contaminants. Therefore, the method of adjusting for control samples by removing 
control-only edges as tested here also did not remove clusters in the network that 
could be considered potential contaminants. 
In conclusion, the PPI network approach was not able to identify functionally 
coherent subgroups of candidate proteins, and other approaches to achieve this were 
therefore explored in the next sections. However, this analysis highlighted that the 
assumption that proteins in the control datasets are contaminants simplifies the issue. 
Thus, while the control datasets could be used to narrow down the candidate list for 
the identification of a single best candidate (as done in section 4.2.4), on the systems 
level the dynamics of biological conditions seem to be reflected in the linking of 
candidates and not in the presence of absence of candidates. Therefore, when 
assessing if candidates are able to interact with Mef2 it is important to look at the 
types of associations that occur and not in removing the proteins that fit all criteria of 
a “perfect” interactor.  
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Table 4.3 Characteristics of networks based on seeds from all datasets, filtered 
or not by CTRL edges 
 All seeds & edges Without CTRL edges CTRL edges 
Schematic 
   
Seeds / Nodes 889 768 788 
Edges 17756 13056 4700 
Isolated seeds 0 0 0 
Diameter 4 4 5 
Radius 2 2 3 
Density 0.045 0.044 0.015 
Heterogeneity 1.861 1.9 2.794 
Centralisation 0.909 0.919 0.896 
Avg. neighbors  39.946 34.0 11.929 
Number of 
nodes (y) vs. 
degree (x) 
   
Avg. clustering 
coefficient  
vs number of 
neighbours 
   
Topol 
coefficients  vs. 
number of 
neighbours 
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Shortest path 
lengths 
   
Shared 
neighbours 
   
Avg. 
neighbour-hood 
connectivity  
vs. number of 
neighbours 
   
Betweenness 
centrality  
vs. number of 
neighbours 
   
Closeness 
centrality 
vs. number of 
neighbours 
   
Number of 
nodes 
vs. stress 
centrality 
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Figure 4.7: Topological characterisation of protein network generated from a 
unified seed list and interactions between seeds stored in DROID 
A) Illustration of the complete network including all seeds from all samples as nodes 
and edges representing interactions derived from the DroID database 
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B) Clusters identified by the MCODE clustering algorithm in the network displayed 
in (A) 
C) Gene ontology terms enriched in the most significant and interconnected cluster 
identified by MCODE in the network depicted in (A), as determined by ClueGO. 
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4.2.10 Functional analysis based on gene expression 
The network analysis can show if there is experimental data available to suggest that 
the candidates can act in similar biological contexts. To test whether the candidates 
had functional and contextual connections with each other we looked at the 
expression data of each candidate in Drosophila embryos from modENCODE  and 
used this information to assess the likelihood of coexpression and functional 
similarly (Graveley et al., 2011). To study these two parameters we took advantage 
of the percent max (pmax) filter, which allows to estimate the likelihood of genes 
being expressed and active in a particular context (Murali et al., 2014). The list of 
candidates included all proteins identified in all datasets even if they were also 
identified in control samples. 
This analysis assumes that a gene is more likely to be functional at a time point when 
its expression is maximal. The pmax index is a relative measure of RNA expression 
of a particular gene at a particular stage during embryonic development, whereby the 
stage with the highest expression has pmax = 1 and all other stages have a pmax 
according to the fraction of RNA expression at that stage. The closer a gene's pmax 
is to 1, the more likely it is the gene product is functionally active at that stage. Many 
proteins that interact with each other are co-expressed in time and space (Murali et 
al., 2014). Therefore their pmax values should correlate across development and 
should be closer to 1 at stages when they are active. To test whether any of the 
candidate proteins identified in this study were co-expressed during Drosophila 
embryonic development, the pmax value was calculated for all candidate genes based 
on RNA expression values obtained from the modENCODE database (Graveley et 
al., 2011) and a hierarchical clustering algorithm was used to estimate the 
coexpression of genes (Gould, 2012). This showed that the majority of candidate 
genes had their highest expression during early embryogenesis (Figure 4.8A). 
However, a relatively small cluster of genes was co-expressed during the later stages 
of embryogenesis (Figure 4.8B), showing a similar pattern as Mef2, whose 
expression levels in muscles increase towards the late stages of embryogenesis. This 
gene group was associated with muscle-related GO terms, specifically sarcomere 
organisation (Figure 4.8C), and may therefore constitute a potential gene network 
that interacts with Mef2 during muscle development.  
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Figure 4.8: Expression distribution of the protein seeds based on the expression 
filter pmax 
A) Heatmap of the expression distribution of the seeds based on relative expression 
at different time points during embryogenesis. Colour indicates the pmax value, i.e. 
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RNA expression level relative to the gene's expression peak, at each embryonic 
stage. Colour scale: blue: pmax = 0, red: pmax = 1. Each line in the heatmap 
corresponds to one gene. The genes have been arranged using a hierarchical 
clustering algorithm. Supporting file with the complete pmax matrix can be found in 
the figshare repository (see data availability statement, section 2.3.13). 
B) Identification of a cluster of genes expressed with a similar relative expression in 
late embryos that are involved sarcomere maintainance. The relevant portion of the 
dendrogram produced by hierarchical clustering is shown on the left, illustrating the 
similarity of these genes' pmax distribution. 
C) GO terms enriched in the cluster identified in (B), determined by ClueGO in 
Cytoscape. 
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Some of these genes were also among the candidates identified as myogenesis-
specific Mef2 interactors in the semiquantiative analysis of section 4.2.4 (Tm2, 
wupA, up, sls) and have been tested for roles in muscle in a specific RNAi screen 
(Schnorrer et al, 2010). The group identified here is more extensive, however, and 
includes further cytoskeletal proteins such as Actin57B, alpha-Actinin, beta-Tubulin 
and Myosin 61F, as well as proteins involved in myoblast fusion such as Lactate 
dehydrogenase and Paxillin. Therefore, using gene expression data and hierarchical 
clustering it is possible to identify groups of proteins that are co-expressed and are 
highly likely to act together with Mef2 in specific biological processes. 
4.2.11 Functional analysis of individual datasets using gene ontology  
While pmax as analysed above provides information on gene expression, gene 
ontology (GO) terms reflect known aspects of a gene's function. Mef2 is annotated 
with an unusually large number of GO terms, reflecting a diversity of biological 
functions (Figure 4.9). The biological roles of Mef2 are assumed to reflect also the 
functions of proteins it interacts with to perform these functions. To try to classify 
the candidates based on the functions they might have in connection with Mef2, they 
were checked against Mef2 specific GO terms. 
GO enrichment was calculated for each dataset and the enrichment p-values for the 
various GO terms enriched in each sample were collated into a single table for 
comparison. Another dimension of resolution was added to the analysis by 
calculating GO enrichment in each case for the whole dataset (ALL), the subset of 
seeds with direct interaction to Mef2 (Level 0), indirect interaction through one other 
seed (Level 1) or two (Level 2). This refers to levels as in section 4.2.8 where the 
interconnectivity between seeds relative to Mef2 was analysed. A hierarchical 
clustering algorithm was used to cluster the GO terms according to their similarity of 
enrichment across datasets. The resulting list of terms which are enriched in one or 
more samples contains a total of 1729 terms and can therefore not be displayed in a 
practical manner. The list was therefore narrowed down to only those terms which 
are also annotated for Mef2 itself (Figure 4.10). 
From the list, clusters which were enriched specifically in the 11-13MEF sample 
were isolated and the proteins which contributed to those GO term clusters identified.   
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Figure 4.9: GO terms associated with Mef2  
Due to spatial constraints, terms are grouped based on biological function similarity. 
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Figure 4.10: Mef2 GO terms enriched in one or more dataset 
The terms have been arranged according to similarity in their enrichment across 
different datasets (clustering dendrogram on the left). Each line in the data matrix 
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represents one GO term and each column represents the enrichment of each term in 
one set of seeds. The colour of each cell represents the enrichment p-value of the 
term in that dataset. GO enrichment was calculated for each sample for the whole 
dataset (ALL), the subset of seeds with direct interaction to Mef2 (0), indirect 
interaction through one other seed (1) or two (2) according to interactions found in 
the DroID database (see section 4.2.8). Individual terms have been manually 
summarised into broader categories for better displayability. Supporting files with 
the complete list of GO terms and GO enrichment matrix can be found in the figshare 
repository (see data availability statement, section 2.3.13).  
 153 
 
 
Figure 4.11: 11-13MEF specific GO term clusters and their constituent proteins 
A) Higher-zoom representation of the GO term clusters of interest (specifically 
enriched in 11-13MEF and the subset of seeds with direct interaction to Mef2) 
identified from Figure 4.9. Proteins identified to be causing the enrichment of these 
terms. Cluster names were assigned manually. 
B) Graph of all GO terms enriched in the proteins from (A). 
C) Protein-protein interaction network of the proteins from (A) derived from 
connections stored in the DroID database. 
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All clusters came from a mostly overlapping list of 10 proteins (Figure 4.11A). To 
assess whether these genes generally have shared functions outside of the context of 
the present datasets, GO enrichment was calculated for the 10 identified proteins. As 
seen from the GO terms enriched in these proteins (Figure 4.11B), these proteins are 
mostly muscle related. Additionally, the DroID-based interactions associated with 
this group of genes was retrieved (Figure 4.11C). This showed that most proteins in 
this group, additionally to their interaction with Mef2, already have known 
associations with others from the group. The co-purification of these proteins with 
Mef2 from 11-13h staged Mef2-GSTAP expressing Drosophila embryos suggests 
that additionally to the known genetic relationships, these proteins may physically 
interact with each other. Several proteins of this group are also present in the co-
expressed cluster identified using the pmax expression filter (section 4.2.9), 
specifically Troponin I (wupA), Troponin T (up/wupB), Titin (sls) and α-Actinin 
(actn) (compare Figure 4.11C and Figure 4.8B). 
Taken together, sections 4.2.9 and 4.2.10 show that using network topology 
information, gene expression data and gene ontology terminology can be integrated 
to break down the highly interconnected candidate network of Mef2 to extract 
protein networks with cohesive expression patterns and functional annotations, 
suggesting that they interact with Mef2 in a specific biological context.  
4.2.12 Functional analysis of all candidates using functional similarity 
The previous approach to identify candidates of interest based on GO annotation was 
successful, but could not be applied to the whole dataset in this form. Besides being 
very time-consuming, the complexity of this analysis is likely to result in human 
error and bias. To evaluate GO annotations on a large scale for the complete network 
of Mef2 candidates, the functional similarity score (FunSim) was therefore used. 
This is a pairwise score where for any two proteins, a semantic measure of similarity 
between the GO terms associated with them can be calculated. This eliminates the 
earlier problem encountered with GO enrichment analysis that the large number of 
GO terms makes any further analysis impracticable. The FunSim score integrates all 
GO annotations and returns a measure of similarity, which can then be used to 
identify groups of proteins with similar existing functional annotations. 
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A FunSim matrix was computed for all pairwise relationships between all 889 Mef2 
candidates using FunSimMat (Schlicker and Albrecht, 2008, 2010). Based on these 
scores, a FunSim network was created where an edge was added between two seed 
proteins if FunSim > 0.7. If a seed did not have any edges by this criterion, the seed 
was eliminated from the network (Figure 4.12A). The primary finding of this 
analysis was that most candidates formed a tight cluster with Mef2, indicating high 
FunSim scores and therefore much overlap in their GO annotations.  
In the previous section, 10 muscle-related proteins were identified based on their 
GO-term specificity for 11-13MEF and their known associations stored in DroID. 
Despite these correlations, in a network representation based on functional similarity 
as this one, these proteins were quite distant from Mef2. This reflects that these 
proteins are specific and similar to each other in their functional annotation, whereas 
Mef2 shares part of its function with them but simultaneously has more diverse 
unrelated functions, leading to a relatively low FunSim score between Mef2 and the 
identified muscle proteins. 
Three quite distant clusters were observable in the functional similarity network. The 
three clusters were related functionally to translation initation (Figure 4.12B), 
cytosolic translation with the help of ribosomes (Figure 4.12C) and proteasomal 
degradation (Figure 4.12D). Proteins that contribute to these functions are typically 
ubiquitous and highly expressed, making them commonly found contaminants in 
protein purification studies (Zanon et al., 2013).  
While the previous approach using only the GO terms for biological process (section 
4.2.10) was able to identify some proteins with associations to muscle, it seems that 
when comparing all GO terms including those for cellular component and molecular 
function for each pair of candidates, the most clearly distinguishable protein groups 
are related to housekeeping functions. According to the "guilt by association" 
interpretation, these protein clusters should be unlikely to be found in similar 
biological contexts as Mef2 and thus could also constitute contaminants in the 
datasets where they were originally found. Overall however, the tight clustering of 
the vast majority of candidates around Mef2 reaffirms that the datasets contain a 
large number of proteins that interact with Mef2 in all of its functions.  
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Figure 4.12: Functional analysis of seeds based on the network generated from 
the most functionally related seeds 
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A) Representation of the Functional Similarity network obtained by linking seed 
nodes that have a FunSim score derived from GO terms annotations above 0.7. Red: 
Mef2. Orange: 11-13MEF GO-specific proteins identified in Figure 4.9 and 4.10. 
Boxes: Large clusters of interest due to their isolation from the main network. The 
complete FunSim network can be found in the figshare repository (see data 
availability statement, section 2.3.13) 
B-D) Functional characterisation (GO enrichment analysis) of the proteins forming 
the most distant clusters that are connected to the main component of the network by 
very few proteins 
  
 158 
 
4.3 Discussion 
4.3.1 Datasets analysed 
The datasets of Mef2 interacting proteins were derived from quite different 
biological backgrounds: one sample included biological material from Drosophila 
embryos of all developmental stages that should give an overview of the most 
consistent functions that Mef2 and its interactors are involved in (ONMEF), while 
11-13h embryos concentrate more on complexes that are involved in muscle 
differentiation (11-13MEF). Equivalent control samples from all stages wildtype 
embryos (ONCTRL) and 11-13h wildtype embryos (11-13CTRL) were also tested in 
order to detect unspecific binders that could be purified from Drosophila embryos. 
The S2-CoAP study (Rhee et al., 2014) was performed in S2 cells, therefore should 
offer more insight into the cellular functions and specifically the transcriptional 
regulation partners of Mef2. Despite the fact that the contexts were so different and 
the exact conditions during the purifications had variations, many of the proteins 
associated with Mef2 overlapped in the three studies. The creation of the overlap 
datasets ON/S2-CoAP and 11-13/S2-CoAP was aimed to test if the genes that were 
shared between datasets identify complexes that are partners of Mef2 in diverse 
biological contexts to achieve particular functions. 
4.3.2 Variety of computational techniques applied 
Two approaches were applied to analyse the Mef2-interacting candidate lists derived 
from TAP purification experiments: 1) a very conservative approach in which Mef2 
interaction candidates were prioritised according to spectral counts, specificity to the 
biological conditions and functional roles according to published literature and 2) a 
computational approach using network properties, gene expression and gene 
ontology data derived from published large scale datasets as ways to investigate the 
different complexes that the candidates might form.  
For the first approach spectral counts and NSAF were used to determine protein 
abundance within a sample and the α-coefficient to assess the enrichment of each 
protein in Mef2-specific datasets compared to control datasets. After classifying the 
candidates as specific and non-specific binders, the ONMEF and S2-CoAP datasets 
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were used as additional controls, and the proteins in these two sets were eliminated to 
narrow down the candidates to a shortlist of Mef2 interaction partners present only in 
the 11-13 hour-old embryos. This approach was considered as an efficient way of 
short-listing candidates that are involved in regulation of Mef2 target genes in 
muscle development. Literature and expert judgment was then used to identify the 
most interesting candidate from this shortlist for further study in Chapter 5. 
The second analysis made use of a variety of different computational methods to 
better understand the sets of proteins that were co-purified with Mef2 in the TAP 
purification experiments. As control datasets the S2-CoAP candidate list was used as 
a positive control, while ONCTRL, 11-13CTRL were used as negative controls.  
By the most naive viewpoint, all proteins contained in the datasets would be 
considered proteins that physically interact with Mef2, because only the GSTAP-
tagged Mef2 bait construct contains the specific protein domains for which the 
purification procedure selects. The parallel purifications performed from wildtype 
(WT) embryos that express no bait demonstrate that this assumption is false, and that 
certain proteins are able to bind non-specifically and withstand the washes during the 
purification procedure. The fact that most proteins identified in WT extracts were 
also present in Mef2 extracts implies that at least some proteins in the datasets are 
likely to be contaminants that were purified not due to a specific physical interaction 
with Mef2 but due to non-specific binding. Additionally, the TAP purification 
method is able to not only extract proteins directly bound to the bait, but also long-
range interactions, i.e. proteins indirectly bound to the bait as part of protein 
complexes. The aim of this computational analysis was to estimate which proteins 
might be contaminants, and which are likely to be genuine Mef2-interacting proteins. 
These interactors then would be likely to be involved in regulating Mef2 activity. 
During the analysis, a specific emphasis was placed on identifying candidates that 
might be involved in a genetic network related to the role of Mef2 in muscle 
development and cell differentiation. 
4.3.3 Analysis of protein abundance derived from mass spectrometry 
The first analytical approach used the abundance of proteins identified by MS to 
estimate which proteins might be contaminants, by comparing the abundances in 
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samples purified from Mef2-GSTAP bait expressing Drosophila embryos to the 
same protein's abundances in samples purified from WT embryos. Protein abundance 
is reflected in the total number of spectral counts that the MS identified as 
originating from each protein. The total spectral counts of proteins obtained from 
TAP experiments in this study were compared to values from the published Mef2 
pulldown studies as a step of quality control. This showed that of the proteins 
purified by TAP, a substantially larger fraction had abundances considered sufficient 
for semi-quantitative analysis. 
To compare between samples, a more reliable measure of protein abundance was 
required, as total spectral counts depend on many sample-specific factors and also on 
the specific protein. Larger proteins have an inherently higher likelihood of 
generating more peptides identifiable by MS. To account for this, the normalised 
spectral abundance factor (NSAF; (Zybailov et al., 2006)) was analysed rather than 
the raw counts. Using NSAF, a statistical analysis was permissible whereby 
effectively each protein's abundance in samples from Mef2-bait expressing embryos 
was compared to its abundance in samples from WT embryos. If a protein's 
abundance was higher in controls, it was classified as a contaminant. This identified 
a substantial number of potential contaminants. 
This analysis is based primarily on the spectral counts identified for each protein by 
MS, and therefore by the concentration of each protein in the purified sample. 
However, the amount of each protein that was purified does not necessarily reflect 
that protein's importance as a Mef2-interacting protein or its relevance to muscle 
development. For example, a highly abundant protein could be enriched due to a 
strong physical interaction with Mef2, in which case it would be a very interesting 
candidate. On the other hand, the high abundance could be due to a generalised high 
expression of the protein, combined with the ability to bind non-specifically during 
the purification. 
As another indication of sample quality, proteins with a higher abundance in the 
sample than the bait are generally considered to have a high likelihood of being 
contaminants, because a specific binder would require an almost permanent physical 
interaction and an n-to-1 stoichiometry with respect to the bait to reach an abundance 
higher than the bait. In this respect, the TAP purified samples had the Mef2 bait 
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either as the most abundant or second-most abundant protein, while both published 
datasets had a substantial number of proteins with abundances higher than the bait. 
This suggests that overall the TAP experiments provided samples of higher purity 
than the published datasets.  
Conversely, a protein with low abundance could still be an interesting candidate that 
plays an important role, but whose abundance is low because its protein expression is 
highly specific to a small subset of cells, or because its activity is not correlated to a 
high amount of protein expression. Consequently, the classification into specific 
binder and contaminant by NSAF and the α coefficient is an estimate and needs to be 
viewed with caution. To assess whether this classification is corroborated by further 
analysis, two additional datasets were created, containing only those proteins that 
were classified as specific Mef2-binding proteins in the overnight and respectively 
staged samples. 
4.3.4 Identification of HDAC4 as a promising candidate for further study 
Besides creating additional subsets of candidates to be analysed by computational 
techniques, the main aim of the first branch of analysis was to prioritise candidates 
that are likely to regulate myogenesis together with Mef2. As a first step spectral 
counts were used to calculate NSAFs for each protein in the list. Working with 
NSAFs is preferable to working with spectral counts since this factor accounts for 
differences in size and length of different proteins, a property which can impact the 
number of spectral counts obtained for each protein. While the NSAF allows to 
compare the different proteins extracted in the same sample, the α-coefficient allows 
to compare the results of the same protein between samples. Since some proteins 
were purified from controls and in Mef2-GSTAP embryos, the α-coefficient of these 
candidates allows to assess if they are real contaminants or this is a case of both an 
unspecific and specific pull down. One such examples is the Act57B protein which is 
the most abundant extracted protein in all samples, including controls. This gene is a 
known target of Mef2 and is one of the few genes that encode myofibrillar actin in 
Drosophila (Kelly et al., 2001; Tobin et al., 1990), and its α-coefficient has shown 
that the interaction with Mef2 is specific, not just a contaminant. Moreover, Act5C 
and Act88F were co-purified with Mef2 from S2 cells nuclear extracts, therefore an 
interaction between Mef2 and the muscle specific Act57B (Rhee et al., 2014) would 
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not be unexpected. Therefore, in order to separate contaminants from specific 
interactions the α-coefficient was used as a separation criterion. The proteins 
classified as specific binders this way were retained in the 11-13MEF* and 
ONMEF* datasets. 
Next, the 11-13MEF* and ONMEF* sets were compared for shared hits. The 
candidates found only in 11-13MEF* were analysed further, since the biological 
material the proteins were extracted from should enrich for differentiated muscle 
specific partners of Mef2, while ONMEF* should contain specific interactors of 
Mef2 that it binds at any point during embryonic Drosophila development. There 
were 15 such candidates found, of which 7 were also found in S2 cells (Rhee et al., 
2014) and were thus discarded as not specific to myogenesis. The remaining 8 
candidates were analysed by STRING database, GO terms and for functional 
relevance in a muscle specific RNAi study (Schnorrer et al., 2010; Szklarczyk et al., 
2019).  
Among the last 8 shortlisted candidates there were 6 well-known sarcomeric 
proteins, which implies a cytoplasmic localisation. The remaining two proteins were 
Brm and HDAC4, two nuclear proteins that are known to be involved in 
transcriptional regulation. When looking how many of the 11-13h shortlisted 
candidates had a role in muscle, as determined by an RNAi approach that provided 
data on 7 of the 8 candidates, only 5 candidates were lethal when knocked down in 
muscles. Of these 5, 3 were also tested for muscle phenotypes, which were abnormal 
in all three cases. Considering the analysis was interested in identifying a candidate 
protein that is able to regulate transcription, the decision in choosing a candidate for 
biological testing was done between the two proteins with characterised functions of 
gene regulation in other cell types and model organisms. 
The Brm protein is a component of the Brahma complex, the SWI/SNF remodelling 
complex homologue identified in yeast. In Drosophila, this protein has been shown 
to repress dedifferentiation of intermediate neural progenitors into neuroblasts in the 
larval body (Koe et al., 2014). The entire complex cooperates with histone 
deacetylase 3 and the Earmuff transcription factor to stop neuroblast overgrowth in 
larval brains. Interestingly, other Brahma complex subunits (Moira, Bap55) have 
been pulled down together with Mef2 from S2 cells and in our study from 11-13h 
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embryos, though their presence in the S2 dataset had ranked them lower in the 
priority list. The Moira subunit has been shown to bind the Mef2 enhancer together 
with Twist and Akirin in Drosophila 2-4 and 4-6 hour-old embryos (Nowak et al., 
2012). In human cancer cell lines the silencing of brm has been associated to the 
interaction between Mef2d and HDAC9, a class IIa HDAC (Dong et al., 2017; Di 
Giorgio et al., 2018). 
HDAC4 is the only class IIa HDAC in Drosophila, while in vertebrates there are 4 
different proteins belonging to this category. The interaction between Mef2 and class 
IIa HDACs has been widely studied in mammalian cell culture, including muscle 
cells (see Introduction and Chapter 5). The cooperation between Mef2 and HDAC4 
in Drosophila is not as frequently addressed, only a link between HDAC4 and Mef2 
being described in adult neurons and larval glial cells (Fitzsimons et al., 2013; Li et 
al., 2019). The mammalian HDAC9, the class IIa HDAC that together with Mef2d 
represses brm, is also a target gene of Mef2 and the protein is able to bind different 
Mef2 variants and repress their transcriptional activity in muscle differentiation 
(Haberland et al., 2007).  
Taking into account the literature available for each of the two candidates and the 
materials available in the lab at the time of performing experiments, the decision was 
made that HDAC4 was a suitable candidate for further biological testing. The results 
of the biological testing of HDAC4 in Drosophila embryos are detailed in Chapter 5.  
4.3.5 Analysis of candidate proteins' network connectivity 
To account for the potential of candidates being specific Mef2-binders regardless of 
their abundance in MS, a protein-protein interaction (PPI) network analysis was 
carried out which assessed all proteins in the different datasets regardless of their 
total spectral counts. The information on known PPIs was queried from the 
Drosophila Interaction Database (DroID), which contains interactions of various 
nature: physical PPIs, for example derived from yeast two-hybrid studies, genetic 
interactions sourced from literature, transcription factor-gene relationships, 
microRNA-gene interactions and predicted protein interactions based on homology 
to human, yeast and worm. There is no accepted standard method for weighing 
different kinds of PPIs from DroID relative to each other. Therefore, all interactions 
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were included in this analysis and the nature of the resulting connections between 
proteins was not interpreted in detail. Rather, the connections were seen as unspecific 
associations requiring further substantiation. 
The information derived from DroID included both interactions between the 
candidates submitted in the query to the database, and connections with other 
potential interaction partners not contained in the list of candidates. The second part, 
predicted potential interaction partners, showed a surprising relationship between the 
published studies and the TAP samples. While the lists of candidates had some 
overlap but many proteins unique to each sample, the predicted interaction partners 
for all samples were largely shared between the samples. This suggested that 
potentially each sample is a subset of a large genetic network around Mef2. 
The availability of large numbers of interactions showed that the proteins pulled 
down in the various purification datasets were well characterised and formed a well 
interconnected network based only on interactions between the candidates identified 
in the datasets rather than on predicted new interactors. The fact that the proteins 
were so well connected not only with the seeds, but were also well studied due to the 
large availability of interactors derived from the database made it possible to study 
the behaviour of the proteins in the network as a whole rather than only small 
subgroups of proteins. A high interconnectivity between the seeds was also a strong 
indicator that the derived information from the screen was reliable. Based on DroID 
interactions, it was also possible to infer which proteins are more likely to be direct 
binding partners of Mef2 (these proteins were referred to as "level 0") and which 
might form longer range interaction (referred to as "level 1" and "level 2"). A 
comparison of level 0 proteins with data derived from yeast two hybrid studies 
should be able to biologically confirm these interactions. 
An interesting finding during the assessment of interconnectivity between candidate 
proteins was that the samples based on 11-13 h staged Mef2-GSTAP embryos had 
more proteins with close connections to Mef2. In the subset of this sample that was 
shared with the S2-CoAP study, this characteristic disappeared, and the connectivity 
towards Mef2 was similar to the non-staged samples and the S2-CoAP study. This 
suggested that those proteins of the 11-13 h dataset which were not shared with the 
S2-CoAP study were closely connected to Mef2.  
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4.3.6 Analysis of candidate proteins' functional relationships 
Since all the seeds formed a very well connected component it was of interest to 
determine which proteins are most likely to functionally be related to Mef2. Two 
different aspects of functional relatedness were analysed: co-expression and 
correlation in functional annotations. 
For co-expression analysis, the percent maximum (pmax) filter for RNA expression 
was used. In this method, all absolute RNA expression values determined for a 
particular gene across Drosophila embryonic development are obtained from 
modENCODE, a large-scale study of Drosophila gene expression in developmental 
stages and different tissues (Graveley et al., 2011). The highest expression value 
(max) is then equalised to 1, and all other values are normalised into fractions of this 
maximum (percent maximum or pmax). The resulting pmax distribution reflects the 
relative expression of a gene across development and allows comparisons between 
different genes. This analysis was applied to all Mef2 interacting protein candidates, 
and hierarchical clustering was used to identify groups of genes whose expression 
patterns across time correlate. Specifically, a cluster was identified which is 
expressed in the late stages of embryogenesis, coinciding with the final stages of 
muscle development. This cluster was revealed to consist of proteins related to 
sarcomere organisation and the actin cytoskeleton, suggesting that this might be a 
genetic network that interacts with Mef2 during this developmental process. Indeed, 
at this late stage, the larval musculature is fully formed and muscle associated 
proteins are mainly focused on sarcomere organisation rather than cell 
differentiation. 
To analyse functional annotations, the gene ontology (GO) was used. GO terms are 
in many cases manually curated annotations available in the Gene Ontology 
Database, describing the gene's molecular function, the biological processes it is 
involved in, and the cellular component where gene products are active. The 
common method of analysing GO terms is to query the GO terms for a given list of 
proteins, and then to compute for each term an enrichment p-value compared to the 
random presence of the term across the genome ("GO enrichment analysis"). Most of 
the GO terms with which Mef2 itself is annotated were also enriched in the candidate 
lists of the purification studies, confirming that the purifications were successful on a 
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basic level. By analysing the GO annotations of the proteins in the datasets it was 
possible to confirm the biological context from which the proteins were extracted, 
further supporting the quality of the datasets. S2-CoAP samples were mainly 
enriched in cell biological functions of Mef2 such as gene expression, metabolism 
and biosynthesis of macromolecules. The 11-13h proteins were found to be 
associated mainly with GO terms associated with muscle related genes. Overnight 
embryos were enriched for a mixture of the functions identified in the S2-CoAP 
study and the 11-13h sample. A strong component of all the GO terms enriched in all 
the samples including controls was metabolic functions. These metabolic function 
terms were enriched in a network consisting of all Mef2 candidates regardless of 
whether connections derived from WT samples (negative controls) were excluded. 
Assuming that the 11-13h staging should enrich for muscle-related Mef2 interacting 
proteins, the enrichments were screened for GO terms which were enriched 
specifically in this dataset. A small group of terms fit this criterion, which were terms 
related to muscle development and cell differentiation. When in reverse the proteins 
were identified that had contributed to the enrichment of these terms, it was found 
that all of these proteins were related to skeletal muscle development and sarcomere 
organisation.  
Finally, the GO terms of all candidates were used to calculate a matrix of functional 
similarity scores between each pair of candidates, which were then used to create a 
network where proteins are associated depending on their functional similarity as 
reflected by GO annotations. This network allowed the categorisation of three 
separated clusters as possible contaminants, since they were remote from the rest of 
the network and only indirectly functionally related to Mef2. All other proteins 
formed a single large cluster around Mef2, meaning that they could not be separated 
into discreet subgroups based on their functional similarities, or dissimilarities, with 
each other. If Mef2 interacted with specific discrete protein complexes for different 
functions, the functional similarity comparison should have separated these 
complexes from each other. This suggests that even if Mef2 forms persistent protein 
complexes, the same complex can then be involved in different biological functions. 
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4.3.7 Identification of a genetic network working around Mef2 in late muscle 
development 
In addition to the shortlist of semiquantitatively identified candidates, the 
biocomputational analysis identified three small sets of proteins as interesting 
candidates for further study related to muscle development: 1) The list of candidates 
from 11-13MEF that did not overlap with the S2-CoAP study. These proteins were 
interesting because their interconnectivity with Mef2 was higher than the remaining 
samples. 2) The list of candidates that is co-expressed during late embryogenesis. 
These proteins were interesting because their expression peaks correlate with Mef2 
and occur at the stage relevant to late myogenesis. 3) The list of candidates that 
caused an enrichment of muscle-related GO terms specifically in the 11-13MEF 
sample. All three sets share most of the sarcomeric proteins that were also in the 
semiquantiative shortlist (up, wupA, Tm2, sls, jar), though each of these three lists 
included some more cytoskeletal proteins that had not been identified 
semiquantitatively, such as Paxillin, Myosin 61F, Tubulins and α-Actinin. The full 
lists of candidates can be found in the figshare repository (see data availability 
statement, section 2.3.13). 
A striking feature of these candidates is that they are classified as mainly cytoplasmic 
due to their nature as sarcomere components. Since they were co-purified with Mef2, 
this implies that they directly or indirectly interact with Mef2 protein physically, but 
Mef2 is a transcription factor and should be present primarily in the nucleus. For 
these proteins to encounter each other, either Mef2 would thus need to be present in 
the cytoplasm or the canddiates would have to be present in the nucleus. Both are in 
principle possible. There is already evidence that proteins like actin and tropomyosin 
can display some nuclear functions. The troponin-tropomyosin complex (composed 
of WupA, Tm1, Tm2 proteins) that is known to regulate muscle contraction through 
controlling actin-myosin interaction in a Ca
2+
-dependent manner. The same complex 
has been shown to regulate nuclear functions, like stable chromosomal integrity and 
cell polarity in early Drosophila embryos (Sahota et al., 2009).  It cannot be excluded 
that such a function could be performed in muscle cells and it depends on interaction 
with Mef2. Actin57B is the actin type specific for muscle fibres, with well 
characterised cytoplasmic functions as part of the cytoskeleton and is a well-known 
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target gene of Mef2 (Kelly et al., 2001). Recently, the idea that actins can also act as 
transcriptional regulators has come back in focus. Actin is associated with all three 
eukaryotic RNA polymerases (Fomproix and Percipalle, 2004; Grummt, 2006; de 
Lanerolle and Serebryannyy, 2011; Philimonenko et al., 2004; Visa and Percipalle, 
2010) and experimental data suggests that it might be involved in transcription 
initiation and elongation. Actin also interacts with a myosin 1C isoform called NM1 
which in turn interacts with Pol I in rDNA transcription. Actin binds Pol I and NM1 
binds translation initiation factor IA to facilitate the assembly of the preinitiation 
complex (Philimonenko et al., 2004; Venit et al., 2018; Visa, 2005). Considering that 
Mef2 is involved in transcription activation and Actins are involved in formation of 
the transcription preinitiation complex, a situation when these proteins like Act57B 
have a nuclear moonlighting function in muscle is plausible. While for the remaining 
sarcomeric proteins, no moonlighting function in regulating transcription has been 
described, it is conceivable that they could similarly be shuttled to the nucleus at low 
concentrations and interact with Mef2 in order to feed back on their own expression. 
The presence of a variety of sarcomeric and cytoskeletal proteins in the pull down 
datasets suggests that this could be a generalised feature of sarcomeric components 
to advance sarcomere maturation. 
In addition to cytoskeletal proteins, all three sets identified further muscle-related 
proteins involved in transcriptional control like Brahma and Histone Deacetylase 4 
(HDAC4), but also a variety of metabolic enzymes such as Pyruvate kinase, Lactate 
dehydrogenase, Glutamate dehydrogenase, and several mitochondrial proteins like 
ATP synthase subunits. An intricate link between metabolism, specifically glycolysis 
and autophagy, and myoblast fusion has been demonstrated for in vitro systems and 
zebrafish embryonic development (Fortini et al., 2016; Tixier et al., 2013). Next to 
their metabolic functions, these enzymes have been known to execute 
"moonlighting" functions, acting for example as protein kinases and regulating a vast 
variety of cellular processes (Kejiou et al., 2019; Lu and Hunter, 2018). The 
prevalence of metabolic components next to muscle components in these high-
interest candidate lists is consistent with the idea that late myogenesis involves far-
reaching modulation of cellular metabolism, and this way supports the energy-
demanding process of muscle growth. Furthermore, transcriptional activation by 
Mef2 includes metabolic target genes at least in fat body cells (Clark et al., 2013). It 
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could thus be a possible transcriptional effector that could be regulated to achieve 
such adaptation of metabolism during myogenesis. 
4.3.8 Further validation of the Mef2 interactome 
The main drawback of this analysis was that the connections drawn between proteins 
are unspecific, and physical interactions cannot be estimated using purely 
computational means. Further experiments would therefore be necessary to validate 
the list of candidates. One possible route for this would be a knockdown screen 
expressing RNA interference (RNAi) constructs targeting each candidate under a 
muscle-specific Gal4 driver. One such study was previously performed by Schnorrer 
et al. (2010) and 82% of all the candidates pulled down together with Mef2 in our 
TAP experiment were tested. Out of 266 candidates tested, 101 showed a wildtype 
phenotype, while 164 proteins had a defect relating to locomotion, flight or posture. 
Only 31 of these candidates showed any observable defect in larval muscle 
morphology or sarcomeric organisation. However, some of these candidates that 
tested negative in the above study have been shown to regulate Mef2 activity in 
muscle in other organisms.  
Through the use of the pmax parameter, which was calculated based on RNA-seq 
information derived from the modENCODE database, it was possible to correlate the 
function of genes in time. A recent method has taken advantage of the Drop-seq 
protocol to map at single-cell resolution the Drosophila embryo transcriptome 
(Karaiskos et al., 2017). Dynamics of transcription derived from mRNA-seq data 
have also been used to study the main events of indirect flight muscle development 
and using “indicator proteins” whose expression correlates with important 
developmental transitions to validate the transcriptionally significant events (Spletter 
et al., 2018). Taking advantage of such tools and approaches, in particular trying to 
link RNA-seq data with proteomic data extracted from carefully staged embryos, 
should be able to offer a better understanding of what events take place in connection 
with Mef2 at significant developmental events and what partners partake in them. 
Therefore, performing Drop-seq extractions in parallel to TAP-purification from 
early (4-6h, 6-8h) and late embryos (10-12h, 11-13h) should offer a comprehensive 
outlook on Mef2 interactome and its dynamics in muscle development. 
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To verify physical protein-protein interactions, one could perform affinity 
purifications in reverse, using the interactor candidates as bait, or use a classic 
system such as yeast two hybrid, or one of the newer fluorescence based systems 
with split fluorophores (Cabantous et al., 2013).  
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Chapter 5: HDAC4 as a potential Mef2 interactor identified by the 
screen 
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5.1 Introduction 
5.1.1 The Mef2 and HDAC axis in vertebrates 
Specialised tissues are formed through cell differentiation programs during 
development, starting from progenitor cells with the ability to turn into specialised 
cell types under cues of cell signalling cascades that use molecules that shuttle into 
the nucleus to interact with transcription factors. Transcription factors are able to 
activate specific gene programs to induce cell differentiation (Perrimon et al., 2012). 
In order to be able to understand the regulation of a developmental process, it is 
important to uncover the link between interactions occurring at molecular level to the 
effects generated on a phenotypic level via mis-expression studies. Myogenesis 
represents a classic paradigm in the study of regulation of differentiation programs 
controlled by key transcription factors and other transcriptional regulators 
(Bentzinger et al., 2012). 
Myocyte enhancer factor 2 (Mef2) is a transcription factor that is the major regulator 
of gene expression and differentiation in muscle, conserved from flies to humans 
(Black and Olson, 1998). Mef2 was first identified in mammalian cell culture and 
many of the regulatory molecules that interact with it during myogenesis have been 
characterised in this system, including class IIa HDACs (Gossett et al., 1989; Yu et 
al., 1992). In vertebrates there are four closely related Mef2 genes, while Drosophila 
has a single Mef2 gene. A similar situation is encountered for class IIa HDACs. The 
only Drosophila class IIa HDAC is dHDAC4, while HDAC4, -5, -7 and -9 are the 
four vertebrate homologues. 
The Mef2 proteins are part of the family of MADS-box proteins and were initially 
characterised in vertebrates as important regulators downstream of the MyoD family 
of transcription factors, while in Drosophila the only Mef2 gene is activated by the 
mesodermal determining factor Twist (Potthoff and Olson, 2007). The central role of 
Mef2 in muscle differentiation was first identified in Drosophila embryos and the 
wide range of muscle specific genes it activates have emphasised the crucial 
importance of studying how Mef2 works in order to understand how muscle is made. 
The role of class IIa HDACs in mammalian muscle in connection to Mef2 has been 
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widely characterised in cell culture, while to date nothing is known about the role of 
dHDAC4 in Drosophila muscle. 
In vertebrates, the four Mef2 transcription factors (Mef2a, -b, -c, -d) have divergent 
as well as overlapping functions, which complicates the study of functional roles 
specific for each isoform. Studies have shown that they act as central regulators in a 
range of cell types (skeletal, cardiac and smooth muscle, brain, neural crest, 
lymphocytes and bone), governing a diversity of developmental programs (cell 
proliferation, survival, apoptosis and differentiation) (Potthoff and Olson, 2007) and 
a trusted interaction partner in all of these contexts is a class IIa HDAC. The 
interaction between Mef2 and a class IIa HDAC in the nucleus leads to 
transcriptional repression, irrespective of the context and a direct physical interaction 
is expected between the two since all the class IIa HDACs present a Mef2 binding 
domain at their N-terminus (Jayathilaka et al., 2012). 
Mammals have 17 histone deacetylases that are grouped in 3 subtypes based on their 
homology with the yeast HDACs: Rpd3 (Class I), HDA1 (Class II), and Sir (Class 
III). The class I and II HDACs are more closely related in terms of sequence and 
base the hydrolysis of the acetyl-lysine amide bond on Zn-catalysis. The Class III 
HDACs do not show sequence similarity with the other two Classes and use NAD as 
the acetyl group acceptor (Blander and Guarente, 2004). The Class I HDACs have 4 
subtypes: HDAC1, 2, 3 and -8, and Class II HDACs are further split into the 
subgroups Class IIa (proteins HDAC4, 5, 7, 8) and Class IIb (only two proteins, 
HDAC6 and HDAC10). HDAC11 is evolutionarily not particularly homologous to 
either Rpd3 or HDA1, therefore it cannot be assigned to either Class I or II HDACs, 
and some studies assign it to a distinct category of HDACs entitled Class IV.  
The mammalian class IIa HDAC proteins have sequence similarity in their catalytic 
domain, the extended long N-terminal domains and the C-terminal tails. The N-
terminus contains one Mef2 binding domain, and two phosphorylation sites specific 
for interaction with 14-3-3 proteins and a nuclear localisation signal (NLS).  These 
proteins also contain a nuclear export sequence (NES) located in the C-terminus 
region (Yang and Grégoire, 2005). These proteins perform their regulatory roles 
mainly independent of their deacetylase ability and they associate with class I 
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HDACs in macromolecular complexes to induce chromatin modifications (Fischle et 
al., 2002; Lahm et al., 2007). 
Their subcellular localization carries an important role in regulating their repressive 
activities, as these proteins shuttle in and out of the nucleus. Various kinases 
activated by extracellular stimuli can alter the balance between nuclear import and 
export of these repressors (Clocchiatti et al., 2013). Mechanisms of nuclear retention 
of class IIa HDACs involve interaction with Mef2 and other factors such as 
Parathyroid hormone related peptide (PTHrP) and Forskolin, which activate protein 
kinase A (PKA), which in turn can phosphorylate a Serine residue in the NLS of 
HDAC5 and block nuclear export (Borghi et al., 2001; Ha et al., 2010). 
In order to reside on chromatin, class IIa HDACs associate with selected 
transcription factors such as the Mef2 family. The binding of class IIa HDACs to 
Mef2s has been extensively characterised in mammals. The Mef2 binding site is 
conserved among the four mammalian HDACs. For HDAC4 and HDAC5 this motif 
overlaps with a Ca
2+
/calmodulin-binding site. Ca
2+
/calmodulin activates specific 
kinases that phosphorylate HDACs for 14-3-3 protein binding, thus promoting their 
nuclear export (McKinsey et al., 2001). In a signal-responsive manner, Mef2 recruits 
HDACs to repress transcription (Yang and Grégoire, 2005). Repression of Mef2 
activity by class IIa HDACs leads to repression of myoblast differentiation 
(McKinsey et al., 2000) and chondrocyte hyperthropy (Vega et al., 2004). The 
binding between HDACs and Mef2 is dynamic and it can be stabilised in myoblasts 
if the PI3K pathway is blocked (Serra et al., 2007). Class IIa HDACs are able to 
increase Mef2 sumoylation which will decrease its transcriptional ability (Grégoire 
and Yang, 2005). Other transcription factors that class IIa HDACs regulate include: 
SRF, Runx2, GATA, Forkhead (Clocchiatti et al., 2011). 
Mammalian class IIa HDACs are expressed in a tissue specific manner. HDAC4, -5, 
-9 show their highest expression in the heart, skeletal muscle and brain, while 
HDAC7 is mostly expressed in the thymus. Knockout of HDAC4 and HDAC7 in 
mice led to embryonic lethal abnormalities, while HDAC5 and -9 knockout mice 
presented cardiac hypertrophy in advanced age. Defects in mobility and breathing 
were the causes leading to embryonic lethality (Clocchiatti et al., 2013).  
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The role of class IIa HDACs in muscle development has been studied in cell culture 
and all the four isoforms are able to repress muscle differentiation by repressing 
Mef2-dependent transcription activation. Their interaction with Mef2 is histone 
deacetylase activity independent and they shuttle between the cytoplasm and the 
nucleus under regulation of signalling cues. In order to stop transcriptional repression 
and allow muscle differentiation to take place, class IIa HDACs are excluded from 
the nucleus via phosphorylation mechanisms. The repressive roles of HDAC4, -5, -7 
and -9 in muscle are redundant since differentiation can continue in absence of a 
specific isoform (Clocchiatti et al., 2011). However, when a mutation that rendered 
the NES of HDAC5 inactive and HDAC5 was trapped in the nucleus, muscle 
differentiation was not impacted (McKinsey et al., 2001), which implies that class IIa 
HDACs undergo regulation in the nucleus as well. Degradation of class IIa HDACs 
and Mef2 activation of genes can cause a switch in muscle fibre properties from fast 
and glycolytic to slow and oxidative (Potthoff et al., 2007). In muscle, all class IIa 
HDACs are regulated at translational levels by miRNAs and only one of the four 
isoform (HDAC9) is a direct transcriptional target of Mef2 (Chen et al., 2006; 
Haberland et al., 2007). MITR is an isoform of HDAC9 that is able to bind Mef2, 
does not have a HDAC deacetylase domain and is exclusively nuclear (Sparrow et 
al., 1999; Zhou et al., 2000). 
5.1.2 Histone deacetylases in Drosophila 
There are orthologues in Drosophila for Class I and II HDACs. In class I, HDAC1 
and HDAC2 are orthologous to dHDAC1 and HDAC3 is similar to dHDAC3.  The 
four subtypes of Class IIa HDACs have only one orthologue named dHDAC4 in 
Drosophila. DHDAC2 is homologous to HDAC6, while dHDACX is the orthologue 
of HDAC11 (Foglietti et al., 2006). 
When knocking down the Class I and II HDACs in Drosophila S2 cells via RNAi, 
only dHDAC1 showed an increase in histone acetylation and only dHDAC1 and 
HDAC3 created a gene expression signature. All the other HDACs when knocked 
down did not show any transcriptional effects leading to the hypothesis that they are 
involved in interacting with nonhistone substrates. Interestingly, knocking down 
dHDAC2 increased tubulin acetylation, an effect that has also been observed in 
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mammals for HDAC6 which acts as a tubulin deacetylase (Foglietti et al., 2006; 
Haggarty et al., 2003).  
A study looking at expression of HDACs at different stages of Drosophila 
development showed that Class I HDACs dHDAC1 and dHDAC3 were highly 
expressed in the embryo, with dHDAC3 being also highly expressed in the adult 
(Cho et al., 2005). Class II HDACs, meaning dHDAC4 (IIa) and dHDAC2 (IIb) 
reached highest expression in the adult. All the Class I and II HDACs had their 
lowest expression in the embryo. The class III HDAC Sir2 has a distinct pattern, with 
the highest expression in the embryo, lowest in the larvae and a recovery of 
expression to half of the embryo levels during pupal and adult stages. In terms of 
subcellular localisation, different HDACs have distinct patterns of expression in S2 
cells when overexpressed: dHDAC1 and Sir2 are mainly nuclear, dHDAC2 is 
predominantly cytoplasmic and dHDAC4 and dHDAC3 shuttle between the nucleus 
and cytoplasm. 
When overexpressed in S2 cells each individual HDAC was able to elevate only its 
own expression levels, no upregulation or repression of another HDAC was 
observed, which suggests that each type of HDAC has a distinct role compared to the 
others. The ratio of upregulated to downregulated genes when one HDAC is 
overexpressed is distinct for each case. HDAC1 overexpression resulted in more 
genes upregulated than downregulated, while dHDAC4 and dHDAC2 showed a bias 
towards more downregulated genes. DHDAC3 overexpression produced a similar 
number of up and downregulated genes. These results show that HDACs can also 
activate transcription, not only repress it. When comparing the identity of genes that 
were mis-expressed when a particular HDAC was overexpressed it was concluded 
that each HDAC regulates a different subset of genes. Therefore HDACs in 
Drosophila have distinct roles and can regulate a variety of target genes. When 
assessing the type of genes mis-expressed by the different HDACs, some patterns 
emerge. Class I HDACs are involved in Drosophila development, in particular 
during embryonic development. The class IIa HDAC regulates organization of the 
cytoskeleton and dHDAC2 regulates genes involved in olfactory receptor activity, 
cell cycle and axon guidance. Sir2 was involved in misregulation of genes involved 
in glycolysis, immune response and aging (Cho et al., 2005).  
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5.1.3 HDAC4, the only class IIa HDAC in Drosophila 
Unlike mammals, lower organisms have only one class IIa HDAC which contains the 
conserved Mef2 domain. HDAC4, the only class IIa HDAC in Drosophila, has two 
putative 14-3-3 binding site and a high sequence similarity to the identified NLS in 
mammals. To date, the interaction of HDAC4 with Mef2 in Drosophila myogenesis 
has not been analysed. However, its functions in other Drosophila tissues have been 
investigated. 
According to in situ hybridisation studies dHDAC4 has a dynamic expression in the 
Drosophila embryo (Zeremski et al., 2003). At pre-blastoderm stages, the gene was 
expressed ubiquitously, with expression concentrated around the nuclei in the 
syncytium. About 2 h after egg laying the expression became localised to a broad 
anterior domain within the embryo, followed by the formation of seven additional 
stripes during cellularization. As development continues with gastrulation, the 
expression of dHDAC4 seems to follow a segment-polarity pattern containing 14 
stripes. When analysing the expression of dHDAC4 in segmentation gene mutant 
backgrounds, it was found that hunchback, knirps, and giant were able to activate 
expression of the gene since the stripes expressed in the area of those particular 
segmentation genes were missing. When expressed in an even-skipped mutant 
background, the pattern of expression of dHDAC4 had broader, unresolved stripes 
compared to the wildtype, therefore even-skipped is able to repress the dHDAC4 
expression in areas where it is expressed. In human 293 cell lines dHDAC4 was 
shown to possess catalytic capabilities and the histone deacetylase activity can be 
supressed by a HDAC specific inhibitor.  
The shuttling of dHDAC4 between the nucleus and the cytoplasm is used in the fat 
body of Drosophila to regulate insulin response. When phosphorylated by SIK3, 
dHDAC4 is trapped in the cytoplasm where it is unable to interact with FOXO. 
Lipolysis and gluconeogenesis are dependent on FOXO activation of specific target 
genes. To bind DNA, FOXO requires to be deacetylated. When fasting occurs, SIK3 
is deactivated and dHDAC4 translocates to the nucleus and deacetylates FOXO. 
DHDAC4 is able to activate FOXO-dependent transcription via dephosphorylating 
the TF directly, or by associating with other HDAC complexes (Wang et al., 2011).  
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A recent study identified that dHDAC4 plays a role in modulation of long-term 
courtship memory. The repressive effects of HDAC4 on long-term memory in 
Drosophila seems to occur through interaction with Mef2 (Fitzsimons et al., 2013), 
which has been implicated in long-term memory regulation in Drosophila 
(Blanchard et al., 2010). In glial cells, HDAC4 regulates Mef2 target gene activation 
under the influence of SIK3. When phosphorylated by SIK3, HDAC4 accumulates in 
the cytoplasm and Mef2 is able to activate target genes with roles in water and K
+
 
homeostasis. If dHDAC4 accumulates in the nucleus, Mef2 gene activation is 
repressed and nerves swell (Li et al., 2019).    
5.1.4 Mef2 in Drosophila muscle and its regulators 
Drosophila has two phases of the myogenic program: the first occurs in the embryo 
to form the larval musculature (somatic, cardical, visceral), while the second one 
occurs during metamorphosis to form the adult muscles (abdominal muscles, indirect 
flight muscles, leg muscles). In the embryo Mef2 is expressed in the mesoderm and 
its muscle derivatives that will form muscle fibres through fusion of founder cells to 
fusion competent myoblasts.  Mef2 is expressed in muscle progenitors and continues 
to be expressed throughout the muscle differentiation process. Mef2 initiates the 
program that regulates myoblast fusion around stage 12 of development and drives 
the differentiation of the resulting myotube into a contractile fibre (Bour et al., 1995). 
The somatic muscle is formed by a pattern of 30 distinct multinucleated muscle 
fibres located in each abdominal hemisegment, with defined size, shape and 
attachments (Bate, 1990) given by the identity genes of the originating founder cell.  
During muscle differentiation, Mef2 activates target genes with a range of expression 
profiles (Elgar et al., 2008; Junion et al., 2005; Sandmann et al., 2006), due to target 
genes responding differentially to Mef2 levels. In vivo occupancy experiments 
revealed that Mef2 binds dynamically to enhancers, although it is expressed 
continuously. One group of enhancers is bound only early in development, while 
another group is bound at late developmental stages (Sandmann et al., 2006).  
In adult myogenesis, Mef2 is first detected in the myoblasts of late third instar larvae 
(Soler and Taylor, 2009) and it is required for the formation of adult fibrillar and 
tubular muscles. These muscles have structurally and physiologically distinct 
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properties and they form through remodelling of larval muscles or de novo assembly. 
Down-regulating Mef2 during adult myogenesis leads to failure of AMPs and FCMs 
fusion or muscle splitting depending on the timing of altering Mef2 activity. AMPs 
are precursors of muscles that were set aside and remained undifferentiated during 
myogenesis (Soler et al., 2012). 
The interaction between dHDAC4  and Mef2 has been documented in Drosophila 
neurons and many of the characteristics found in mammals are also found in 
Drosophila. 
Considering the diverse interactions between HDAC4 and Mef2 transcription factors 
to regulate various developmental processes in mammals, we believe HDAC4 
represents one of the co-regulators of Mef2 that are able to modulate its activity. 
There is substantial evidence in mammals that supports the importance of class IIa 
HDACs-Mef2 interaction during muscle development. Considering these, we are 
interested to characterise the role of HDAC4 in Drosophila myogenesis. Based on 
the information from vertebrates, we hypothesise that HDAC4 is an inhibitor of 
muscle differentiation, the protein interacting with Mef2 to repress muscle specific 
genes. Therefore, HDAC4 is a potential muscle differentiation inhibitor keeping 
progenitor cells in an undifferentiated state. The TAP experiments identified 
dHDAC4 as a Mef2-interacting protein in 11-13h old embryos, which corresponds to 
stage 14-15 when the muscle pattern is fully differentiated. However, in mammals 
class IIa HDACs have been shown to affect myogenesis also at myoblast levels, 
therefore the interaction between Mef2 and dHDAC4 will be assessed both in early 
and late embryogenesis. 
5.1.5 Experimental approach 
To study the relationship between HDAC4 and Mef2, classic molecular biology 
techniques and genetics were used. This included RNA in situ hybridisation and 
immunohistochemistry to test expression of HDAC4, as well as Gal4/UAS-driven 
overexpression of fly HDAC4 and human HDAC5 transgenes. Using Flippase-
mediated recombination, two new null alleles of the HDAC4 gene were generated for 
phenotypic loss-of-function studies. 
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5.2 Results 
5.2.1 HDAC4 expression in Drosophila embryos 
A gene's expression pattern can provide information on its possible roles during a 
developmental process. By analyzing both the expression at RNA and protein level 
of HDAC4 it is possible to asses in which developmental processes the protein is 
potentially involved in.  
Gene model 
The HDAC4 gene is located in the Drosophila genome on the X chromosome, 
cytogenetic map 11E8-11E9, Sequence location X:13,262,687..13,285,632 [-] 
(Flybase FB2018_05, released Oct 16, 2018). There are 8 transcripts assigned to this 
gene and a number of unique peptides. The protein isoforms do not share the same 
N-terminus, but they overlap in the C-terminal region, an aspect which can impact 
the creation of loss-of-function mutants.  
RNA expression 
To determine if HDAC4 is expressed in Drosophila embryos, the gene expression 
was initially analysed via published RNA-seq data. The modENCODE temporal 
expression data (Graveley et al., 2011) comprises RNA-seq data of genes' expression 
throughout Drosophila development from early embryonic stages to adulthood. For 
the embryonic part of development, the analysis of the genes expression was 
performed in 2 h embryonic developmental windows. HDAC4 has a relatively low 
expression in Drosophila and the peak is achieved in the 8-10h old embryos. The 
peak of expression of HDAC4 is observed in a 10 h interval, starting at 6 h AEL and 
ending at 16 h of development. Based on this information the gene should be 
expressed in embryos and in order to analyse where the gene is expressed in situ 
hybridisation was prepared.  
The expression of HDAC4 RNA in embryos was analysed using in situ hybridisation. 
An RNA in situ probe was prepared based on a cDNA clone (FBcI0212840) gifted 
by the Drosophila Genomics Research Centre. The in situ hybridization assay was 
performed on wildtype embryos using an antisense probe. The control was a sense 
probe generated from the same cDNA clone. This control is particularly important to 
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distinguish the background from the signal of the probe labelling HDAC4 mRNA. 
HDAC4 has 8 annotated transcripts in Drosophila. The cDNA used to generate the 
RNA in situ probe represents the mRNA sequence of the HDAC4-B variant. 
However, due to shared exons between the 8 isoforms of HDAC4 it was possible to 
target all the mRNA variants. The RNA in situ protocol involves using small RNA 
from the probe used that are able to interact in the experiment with HDAC4 
transcripts. 
Based on our data the mRNA of HDAC4 is expressed throughout the embryo at all 
embryonic stages (Figure 5.1A). Expression of HDAC4 specific mRNA is detected 
in very early embryos, thus indicating a potential role of HDAC4 in muscle 
progenitor cells together with Mef2. There are particular regions of the embryos 
where the in situ results show a higher expression, however it is difficult to assess the 
specificity of such tissues considering that the embryos have more opaque areas in 
the wild-type embryos. 
Protein expression 
To complement the gene expression study, the protein expression in Drosophila 
embryos was analysed as well. HDAC4 protein expression was investigated using 
immunohistochemistry on embryos containing a YFP insertion in the HDAC4 region 
(line CPTI77). By using an anti-GFP antibody it was possible to visualise the 
expression of the fusion protein (Figure 5.1B).  
The CPTI77 line used to study HDAC4 protein expression was generated using a 
piggyBAC protein tag construct containing a splice acceptor and donor site, 
purification tags for StrepII and FLAG and a functional YFP exon. The YFP 
insertion in the CPTI77 line was mapped in the N-terminal region of HDAC4 (site 
13174889), in frame with the HDAC4 sequence. 
The expression of YFP-fused HDAC4 was studied using an anti-GFP antibody 
generated in Rabbit. The expression of HDAC4 in Drosophila embryo can be 
observed in Figure 4.1. OregonR/wildtype embryos were used as a negative control, 
while embryos expressing a handGFP construct were used as a positive control. 
Based on our data the protein is expressed throughout the whole embryos at all 
embryonic stages. No particular areas seem to be enriched for HDAC4. By   
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Figure 5.1: mRNA and protein expression of HDAC4 in Drosophila embryos 
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A) Wildtype embryos were incubated with either an antisense RNA probe to detect 
hdac4 mRNA, or with a sense RNA probe as a negative background control. Lateral 
views are shown. 
B) Immunohistochemistry using an antibody against GFP to assess HDAC4 protein 
expression using a YFP-HDAC4 protein trap line. Oregon-R: Wildtype control not 
expressing GFP. CPTI77: transgenic line containing a YFP insertion resulting in a 
YFP-HDAC4 fusion protein. handGFP: Positive control with high expression of 
GFP. Lateral views are shown. Note that most anti-GFP antibodies crossreact with 
YFP.  
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comparison the hand protein is ubiquitously expressed in early stages, while starting 
from mesodermal differentiation the proteins is present in the visceral mesoderm and 
the dorsal tube and the visceral musculature. The ubiquitous expression of HDAC4 
seems to suggest that the protein could be expressed in muscle. 
HDAC4 and Mef2 co-expression across development 
HDAC4 was suggested as a Mef2 interacting protein as part of a TAP purification 
study from 11-13h embryos where GSTAP-tagged Mef2 acted as bait. The validity 
of the interaction was determined both via spectral counting (where HDAC4 was 
determined as a specific binder as determined via statistical analysis) and through 
network models. In a PPI network constructed on information derived from DroID 
database HDAC4 was determined as a direct interactor of Mef2. A direct interactor 
in this network model does not necessarily imply a physical binding between Mef2 
and HDAC4, but a very strong connection in functional relatedness. In this PPI 
network, HDAC4 was found to interact with 17 other proteins, 5 of which were 
found to also be direct interactors of Mef2. The other 12 proteins are contextually 
connected to HDAC4 as well as the other 5 direct interactors.  
A gene is considered more likely to be active in contexts where it is expressed close 
to its maximal level. To determine a subnetwork of genes active in specific contexts 
an expression filter was defined in order to determine if two genes are likely to be 
expressed and active in the same tissue or stage. A gene’s expression level in each 
stage or tissue (pmax) can be calculated as a percentage of its level in the tissue or 
stage where it is maximally expressed (more detailed explanation in the previous 
chapter). Based on different filters tested it was determined that proteins that have a 
pmax higher than 45% in the same tissue or stage are involved in the same biological 
context (Murali et al., 2014). To determine if Mef2 and HDAC4 are active in the 
same developmental stage during Drosophila embryonic development, the pmax for 
these proteins was determined throughout the different embryonic stages of 
development. The expression information was determined from RNAseq data from 
modENCODE which was measured throughout the lifetime of a fly. The pmax of 
Mef2 and HDAC4 was compared at different embryonic developmental stages 
(recorded in 2 h windows). A third gene that shows a similar behaviour in the 
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HDAC4 subnetwork in terms of connectivity with Mef2, other level 0 seeds and 
level 1 proteins was included for comparison. 
In the embryos, HDAC4 has the highest expression in 0-2h embryos, afterwards its 
level drop under the considered threshold of 0.45. At 10-12h of development 
HDAC4 levels start increasing slowly close to a significant pmax expression, a 
second expression peak being obtained at 20-22h. Mef2 expression levels slowly 
increase in the early developmental stages, the maximal peak being reached at 8-10h. 
From then on the levels start decreasing, but maintain a value above the threshold 
until 16-18h embryonic development. In late embryonic development Mef2 levels go 
under the threshold but stay at a higher level than in early embryonic development. 
The Ubi-p63E protein has relatively low levels in early and late embryonic 
development. A tripling of the expression level is observed in 6-8 h embryos and 
stays similarly high until 12-14h of development when the level suddenly drop to 
very low levels in late embryogenesis. 
It is important to note that in the TAP purification proteomic study, HDAC4 was co-
purified with Mef2 from 11-13h embryos while Ubi-p63E was found both in Mef2 
bait-expressing overnight embryos and wildtype control purification samples. Based 
on spectral counting both HDAC4 and Ubi-p63E were classified as specific binders. 
According to the analysis of the pmax expression filters it is visible that at 10-12h of 
development all the three analysed genes are above the activity threshold and should 
be involved in the same biological context.  In the case of HDAC4 and Mef2 the 
developmental stage of 14-18h  seems to show another context when the two genes 
could be acting in the same context.  
5.2.2 Colocalization of HDAC4 with Mef2 
In order to better understand the role of HDAC4 in muscle, a colocalisation study 
between HDAC4 and Mef2 was carried out. Mef2 is expressed in both muscle 
progenitor cell and differentiated muscle, and we tested whether HDAC4 is 
expressed in these cells, in which subcellular localisation, and at what time during 
development. 
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Figure 5.2: Relative mRNA expression of Mef2 and two co-expressed candidates 
across embryogenesis 
HDAC4 and Ubi-p63E were identified as potentially interesting candidates that are 
part of a muscle-specific group of Mef2-interacting proteins in the previous TAP 
experiments. Graphs show percent max (pmax), the relative RNA expression level at 
each stage. Pmax at each stage is the fraction of the expression at the stage with the 
highest level. The expression peak for Ubi-p63E did not occur during 
embryogenesis, hence no value on the graph is 1. Black line: 0.45 cutoff, a gene is 
considered to be actively expressed when above this cutoff. 
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The relationship between Mef2 and class IIa HDACs has been widely documented in 
mammalian studies. The interactions between the two types of proteins was studied 
in many tissues and cell types such as muscle, brain, neurons, thymocytes. In 
myogenesis, class IIa HDACs act as repressors by binding directly to Mef2 at some 
critical promotors for the muscle differentiation programme (McKinsey et al., 2001; 
Lu et al., 2000). It is believed that the HDAC maintains the muscle progenitor cells 
in a repressive state until the appropriate myogenic differentiation signal is delivered. 
When muscle differentiation is underway, class IIa HDACs shuttle to the cytoplasm. 
A similar interaction was reported in Drosophila neurons (in particular Kenyon cells) 
between HDAC4 and Mef2. The HDAC4 protein and Mef2 were reported to 
colocalise at specific loci within the nucleus of neurons when HDAC4 was 
overexpressed. This overexpression had an impact on long term memory because 
plasticity genes were being repressed (Fitzsimons et al., 2013; Sando et al., 2012). 
The nuclear bodies observed in this case have also been reported in mammalian cell 
culture. The nuclear localization domain of the MEF2 family of transcription factors 
shows member-specific features and mediates the nuclear import of histone 
deacetylase 4 (Borghi et al., 2001; Miska et al., 1999). The localisation of HDAC4 in 
the Drosophila brain has been reported as a cytoplasmic halo around the nucleus and 
a punctate nuclear localisation (Fitzsimons et al., 2013). 
We used the CPTI77 Drosophila line to study the colocalisation of HDAC4 to Mef2 
in muscle cells throughout embryogenesis. A primary antibody against GFP was 
used to observe the localization of HDAC4 since this antibody detects the YFP insert 
of this stock. It was possible to identify embryonic regions that will result in the 
formation of muscle due to the specific localisation of Mef2 in the mesoderm and to 
the nuclei of the muscle fibre at different development stages of Drosophila. The 
specific expression of Mef2 in the mesoderm is observed starting with stage 9 and 
continues until the end of embryogenesis in the developing muscle fibers. 
We observed that HDAC4 expression throughout the embryos had a honeycomb-like 
pattern. This expression pattern seems to be due to a cytoplasmic, rather than nuclear 
expression of the protein. Although it is known that class IIa HDACs shuttle between 
the cytoplasm and the nucleus. Interestingly, at no embryonic stage the YFP-HDAC4 
and Mef2 signals overlapped. Considering that Mef2 expression is mainly nuclear,  
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Figure 5.3: Colocalisation of YFP-HDAC4 with Mef2 during Drosophila 
embryogenesis.  
Confocal micrographs of muscle precursors during Drosophila embryogenesis. Red: 
YFP-HDAC4 stained with anti-GFP in the CPTI77 transgenic line. Green: Mef2 
antibody.   
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this stain seems to suggest that the HDAC4 protein is mainly expressed in the 
cytoplasm. However in order to confirm this hypothesis, the colocalisation of Mef2 
expression with a nuclear specific marker like DAPI is required. 
5.2.3 Functional comparison to human HDAC5 
The role of class IIa HDACs has been widely studied in mammalian systems, 
however not much is known about their role in Drosophila melanogaster, in 
particular at embryonic level. There are 4 mammalian class IIa HDACs compared to 
only one in Drosophila which is referred to as HDAC4. To understand the role of 
HDAC4 in myogenesis in Drosophila, the effects of overexpressing this protein in 
the embryo was compared to the effects of overexpressing the human HDAC5 
protein which has been shown to repress myogenesis by interacting with Mef2. 
Mammalian class IIa HDACs have sequence similarity in their catalytic domain, the 
extended long N-terminal domains and the C-terminal tails (Figure 5.4A). The N-
terminus contains one Mef2 binding domain, and two phosphorylation sites specific 
for interaction with 14-3-3 proteins and an NLS signal. The C-terminus contains the 
catalytic deacetylase domain and the nuclear export sequence (Di Giorgio et al., 
2015). Drosophila HDAC4 (dHDAC4) has a deacetylase catalytic domain at its C-
terminus, as well as a Mef2 binding site at its N-terminuus. Drosophila HDAC4 is 
relatively highly conserved, with 57% amino acid identity and 84% similarity to 
human HDAC4 across the deacetylase domain C terminus, and 35% identity and 
59% similarity across the whole protein (Fitzsimons et al., 2013). The Mef2 binding 
domain is conserved in dHDAC4 and the Serine residues that are involved in the 
shuttling in and out of the nucleus are conserved. The NLS is located in between the 
two serine residues and is hidden when the HDAC activity is inhibited. The C-
terminal histone deacetylase domain is maintained in the Drosophila HDAC4 as 
well.  
The activity of HDAC4 in Drosophila embryos and its involvement in muscle 
development was studied by modulating its activity. The effects on muscle formation 
and on Mef2 protein levels was studied at two important events in muscle 
development: at stage 12 when mesodermal specification occurs and at stage 16 
when the muscle pattern should be fully developed. The structural characteristics of  
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Figure 5.4: Structure of HDACs and transgenically expressed mutants 
A) Structure of Drosophila HDAC4 (dHDAC4) in comparison to human class IIa 
HDACs 4 and 5. 
B) Wildtype and mutant versions of human HDAC5 that were transgenically 
expressed in this study. 
C) Wildtype and mutant versions of Drosophila HDAC4 that were transgenically 
expressed in this study. 
MEF2, Mef2-binding domain; S, serine phorphorylation site for interaction with 14-
3-3 proteins; NLS, nuclear localisation signal; NES, nuclear export signal; numbers 
below S denote residue number.  
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the class IIa HDACs were taken into consideration and transgenic variants were also 
tested in the same experimental set-up. The overexpressed protein should be able to 
shuttle between the nucleus and the cytoplasm as no modification was made to its 
nuclear export/import system. The deletion of a portion of the C-terminus results in 
the elimination of the HDAC domain which should create a version similar to Mef2-
interacting transcription repressor (MITR) that contains only the non-catalytic N-
terminus part of HDAC9 (Sparrow et al., 1999).  
It is important to note that MITR is able to repress Mef2 mediated transcription, 
however not the one specific for muscle development (Zhang et al., 2001). MITR is a 
protein that is mainly nuclear and its inhibitory function is blocked when the two 
conserved Ser residues are phosphorylated causing the interaction with the 14-3-3 
chaperone that alters MITR’s nuclear distribution. Human HDAC5 was found to be 
able to repress Mef2 mediated transcription in absence of its HDAC domain as long 
as the two repressive regions were present (Lemercier et al., 2000). However the 
presence of HDAC5 in the cytoplasm is necessary in order to allow execution of the 
myogenic program (McKinsey et al., 2000). In the case of human HDAC4 both the 
Mef2-binding domain and the HDAC domains were required to repress muscle 
differentiation. The protein is maintained in the cytoplasm of myotubes by 
interaction with the 14-3-3 chaperone and when the myogenic signal retracts it is 
able to enter the nucleus, which most probably enables Mef2 to repress transcription 
of particular subsets of target genes (Miska et al., 2001).  
In order to test the above mentioned characteristics in dHDAC4 and hHDAC5, both 
proteins were expressed in Drosophila embryos under the twi-Gal4;twi-Gal4 driver. 
Taking into account the information available from literature, both proteins are 
expected to be able to shuttle between the cytoplasm and the nucleus based on their 
phosphorylation state of the two conserved serine residues. The Drosophila HDAC4 
is assumed not to have a nuclear export signal (NES) in its C-terminus while all the 
human versions of Class IIa HDACs do (Yang and Grégoire, 2005). The NES is 
eliminated together with the HDAC domain in the hHDAC5ΔC construct. In this 
situation, the variant of hHDAC5 is expected to be sequestered in the nucleus and be 
able to repress myogenesis since it can achieve this even in the absence of its 
catalytic domain. The exchange of Ser259 and Ser498 to alanine interferes with the 
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shuttling of hHDAC5 from the nucleus to the cytoplasm and it has been shown that 
the protein cannot be properly transported out of the nucleus in such mutants, 
therefore muscle development is expected to be repressed in these experiments 
(McKinsey et al., 2000). Since the hHDAC5 protein is expressed in a new system 
this mechanistic characteristics could be impacted and the effects could have less 
strong effects compared to cell culture. 
In adult flies, dHDAC4 has been reported to bind Mef2 when overexpressed in so 
called nuclear bodies, which was not observed when dHDAC4 was not present in the 
nucleus or when it was not overexpressed (Fitzsimons et al., 2013). 
To study the interaction between HDAC4 and Mef2 the two HDACs, dHDAC4 and 
hHDAC5 were overexpressed in Drosophila embryos. The effects on early 
myogenesis was studied on embryos undergoing mesodermal specification 
equivalent to stage 12. The effects on late myogenesis was studies in embryos of 
stages 16 in order to have the developmental age where the muscle pattern should be 
fully developed. Both the full length and the mutants were overexpressed under 
similar conditions. The readout of the overexpression results were the following: 
stage 12 embryos were immunostained with a Mef2 antibody to analyse effects on 
the protein level, the effects on a target gene of Mef2 in the somatic mesoderm was 
assessed via in situ RNA hybridisation experiments of β3-tubulin. In late stage 
myogenesis the effects on the β3-Tubulin protein levels was assessed via 
immunostaining for that protein. 
β3-Tubulin has a cell-type-specific relationship with Mef2 in Drosophila embryos. 
The genes expression has a Mef2 binding site in its enhancer and full expression in 
the somatic muscle is dependent of the TF starting from stage 12 (Damm et al., 
1998). The visceral enhancer of β3-Tubulin does not present a Mef2 binding site and 
its activation is independent of Mef2. Him is a negative regulator of Mef2 activity 
and is able to repress transcriptional activation of Mef2 target genes in somatic 
musculature (Liotta et al., 2007). β3-Tubulin is a Mef2 target that is responsive to 
Him mis-expression during muscle development. Since we hypothesise that 
dHDAC4 is also a repressor of Mef2 activity during myogenesis, β3-Tubulin is the 
target gene of choice to study effects of overexpressing Class IIa HDACs in 
Drosophila muscle. 
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The effects of hHDAC5 and its variants overexpression was studied in early 
myogenesis by looking at the effects on the levels of Mef2 protein and one of its 
targets β3-tubulin. Mef2 is expressed both in the visceral and the somatic mesoderm, 
however only in the somatic mesoderm Mef2 has β3-tubulin as a target gene. It is 
visible that both Mef2 protein levels and β3-tubulin expression are unaffected by 
overexpression of hHDAC5 and hHDAC5SA (Figure 5.5A). In the case of 
hHDAC5ΔC it is noticeable a reduction in β3-tubulin levels in the somatic mesoderm 
(Figure 5.5B). 
In stage 12 embryos, when mesodermal specification occurs, it is observable that 
dHDAC4 and all its variants dHDAC4ΔC and dHDAC4SA are able to inhibit Mef2-
regulated gene transcription by affecting expression of its target genes, but not of the 
Mef2 protein itself whose levels seem wildtype (Figure 5.6A). The full length 
dHDAC4 was able only partially to inhibit transcription of β3-tubulin, a Mef2 target 
gene in the somatic musculature (Figure 5.6B). The effects of overexpressing 
dHDAC4 in the Drosophila embryonic musculature are more severe compared to the 
effects of gain of function experiment of hHDAC5.  
In late stage myogenesesis the effects on muscle development are more severe 
(Figure 5.7). To quantify the effects of the overexpression experiments the muscle 
pattern phenotype was split into 5 categories: 1) wild-type: the muscle pattern 
presents no defects; 2) weak: a very small number of muscles are affected, mostly 
displaying defects in shape but the pattern appears mostly wild-type; 3) moderate: 
Most muscles are present and correctly shaped; 4) Severe: The muscle pattern is 
significantly affected, many muscles are misshapen or missing but a slight outline of 
the expected muscle pattern is still observable; 5) Extreme: No muscle is formed 
correctly.  
The effects in late myogenesis are stronger than in early development, however the 
pattern of having stronger effects while overexpressing dHDAC4 compared to 
overexpressing hHDAC5 is maintained. The dHDAC4 embryos had very severe to 
extreme phenotypes of muscle disruption in late embryos. The least severe of the 
three versions was observed when overexpressing dHDAC4ΔC since there were still 
some muscle fibres at the stereotypical location that could give an impression of a 
reminiscent muscle pattern. In dHDAC4 and dHDAC4SA the embryos were missing 
 195 
 
most muscles and it was not possible to conclude which type of fibre the fragments 
originated from. These muscles had very little plasticity, did not maintain the usual 
rounded shape and the cuticle broke easily when handled. 
In contrast, the muscle pattern when overexpressing hHDAC5 and its mutants was 
still recognisable. The hHDAC5 gain-of-function embryos had a very weak 
phenotype, only the ventral muscles displaying a shaping problem due to extension 
of these muscles into the ventral side of the embryo more than in wildtypes. The 
consequence of this defect resulted in the embryo appearing less rounded and more 
elongated on the ventral side. Both the  hHDAC5ΔC and the hHDAC5SA muscle 
phenotype could be classified as severe since most of the muscles were missing or 
misshapen, but the gross pattern was still observable. The hHDAC5SA was 
comparable to the severity of  dHDAC4ΔC phenotype, while the hHDAC5ΔC 
seemed to be milder. When looking at the Mef2 expression in late embryogenesis it 
is clear that most of the nuclei are not properly positioned in these mutants. 
Based on the phenotypes obtained in early development it is possible to conclude that 
most probably class IIa HDACs do not play a very strong role in muscle progenitor 
cells to repress Mef2 activity. It is likely that the default localisation for HDAC4 in 
myoblasts is in the cytoplasm as it was observed in the colocalisation study (section 
5.2.2). The same effect is most probably applicable for hHDAC5 in this system. The 
lack of effects on muscle specific genes expression early in myogenesis when the 
full-length HDACs are overexpressed could support an active sequestration of the 
class IIa HDAC in early myogenesis in order to allow muscle differentiation, a 
pattern which seems to support the mechanistic model proposed of hHDAC5 in 
mammalian cell culture. The fact that there is a reduction in β3-tubulin expression 
for the mutants lacking a HDAC domain suggests that dHDAC4 is able to effect 
muscle repression despite lacking its catalytic domain. The lower effects in 
myogenesis observed for hHDAC5 could be due to the fact that the mechanisms 
regulating class IIa HDACs in Drosophila are able to compensate for the gain of 
function. The lack of effects in constitutively nuclear-localised hHDAC5 could be 
due to other proteins that are able to block the activity of hHDAC5SA in the nucleus.   
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Figure 5.5: HDAC5ΔC overexpression downregulates Mef2 activity 
Expression of UAS HDAC5, UAS hHDAC5ΔC, UAS hHDA54SA driven by twi-Gal4; 
twi-Gal4 at 25°C. The overexpression of human HDAC5 and its modified versions 
HDAC5ΔC (a HDAC4 version lacking its histone deacetylase domain) and  HDAC5 
SA (lacks the phosphorylation site ensuring shuttling of the HDAC between the 
cytoplasm and the nucleus) does not affect Mef2 protein expression, but HDAC5ΔC 
downregulates its β3-tubulin  target gene expression in the somatic mesoderm. Mef2 
protein is visualised by an immunostain of stage 12 embryos. Expression of a Mef2 
target in the developing somatic muscle, β3-tubulin, is visualised by in situ 
hybridisation of stage 12 embryos. OR, Oregon-R (wildtype). 
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Figure 5.6: HDAC4ΔC overexpression downregulates Mef2 activity 
Expression of UAS-HDAC4 driven by twi-Gal4; twi-Gal4 at 25°C. The 
overexpression of HDAC4 and its modified versions HDAC4ΔC (a HDAC4 version 
lacking its histone deacetylase domain) and  HDAC4 SA (lacks the phosphorylation 
site ensuring shuttling of the HDAC between the cytoplasm and the nucleus) does 
not affect Mef2 protein expression, but downregulates its β3-tubulin target gene 
expression in the somatic mesoderm. Mef2 protein is visualised by an immunostain 
of stage 12 embryos. Expression of a Mef2 target in the developing somatic muscle, 
β3-tubulin, is visualised by in situ hybridization of stage 12 embryos. OR, Oregon-R 
(wildtype). 
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Figure 5.7: Overexpression of Drosophila HDAC4 and human HDAC5 affects 
muscle differentiation in late stage embryos 
Stage 16 embryos were immunostained for β3-Tubulin protein. Descriptions in 
brackets denote the phenotype category caused by each transgene. At least 10 
embryos were examined for each condition. Quantification was ommitted since 
phenotypes were consistent. OR, Oregon-R (wildtype). 
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5.2.4 Generation of targeted deletion HDAC4 null mutants 
A classic genetic approach to functionally characterise the role of a specific molecule 
is to do gene perturbation studies, in which the molecule of interest is either 
overexpressed or its activity is impaired. The loss-of-function approach can be 
achieved through two methods: 1) by generating a null mutant of the protein of 
interest; 2) the use of a knockdown approach such as RNA interference, in which the 
expression of the protein of interest is inhibited at RNA level. The second approach 
is dependent on the existence of a specific Gal4 driver for the tissue of interest, as 
well as the strength of that driver. A targeted deletion of HDAC4 locus was 
attempted in order to obtain a null mutant that would not depend on the strength of 
the driver. 
A targeted deletion generated by P-element transrecombination was used to generate 
HDAC4 null mutants. There were three potential P-elements within the HDAC4 
region that allowed partial or complete deletion of the gene (Figure 5.8C). 
Recombination between compatible pBAC{RB} elements can result in either a 
duplication or a deletion of the DNA region between the two inserted elements. The 
pBAC{RB} e04575 element inserted within the HDAC4 gene region was paired with 
pBAC{RB} e02449 located upstream of the HDAC4 region to generated a partial 
deletion of HDAC4 targeting the N-terminal part of the protein.  
The recombination of the elements pBAC{RB} e02449 and the pBAC{RB} e03932 
(downstream of the comt gene) allowed complete removal of HDAC4 together with 
the comt gene. The compatibility of the combined sites was given by the 
directionality of their FRT that allow transrecombination by the Flippase enzyme. 
The recombination experiments were performed by Ms Jun Han. 
Because all elements contained w+ insertions, eye colour could not be used as a 
marker to screen for a recombination event. A red w+ eye colour would be 
observable in the event of a duplication, a deletion or the occurrence of an 
unrecombined element. Recombination events were screened solely by PCR using a 
combination of a P-element specific primer and a genomic primer targeting the 
region around the element. A successful deletion event took place only when a PCR  
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Figure 5.8: HDAC4 deletion screening  
A) Recombination strategy with recombination event taking place at the HDAC4 
locus during the FLP/FRT recombination.  
B) Possible combinations of primer pairs and their interpretation during screening.  
C)  Deleted genomic regions in the two lines that scored positive during the 
screening process (they had a positive PCR A and D and a negative PCR B and C).   
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product for the region targeting the downstream region of the first P-element, 
respectively the upstream region of the second element was obtained.  
For each combination of P-elements 50 different crosses were tested for 
recombination events. Most of the lines were non-recombination events, less than 5% 
resulting in duplication or deletions. Only line 6 for the e04575/ e02449 
recombination and line 48 for the e03932/ e02449 combination were confirmed to 
contain the targeted deletions. Because the two lines presented no red eyed males it 
was concluded that the two deletions were lethal, therefore stocks were maintained 
over an FM7 balancer.  
In order to check if the recombination events successfully deleted the HDAC4 
regions predicted, we performed PCR studies in which two primer pairs targeting a 
part of the deleted region were tested. PCR was performed on previously screened 
homozygous null embryos since the balanced embryos would give a positive 
fragment for the deleted region. 
Based on the PCR screen performed, it was confirmed that the HDAC4 deletion 6 
line is indeed a null mutant for the HDAC4 gene, while further analysis of the 
HDAC4 deletion 48 line is required, since the deletion 48 genomic DNA line gives a 
positive fragment in the region of bPBAC (Figure 5.9B), although if the deletion 
event was successful that part of the genome should not exist in the mutants. It is 
important to note that the positive fragment is observed in the PCR where the 
genomic DNA came from embryos, while in the pupa the fragment for the bPBAC 
primer region is negative as expected if the mutant HDAC4 deletion 48 is a true 
deletion. A potential contamination with a heterozygous embryo of the genomic 
DNA could be the cause of this observed fragment. 
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Figure 5.9: HDAC4 successful deleted region screening  
A) Map of the location of the two deleted regions in the genome.  
B) The table shows possible combinations of primer pair and the expected for a 
successful generation of a null mutants.  
C) Agarose gel showing PCR results of fragments located inside the deleted regions. 
Samples: Positive control: OR1 (genomic DNA from Oregon-R embryos), OR2 
(genomic DNA from OR pupa), HDAC4 del6 Emb/Pupa (genomic DNA extracted 
from HDAC4 deletion 6 homozygous embryos/pupa), HDAC4 del48 Emb/Pupa 
(genomic DNA extracted from HDAC4 deletion 48 homozygous embryos/pupa), 
Negative control: C- (H2O instead of genomic DNA template).  
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5.2.5 Hatching and survival assay of potential HDAC4 null mutants 
All the investigated lines were homozygous lethal at adult stage and in order to test at 
what stage the lethality occurred a hatching and survival assay was performed for 
each line confirmed positive as a potential HDAC4 deletion. The lethality of the two 
HDAC4 targeted deletions was initially determined based on the absence of any red 
eyed males in the initial cross, only white eyed males being viable.   
In order to distinguish the homozygous embryos from the heterozygous ones, the 
heterozygous maintained stocks were crossed over an FM7,ActGFP balancer. Based 
on the fluorescence of the ActGFP marker it was possible to select only the 
homozygous embryos for further inspection. Since the homozygous embryos should 
not carry the GFP marker, embryos that did not show fluorescence were selected for 
the hatching and survival assay. The autofluorescence of the chorion membrane 
made it very difficult to separate the homozygous embryos from the rest at early 
stages, therefore the embryos were allowed to reach stage 14 before selecting the 
homozygous embryos. 
The hatching and survival assay performed on homozygous mutants of the two 
potential null mutants showed that both lines die at pupal level. Only 35% for the 
HDAC4 del 48 and 42% for the HDAC4 del6 reach this developmental stage. None 
of the homozygous flies develop to adulthood. 
Lethality is one of the most striking phenotypes observed in these HDAC4 null 
mutants and in order to show that this phenotype is due to HDAC4 loss of function, a 
rescue experiment of HDAC4 was attempted. The rescue of HDAC4 deletion 6 
lethality was attempted. 
5.2.6 Rescue of lethality of HDAC4 null mutants 
In order to prove that lethality is due to HDAC4 deletion rescue experiments using a 
UAS-HDAC4 construct were designed. A rescue experiment for deletion HDAC4 
deletion 6 using a Da-Gal4 universal driver was attempted. The deletion stocks are 
maintained over FM7 balancers due to the lethality of the mutated X chromosome, 
which means that the deletion is transmitted from generation to generation in 
females, but not in males (all males in the stable line have FM7). If overexpressing 
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HDAC4 rescues the deficiency, then it would be possible for males with the mutated 
X chromosome to survive. The characteristic of males containing the FM7 balancer 
is the presence of Bar eyes. The presence of males having wild-type eyes was 
therefore used to screen for males with a successfully rescued deletion (Figure 5.11).  
The rescue experiment performed was not successful since no wild-type eyed males 
were observed. Only bar eyed progeny, both male and females resulted from the final 
cross. The strength of the DaGal4 driver can influence the outcome of the rescue 
experiment, therefore the use of another ubiquitous driver is advisable before it can 
be concluded whether this X chromosome is lethal due to HDAC4 deficiency or for 
other reasons. 
However, it was possible to obtain viable males with the mutated HDAC4 deletion 6 
chromosome by crossing the heterozygous null mutants females with a line 
containing an insertion of the deleted region of the X-chromosome on another 
chromosome (Figure 5.12). However, because the insertion does not exclusively 
contain the deleted region, but also neighbouring regions, it is not possible to finally 
conclude that the lethality phenotype is due only to the HDAC4 gene deletion. 
5.2.7 Muscle phenotype analysis for the potential HDAC4 null mutants 
To test whether the deletion of HDAC4 disrupts muscle development, homozygous 
HDAC4 deletion embryos were screened for muscle-related phenotypes. The types 
of muscles analysed included: somatic, visceral, heart and pharyngeal. Any 
difference in muscle pattern formation was determined by qualitative phenotypic 
comparison with wild-type embryos. All embryos analysed are homozygous for the 
deletion as indicated by absence of the ftz-lacZ element indicative of the FM7 
balancer. Both deletion mutants showed no disruptions in the somatic muscle pattern 
(Figure 5.13). All the other types of muscle tissue did not show any defects.  
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Figure 5.10: Hatching and survival assay of potential HDAC4 null mutants 
The HDAC4 deletion lines were balanced over a fluorescent balancer chromosome to 
allow screening for homozygous null embryos. Embryos collected from each line 
were counted and allowed to develop. Once the cultures reached each of the given 
stages, the remaining surviving individuals were counted. The hatching and survival 
assay performed on homozygous mutants of the two potential null mutants showed 
that both lines die at pupal level. Only 35% for the HDAC4 del 48 and 42% for the 
HDAC4 del6 reach this developmental stage. None of the homozygous flies develop 
to adulthood. 
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Figure 5.11: Genetic scheme of attempted rescue experiment of HDAC4 del6 
using a UAS-HDAC4 construct and a DaGal4 driver 
All the crosses, including the overexpression experiment were performed at 25°C. 
  
1a) V♀ HDAC del6/FM7 ftz lacZ x ♂ FM6/Y;; TM3 Ser/Sb  
Select v ♀ HDAC del6/FM6;;TM3 Ser/+  
1b) V♀ wl/FM6;;TM3Ser/Sb x ♂ w/Y;;DaGal4/DaGal4  
Select ♂ FM6/Y;;Dagal4/Sb  
2a) v ♀ HDAC del6/FM6;;TM3 Ser/+ x ♂ FM6/Y;;Dagal4/Sb  
Select v ♀ HDACdel6/FM6;; DaGal4/TM3Ser  
2b) V♀ wl/FM7grhlacZ; sco/CyO x ♂ w/Y; UASHDAC4/ UASHDAC4; 
TM3/TM6  
Select ♂ FM7 grhlacZ; UASHDAC4/sco; TM3/+ or TM6/+  
3) v ♀ HDACdel6/FM6;; DaGal4/TM3Ser x ♂ FM7 grhlacZ; UASHDAC4/sco; 
TM3/+ or TM6/+  
If rescue worked: ♂ HDACdel6/Y;UASHDAC4/+;DaGal4/+ or TM3 or TM6  
(i.e. if there are males with wildtype eyes the rescue worked)  
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Figure 5.12: Rescue of HDAC null mutants by genomic duplications of the X 
chromosome 
A) HDAC4 locus and regions replicated by the duplications Dp(1;3)DC266 and 
Dp(1;3)DC267, lines available commercially. 
B) Number of surviving HDAC4 null hemizygous males compared to males with 
hemizygous balancer. Duplication of each region of X on the third chromsome.  
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Figure 5.13: Muscle phenotype in HDAC deletion mutants 
Immunostain against β3-Tubulin in late-stage embryos. Genotype of the embryos as 
indicated in each column. The embryos with HDAC4 deletions were screened 
against ftz-lacZ for homozygosity. 
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5.3 Discussion 
5.3.1 HDAC4 is expressed in an unspecific pattern in Drosophila embryos and 
does not localise to the nucleus of muscle precursors 
The HDAC4 protein was discovered in the 11-13MEF sample as a possible interactor 
of Mef2. The interaction of class IIa HDACs with Mef2 in vertebrates has been 
widely studied, including in myogenesis, however little is known by the interaction 
of Mef2 with HDAC4 in Drosophila embryos. Class IIa HDACs are a class of 
HDAC isoform that shuttle between the nucleus and the cytoplasm. In vertebrates, 
they are specifically expressed in certain tissues like muscle, heart, brain or neurons, 
unlike other classes of HDACs. In mammalian cells there are four class IIa HDACs: 
HDAC4, 5, 7 and 9. In their nuclear roles these proteins have a repressive role and 
are involved in some developmental and differentiation processes. HDAC4 regulates 
chondrocyte hypertrophy, skeletal development and neural death (Vega et al., 2004; 
Bolger & Yao, 2005). HDAC7 is involved in regulation of T-cell development and 
vascular integrity (Kasler & Verdin, 2007; Bolden, Peart & Johnstone, 2006). The 
last two class IIa HDACs are responsible in cardiac hypertrophy (Zhang et al., 2002). 
It was therefore surprising to find that HDAC4 in Drosophila embryos did not show 
specificity to any particular tissue. Furthermore, we found no colocalisation between 
Mef2 and HDAC4. Although HDAC4 seems to be expressed throughout the embryo, 
it was not present in the nucleus in any muscle-related cells at any stage of 
embryogenesis. Unless the activity of HDAC4 in muscle cells can be confirmed 
through other assays, the interaction between Mef2 and the class IIa HDAC4 in the 
Drosophila muscle remains elusive. The presence of Drosophila class IIa HDAC in 
both nucleus and cytoplasm has only been confirmed in S2 cells (Foglietti et al., 
2006), and Drosophila adult neurons (Fitzsimons et al., 2013). In its subcellular 
localisation, dHDAC4 therefore seems more similar to hHDAC4, which was also 
distributed in the cytoplasm in cultured cells but could be shuttled into the nucleus by 
Mef2 (Borghi et al., 2001). 
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5.3.2 Drosophila HDAC4 is able to repress myogenesis in embryos 
Nucleocytoplasmic shuttling is an important mechanism to regulate the activity of 
class IIa HDACs in mammals. When present in the nucleus these enzymes are able to 
repress transcription by interacting with nonhistone targets and not by performing a 
deacetylation function. The intracellular localisation of the class IIa HDACs seems to 
be dependent on signalling cues and upon being phosphorylated they are excluded to 
the cytoplasm (Bertos et al., 2004; Khochbin et al., 2001; McKinsey et al., 2001, 
2002b). The default intracellular localisation of HDAC5 and HDAC7 is nuclear in 
proliferating myoblasts and upon differentiation they are transferred to the cytoplasm 
(Dressel et al., 2001; McKinsey et al., 2000). HDAC4 on the other hand is 
cytoplasmic in undifferentiated myotubes and when fusion has occurred it is 
translocated to the nucleus of C2C12 cells. In myotubes HDAC4 is found both in the 
cytoplasm and the nucleus c.  When present in the nucleus HDAC4 can change the 
pan-nuclear pattern of Mef2 into distinct clusters of nuclear bodies, a characteristics 
that is found in other class IIa HDACs like HDAC5 and -7 (Downes et al., 2000). 
HDAC4 can be actively and rapidly transported outside of the nucleus and it seems 
that the number of Mef2 molecules present in the nucleus could act as the limiting 
factor that stops HDAC4 translocation into the cytoplasm (Chan et al., 2003). 
DHDAC4 is mainly cytoplasmic throughout the Drosophila developing embryonic 
stage. A similar pattern was observed in neurons of Drosophila adult brains when 
dHDAC4 was overexpressed and its nuclear localisation was noted in only a subset 
of neuronal nuclei. A punctate redistribution of Mef2 localisation pattern in the 
nuclei of certain subsets of neurons when dHDAC4 was overexpressed was also 
detected (Fitzsimons et al., 2013). DHDAC4 is also expressed in the Drosophila 
larval fat body and its intracellular localisation is regulated by dietary status. Upon 
fasting dHDAC4 is shuttled into the nucleus, while under feeding conditions 
dHDAC4 is phosphorylated by SIK3 and translocates to the cytoplasm (Wang et al., 
2011). All these data from Drosophila seem to express that the dHDAC4 is 
responsive to the same regulatory mechanisms identified for class IIa HDACs in 
mammalian cell culture. The line we used to study the colocalisation of Mef2 with 
dHDAC4 in the embryo expressed dHDAC4 at physiological levels, aspect which 
could impact the ability to identify nuclear expression of dHDAC4 if the levels are 
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under the detection limit of the confocal microscope. Considering that dHDAC4 
seems to be mainly cytoplasmic and its nucleus import occurs under very specific 
conditions, and due to sequence similarity, we postulate that dHDAC4 is regulated 
by similar mechanisms that control the activity of the mammalian HDAC4.    
When overexpressed in the embryo, dHDAC4 was able to impact the development of 
somatic musculature and the expression of B3-tubulin, a gene that is both a Mef2 
target and that expresses a structural protein that can be used as a marker for staining 
the muscle pattern in Drosophila embryos (Damm et al., 1998). The direct 
interaction between Mef2 and dHDAC4 was also identified in our pull down study 
from Drosophila embryos where Mef2 acted as the bait. Taken together, we can 
hypothesise that the two proteins are able to interact in the nuclei of muscle cells to 
repress the expression of certain Mef2 target genes. Mammalian HDAC4 was shown 
to specifically modulate the activation of structural and contractile genes that are 
expressed in a Mef2-dependent manner in muscle (Cohen et al., 2009). The 
expression of B3-tubulin in muscle was downregulated when dHDAC4 was 
overexpressed in Drosophila muscle. This experiment seems to highlight that the 
group of structural proteins activated by Mef2 can have their expression repressed by 
dHDAC4. The larval musculature fails to form properly when dHDAC4 is 
overexpressed, therefore it seems dHDAC4 is able to affect muscle integrity. 
Nucleoplasmic shuttling is an important mechanism to regulate dHDAC4 activity in 
Drosophila. The predominant cytoplasmic localisation of dHDAC4 could be related 
to a rapid translocation of the protein from the nucleus. This could be the reason why 
the effects of the full length dHDAC4 overexpression is less penetrant compared to 
the forms of dHDAC4 that cannot be exported from the nucleus. Additionally, the 
effects of dHDAC4 overexpression worsen as the development process gets further 
along. This aspect emphasises that there needs to be a balance of input from 
dHDAC4 throughout the muscle development process, most probably highly 
dependent on signalling cues.     
The two modified versions of dHDAC4 cannot be shuttled out of the nucleus and 
have a stronger ability to repress Mef2 activity and muscle development. This effect 
is visible early in muscle development since expression of Mef2 genes seems to be 
impacted starting from the myoblast stage. The absence of the HDAC catalytic 
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domain does not seem to impact the ability of dHDAC4 to repress transcription 
during myogenesis. The four Class IIa HDACs from vertebrates also present an N-
terminal domain that is able to repress Mef2 mediated transcription. Mammalian 
HDAC4 was also shown to repress expression of structural proteins even when 
overexpressing a form that lacks the phosphorylation prone serine residues required 
for nuclear translocation or a deacetylase defective form of the protein (Cohen et al., 
2009). 
The overexpression of the human HDAC5 protein in the Drosophila embryo seems 
to have some limited effects in Drosophila myogenesis. The consequences are 
visible in later stages of development, not from the onset of myogenesis. The limited 
penetrance could be given by the fact that the hHDAC5 and dHDAC4 are not as 
similar and the affinity of Drosophila Mef2 is reduced for this mammalian class IIa 
HDAC. When looking at the overexpression experiments of the three variants of 
hHDAC5 in Drosophila embryos, only the hHDAC5ΔC overexpression had any 
effect on transcriptional regulation of B3-tubulin. Considering that both hHDAC5ΔC 
and hHDAC5SA should be mainly nuclear, a repression phenotype would be more 
likely for the two variants compared to the case of overexpressing the full length 
protein. The lack of a repression phenotype on transcription observable in stage 12 
embryos for the phosphorylation defective hHDAC5 could be due to the fact that 
hHDACSA has a reduced binding affinity, closely comparable to the one of full 
length hHDAC5, but lower when compared to hHDAC5ΔC. The effects of 
overexpressing hHDAC5 and all its variants are mainly observable in late stage 
myogenesis. The mainly nuclear variants have a stronger capacity in inducing muscle 
damage compared to the full length protein. The defects observed so late in 
development could be due to the fact that the dHDAC4 levels present in the nucleus 
need to be tightly regulated throughout the development process and the constant 
increased levels surpass the capacity of compensatory mechanisms available. Overall 
the effects of overexpressing the human HDAC5 in Drosophila embryos is reduced 
compared to the overexpression of the Drosophila version itself. The degree of 
effects oberved could be a consequence of affinity binding differences between 
hHDAC5 and dHADC5 and/or due to the fact that human HDAC4 is a more 
appropriate orthologue for the Drosophila HDAC4. 
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Similarly to other class II a HDACs, dHDAC4 was found capable of repressing 
myogenesis in Drosophila embryos. The overexpression of constitutively active 
versions of dHDAC4 showed that it can repress Mef2 target genes even in absence of 
its HDAC domain. This behaviour is thus conserved with vertebrate class IIa 
HDACs, in which a tyrosine residue in the catalytic site is exchanged to histidine, 
reducing the deacetylase activity to close to none. Instead, class IIa HDACs function 
as corepressors of transcription factors in mammals (Fischle et al., 2002). The 
overexpressions have also shown that shuttling the protein out of the nucleus is 
necessary to allow muscle differentiation. Considering this ability to repress muscle 
development, dHDAC4 could function like hHDAC4 in cell culture in that Mef2 can 
stop its shuttling outside of the nucleus (Fischle et al., 2002). Another alternative 
could be this suggests that muscle precursors have a regulatory mechanism excluding 
dHDAC4 from the nucleus to prevent it from disrupting myogenesis. If this was the 
case, a cytoplasmic localisation as found here would be expected. 
5.3.3 HDAC4 null mutants are lethal but have a normal muscle phenotype 
After establishing that overexpression of HDAC4 has negative effects on embryonic 
myogenesis, we postulated that decreasing the amount of HDAC4 would release the 
constraint on the muscle tissue and potentially result in excessive muscle growth. 
However, mutants which do not express a functional HDAC4 showed wild-type 
muscle patterns. This suggests that suggests that wild-type levels of HDAC4 are 
required for normal formation of muscles and that the loss of this protein either is 
compensated by other regulatory mechanism or by the presence of maternally 
deposited HDAC4. The maternal contribution could be addressed by generating 
germline clones and studying gene expression of Mef2 target genes in such mutants. 
Despite the absence of a muscle phenotype, HDAC4 null mutants were not viable. It 
is not possible to assess why the null mutants do not reach adulthood. It is known 
that embryos that do not form a muscle pattern are unable to hatch. However, the 
muscle pattern was normal in these embryos and can therefore be excluded as a 
cause for lethality. These data also contradict a previous suggestion that HDAC4 is 
involved in patterning the segments of the embryo (Zeremski et al., 2002). Taking 
into consideration the broad expression in the embryo and the lack of myogenesis 
defects it seems that HDAC4 might impact another tissue.   
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Chapter 6: General discussion 
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6.1 The main findings of the work 
The work presented here explored types of Mef2 interacting proteins in the 
development of muscles in Drosophila melanogaster embryos. The central aim of 
my work was to conduct a large scale purification screen across embryonic 
development to identify Mef2 interacting proteins in a high throughput manner. This 
led to a three-part structure of my work. The first part was an exploratory Mef2 
protein purification study under different conditions, which established the ground 
work for systematic extraction of Mef2 interacting proteins from Drosophila 
embryos and thereby enabled the appropriate investigation of the results of the 
screen. The second step was the analysis of the candidate lists based on 
computational approaches and literature data available and the validation of its 
results. The third part was the investigation of the function of HDAC4 in 
myogenesis, a candidate identified in the screen as potentially unique among Mef2 
interacting proteins. 
This work presents the first comprehensive study of Mef2 interacting proteins in 
Drosophila embryos, taking into account the expression of the bait protein under 
physiological conditions, and attempting to compile a complete list of candidates 
both from tigthly staged embryos and a sample covering all developmental stages. 
The initial analysis (described in chapter 3) mainly answered the question: 1) Can we 
extract Mef2 interacting proteins from Drosophila embryos, if the bait is expressed at 
"normal" levels? The answer was affirmative, extraction of candidates being possible 
both from late-staged embryos and an “average” sample that spanned all 
developmental stages. These lists of proteins pulled down with Mef2 had both 
overlapping and unique hits. 
The second question considered: 2) How to analyse lists of candidate proteins 
generated via a purification study to better understand the Mef2 interactome? Two 
approaches were adopted to answer this question: a) a narrowing down of a candidate 
list extracted from staged embryos based on spectral counts, the use of genome wide 
datasets to explore links between them and to extract an interesting candidate for 
further biological testing; b) a general approach where the obtained Mef2 
interactome particularities are explored. Both approaches proved valuable in 
understanding which candidates have interesting biological functions as it relates to 
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Mef2. Approach (a) highlighted two intersting candidates (HDAC4 and Brahma) 
found in the nucleus that potentially modulate with Mef2 target gene activation. 
Additionally it was found that Mef2 is able to interact with certain proteins that are 
reported as cytoplasmic, while literature categorises Mef2 as only nuclear. Mef2 is 
able to create protein interactions not only with muscle structural proteins, but also 
ribosomal proteins and  proteasomal complexes (as shown by approach b). 
Lastly, I characterised the function of HDAC4 in muscles, since this was an 
interesting candidate found to directly interact with Mef2 and that seemed not to be 
part of a bigger protein complex. By conducting overexpression experiments, I was 
able to show that HDAC4 functions in muscles and its mis-expression can affect 
muscle differentiation and gene activation. Of particular interest could be that despite 
being reported to shuttle between nucleus and cytoplasm, HDAC4 was mainly 
cytoplasmic in Drosophila embryos throughout development. 
 217 
 
 
Figure 6.1: Graphical abstract 
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6.2 The role of large scale purification methods in studying protein 
interactions  
The potential functions that a protein can carry out are defined by its ability to 
interact physically with other molecules in the cell, including ions, metabolites, 
lipids, RNA, DNA and other proteins. Proteomics has become a widely-used 
technique to identify and analyse proteins at large scale. Traditional yeast two-hybrid 
studies have addressed similar questions by testing thousands of binary protein-
protein interactions and constructing "interactome" maps by connecting proteins 
based on positive interactions in the yeast two-hybrid setup (Giot et al., 2003; 
Stanyon et al., 2004). In the last two decades, the use of co-affinity purification has 
been increasing, whereby protein extracts are generated that contain a mixture of 
proteins "pulled down" by transgenically expressing a tagged version of a protein of 
interest ("bait"). The tag is then used for purification, and proteins interacting with 
the protein in the desired biological context ("prey") are co-purified with the bait. 
Proteins contained in the mixture can be identified with high sensitivity but low 
throughput using for example Western blot, or with low sensitivity but high 
throughput using mass spectrometry (MS). In contrast to the yeast two-hybrid 
method, this allows screening 1-to-n interactions rather than testing one binary 
interaction at a time. Consequently, datasets from such studies tend to be very large, 
providing a wealth of information on protein-protein interactions that was 
unobtainable previously. Two hallmark studies that were also integrated in the 
present analysis produced large interaction networks for, respectively, most proteins 
of the Drosophila melanogaster proteome (Guruharsha et al., 2011), or specifically 
for 459 Drosophila transcription factors (Rhee et al., 2014). Inevitably, some quality 
must be sacrified in exchange for quantity. In the case of both of these studies, the 
data were obtained from S2R+ cell cultures, meaning that the data on protein-protein 
interactions obtained are not contextualised with development and different tissue 
types. However, as more datasets become available, our confidence in individual 
associations will improve, and it is through such large-scale studies that predicting 
the protein interaction networks of new proteins of interest will become more 
reliable. Candidates of interest extracted from this data must nevertheless be 
validated individually before conclusions about their functions can be drawn. 
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The successful application of TAP experiments is very specific to the type of 
biological materials used and many tag variants have been optimised for a particular 
system. Such type of purification experiments could be applied at organism level in 
single cell organisms like yeast (where the method was initially developed) and 
bacteria and lower level multicellular model systems like Drosophila and C. elegans 
(Kyriakakis et al., 2008; Pepper et al., 2012; Puig et al., 2001; Rigaut et al., 1999; 
Veraksa et al., 2005; Viala and Bouveret, 2017; Zanin et al., 2011). In mammals, 
only cell culture TAP purifications were performed and different types of tags were 
developed to try to optimise the recovery of native complexes (Bürckstümmer et al., 
2006; Ma et al., 2012). The original TAP tag consisted of protein A and calmodulin-
binding peptide (CBP) moeities (Puig et al., 2001; Rigaut et al., 1999). A later 
version used FLAG and HA peptide tags for sequential immuno-affinity purification 
(Nakatani and Ogryzko, 2003). The GSTAP system used here is a combination of 
two protein G domains, together with a streptavidin binding peptide (SBP) 
(Kyriakakis et al., 2008), while the BIOTAP system has a Protein A moiety (Rigaut 
et al., 1999) and a biotinylation targeting signal consisting of a 75-amino acid 
sequence derived from a P. shermanii transcarboxylase (Alekseyenko et al., 2015; 
Guerrero et al., 2005). Another variant called the LAP tag contains GFP (or 
mCherry) and S peptide and was used successfully in C. elegans (Zanin et al, 2011). 
Despite the different tags available, the principles of the purification protocol remain 
similar: biological material is lysed to generate whole extracts or cytoplasmic or 
nuclear extracts, protein native complexes are extracted via two subsequent affinity 
purification steps and the eluted proteins are analysed most commonly by MS. 
Generally these experiments can generate quite a long list of candidate proteins that 
need to be screened via computation means to extract the best hits. 
In this study we were able to extract Mef2 interacting proteins from Drosophila 
embryos using a TAP purification protocol. The idea of tagging Mef2 with TAP for 
purification has been successfully applied in mammalian cell culture as well, where a 
TAP-tagged Mef2a was used to co-purify with Mef2c and to concentrate the low 
expressing Mef2a in COS7 and HeLa cell in order to allow determining its 
phosphorylation states via Mass Spectrometry (Aridgides et al., 2002; Cox et al., 
2003). 
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6.3 Highlighting important biological processes from complex data using 
bioinformatic analyses 
Such large amounts of data require computational methods to extract meaning from 
them. A major problem in the field of proteomics studies as of yet is standardisation, 
both in technical aspects, and in the analysis of obtained data. The experimental 
methods for purifying proteins vary substantially between studies because they 
inevitably have to be adjusted to each specific scientific question. As illustrated in 
chapter 3, a variety of affinity tags have been developed just for tandem affinity 
purification (TAP) and there are many more variants of purification tags for different 
protocols depending on the biological context. Recent efforts to make proteomics 
more robust have included quantitative proteomics (Schubert et al., 2017) whereby 
amino acids labelled with stable isotopes are incorporated into the proteins analysed 
by MS, as well as some statistical approaches (Aggarwal and Yadav, 2016). 
However, there is no standard set of methods used to analyse proteomic datasets and 
consequently few studies analyse their data using similar techniques. 
The use of proteomics in this study represents a comparably small-scale application, 
focussing much effort on optimising the purification of a single bait. It is 
commonplace at this level for studies to not perform an in-depth analysis but instead 
to discard all but a small number of the most abundant proteins identified by MS. 
The remaining proteins are then manually curated and candidates are selected for 
further experiments based on literature context. The data obtained from TAP extracts 
for Mef2 lent itself to a more in-depth analysis because the TAP procedure maintains 
physiological conditions and thus preserves protein complexes beyond direct 
physical bait-prey interactions. The subsequent data analysis used several methods 
that were previously described in different published studies. The largest part of the 
analysis followed a similar pipeline as the ParkinTAP project (Zanon et al., 2013). In 
this study, a similar procedure of network analysis was used to correlate proteins 
purified using Parkin as bait with databases of known proteins related to 
parkinsonism. To analyse the Mef2 datasets, the procedures had to be adapted for the 
Drosophila model system, and suitable databases had to be identified. The results 
showed that both the datasets derived from unstaged (overnight-collected) and staged 
(11-13 h) Drosophila embryos likely contained few genuine contaminants, since the 
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vast majority of proteins had known associations with Mef2 and a functional 
comparison showed that the vast majority of proteins in the datasets cluster around 
Mef2 when their annotation with gene ontology (GO) terms is taken into account. It 
should therefore be interesting for future research to determine the biological 
relationship between Mef2 and each of the identified interaction candidates. 
Similar methods of analysis have been used in two TAP studies targeting other TFs, 
with the specific aim of distinguishing proteins that TFs interact with while bound to 
chromatin, and while not bound to chromatin. The first, a study of 56 human TFs in 
HEK293T cells (mostly Forkhead box TFs but also including Mef2a), showed that 
TFs interact with diverse complexes on and off chromatin (Li et al., 2015). The "off 
chromatin" fraction in this study should be methodologically equivalent to the 
cytosolic fraction used here, while the "on chromatin" fraction, the pellet, was not 
used in our case. The complexes found in the solubilised fractions of TFs were 
significantly different than the chromatin bound complexes obtained from protein 
complexes pulled down from the pelleted fractions. The soluble fractions did not 
only contain proteins released from the chromatin, rather also proteins that interact 
with TFs independently of DNA binding. While the “on chromatin” section enriched 
for transcription related proteins, the soluble fractions enriched for kinases, peptidase 
and transmembrane proteins. Many of the analysed TFs were classified mainly 
nuclear via immunohistochemistry, like Mef2, but they were detected both in the 
soluble fraction and the chromatin fractions. A similar behaviour was observed in the 
case of Mef2a and many of the proteins purified together with Mef2a from soluble 
fractions were involved in post-translational regulation and trafficking. This could 
imply that the Mef2 purification experiments performed here potentially enriched for 
complexes that have functions in post-translational regulation, rather than 
transcriptional modulation, which would explain why we did not pull down any of 
the TFs with which Mef2 is known to physically interact in Drosophila, like 
Vestigial, Scalloped or Twist. Another explanation for this could also be that TAP is 
a relatively conservative pulldown method that tends to identify only a fraction of the 
full interactome (Liu et al., 2004). However, there were transcription associated 
complexes found both in on chromatin and off chromatin (soluble) purified fractions, 
explaining why it was possible to identify transcriptional modulators among the 
candidates of Mef2 interacting proteins extracted from solubilised fractions.   
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The second study focussed on MyoD as the bait, a basic helix-loop-helix (bHLH) TF 
known to induce muscle differentiation together with Mef2 in vertebrates 
(Boyarchuk et al., 2016). The interactions of this protein were studied in HeLa cells 
via TAP purification of a Flag-HA tagged MyoD, in this case specifically in nuclear 
soluble and chromatin bound fractions. The MyoD partners found included TFs and 
co-repressors, the SWI/SNF complex and other chromatin remodellers, RNA 
processing factors, kinases, histones, histone chaperones, protein trafficking factors 
and DNA replication factors. Any ribosomal proteins, translation-initiation factors, 
DNA repair factors and the tubulin isoforms were directly regarded as contaminants 
and excluded. Several of these protein groups were present both on and off 
chromatin, though every group had unique members only found in one fraction. In 
follow-up experiments, MyoD was found to interact in muscle cells with proteins 
that functionally act as TFs, transcription co-repressors and SWI/SNF complexes 
when considering the chromatin bound partners. The interacting partners retrieved 
from the soluble fraction included TFs, chromatin remodelers, transcription co-
repressors, SWI/SNF complexes and RNA processing factors. Our study identifying 
Mef2 partners in Drosophila muscle recovered many proteins of the same groups: 
transcription factors, SWI/SNF subunits, transcriptional regulators, transcription co-
repressors, but also ribosomal proteins, translation-initiation factors, actin and 
tubulin isoforms and several heat shock proteins. Many of the protein belonging to 
the last 5 categories would be considered contaminants. However, Mef2 has been 
shown to interact with proteins like heat shock proteins in different contexts (Wang 
et al., 2019; Yang et al., 2009; Zhang et al., 2014). Additionally, Mef2c directly 
binds to the MyoD-E12 heterodimer and activates transcription necessary for 
myogenesis to occur (Molkentin and Olson, 1996). However, no Mef2 isoform was 
pulled down with MyoD  in the TAP purification, despite the fact that the Brg1 
subunit known to mediate the interaction between MRFs and Mef2s was recovered 
(Ohkawa et al., 2006). 
The candidates extracted via TAP purification of Mef2 in Drosophila embryos were 
derived from a non-chromatin bound fraction. Given published results, this could 
have biased the candidates towards post-translational regulation, rather than 
transcriptional regulation. However, this does not mean that proteins involved in 
modulation of transcription cannot be found in the soluble fraction. Most of the 
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MyoD interaction partners belonged to similar types of complexes both when 
looking at the chromatin bound sample or the soluble fraction. Given the technical 
challenges, involving additional optimisations, and potential risk for other 
contaminants in the pellet, the soluble fraction was thus the best way to get an 
overview of the types of complexes a certain transcription factors comes in contact 
with. 
6.4 Biological validation of candidates identified from purification data  
We selected one candidate of the dataset that appeared interesting based on its 
functional association with muscle-related proteins and its known association with 
muscle in other organisms. HDAC4 was indeed able to repress muscle development 
when a mutant variant was overexpressed that was lacking the nuclear export 
sequence and would thus localise to the nucleus constitutively. However, in the 
reverse experiment where we deleted the hdac4 gene, we found no muscle-associated 
phenotype in HDAC4 null embryos. This could be simply due to redundancy and 
therefore compensation by another regulatory mechanism, or due to rescue by 
maternally deposited HDAC4. If neither of these were the case, this could suggest 
that HDAC4 represses other cell types, potentially non-muscle cells, from activating 
muscle-specific transcription. The broad expression pattern of hdac4 mRNA and 
HDAC4 protein would allow for such a function. The fact that HDAC4 is found to 
bind Mef2 in late myogenesis, suggests that its role goes beyond the known function 
in vertebrates of impeding muscle differentiation by interfering with the fusion 
process (Miska et al., 2001). The fly HDAC4 seems to closely mimic the activity of 
the mammalian HDAC4, therefore a role for HDAC4 in the maintenance and/or 
modulation of fibre type-specific gene transcription could also be present in 
Drosophila (Cohen et al., 2015). 
These experiments can serve as a proof-of-concept that larger-scale studies and 
careful computational analysis can indicate promising avenues of further research. 
We attempted to use Drosophila embryos as an in vivo model for acquiring 
candidates specific to a developmental process, which was in principle successful. 
However, this work also required significant investments. 
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The TAP purification screen has proven to be able to create a full picture of the kind 
of proteins Mef2 interacts with. The array of functions discovered has shown that 
Mef2 is involved in many different functions but that are very much interconnected. 
The reliability of these functions is supported both by the facts that most of the 
identified candidates were well characterised and that many of them were purified 
together with Mef2 under very different conditions.  
The coherence of the data proven through in silico assessment leads us to believe that 
using TAP purification to understand the way a protein performs its activity at a 
proteomics level is a productive approach. TAP screens in themselves are quite time 
intensive and require a significant input of biological material to obtain valuable 
results. The ability to validate such results through computational approaches is a 
quicker and more systematic way than to perform genetic screens. The methodology 
described in this study could serve as a pipeline to confirm the most reliable 
candidates that can be further used for in vivo validation. One important aspect of the 
analysed samples was to highlight that just disregarding the unspecific binders pulled 
down in the control can bias the results. Mef2 shows to play an important role in 
metabolism and proteolysis, some of the proteins being classified as contaminants in 
other studies. 
6.5 Conclusions and Perspective 
In this work, we focussed on the characterisation of Mef2 partners in Drosophila 
embryos, partially because all known regulation mechanisms related to Mef2 activity 
primarily relate to activation of target genes and only as a secondary consequence to 
how the Mef2 protein dynamics are kept in check during development. Prior to the 
advent of proteomics, performing large scale protein purification studies was 
challenging, because generating the required biological input material was difficult 
and the analytical methods available did not allow for high throughput results. In 
many prior studies, interactions between two proteins were assessed in small scale 
studies or in yeast two hybrid test. While in many tissues the key players were 
discovered by genetic studies, a systematic interactome approach is required to 
understand which proteins are associated with different molecular functions in order 
to achieve cell differentiation. My work thus provides a valuable reference of Mef2 
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interacting proteins that should enrich our understanding of how Mef2 acts in 
muscle, and allows future work on muscle development to proceed with clearer 
directions.  
The main part of my thesis comprises a large scale screen of Mef2 interacting 
proteins, executed using a tandem affinity purification approach that has proven in 
many studies to provide substantial benefits over other types of extraction methods. 
By knocking-in the GS-TAP tag, Mef2 was made compatible for extraction 
experiments at physiological conditions. This approach, combined with 
computational analytical methods, revealed a number of protein complexes that 
modulate Mef2 activity in muscle. It further implicated Mef2 in regulatory 
mechanisms that involve direct interactions with many of its target gene products 
that are involved in muscle structure. Of particular interest could be Actin57B and 
WupA, neither of which have been characterised previously as shuttling to the 
nucleus in muscle cells. Of interest would be to study in more detail if these genes 
translocate to the nucleus to perform “moonlight functions”. 
Lastly, I characterised the function of HDAC4 in Drosophila embryos, since this was 
one of two candidates whose presence in fully differentiated myotubes could imply a 
role in transcriptional regulation through direct binding to Mef2 and its role in late 
embryogenesis has not been studied. By conducting mis-expression experiments, I 
was able to show that HDAC4 functions in muscle cells and can affect muscle 
specific transcription. Mef2 protein levels are not impacted when HDAC4 is 
overexpressed, but activation of its target genes and muscle differentiation are 
impacted. Therefore, direct binding of HDAC4 to repress Mef2 activity in muscle is 
plausible. It will be interesting in the future to identify if HDAC4 colocalises with 
Mef2 in nuclear bodies of muscle cells as observed in neurons and if there is a direct 
functional link between HDAC4, the Brahma complex and Mef2 in regulation of 
muscle maintainance in differentiated myotubes. 
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